| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.826 | 0.004 | 0.868 | Tumour necrosis factor alpha release inhibitor | 0.856 0.004 DBMET00033 0.423 0.023 DBMET00035 0.763 0.004 DBMET03456 0.868 0.004 DBMET03457 0.768 0.004 DBMET03458 0.429 0.022 DBMET01115 0.508 0.013 DBMET01116 0.243 0.078 DBMET01118 0.778 0.004 DBMET00034 0.83 0.004 DBMET03444 0.538 0.011 DBMET01117 0.372 0.032 DBMET03446 0.799 0.004 DBMET01114 | DBMET03457 | |
| 0.758 | 0.005 | 0.798 | Immunomodulator | 0.576 0.014 DBMET00033 0.374 0.052 DBMET00035 0.708 0.005 DBMET03456 0.669 0.006 DBMET03457 0.683 0.006 DBMET03458 0.243 0.121 DBMET01115 0.205 0.159 DBMET01116 0.41 0.041 DBMET01118 0.659 0.007 DBMET00034 0.494 0.024 DBMET03444 0.337 0.064 DBMET01119 0.373 0.052 DBMET01120 0.798 0.005 DBMET03446 0.685 0.006 DBMET01114 0.369 0.053 DBMET01121 0.601 0.011 DB03091 0.589 0.012 DB00130 0.631 0.009 DB00142 | DBMET03446 | |
| 0.606 | 0.003 | 0.606 | Interleukin 2 agonist | 0.512 0.007 DBMET00033 0.39 0.03 DBMET00035 0.58 0.004 DBMET03456 0.386 0.032 DBMET03457 0.553 0.004 DBMET03458 0.389 0.031 DBMET01115 0.327 0.057 DBMET01116 0.379 0.034 DBMET01118 0.573 0.004 DBMET00034 0.494 0.009 DBMET03444 0.383 0.033 DBMET01117 0.41 0.024 DBMET01119 0.408 0.025 DBMET01120 0.322 0.06 DB02746 0.488 0.009 DBMET03446 0.581 0.004 DBMET01114 0.454 0.015 DBMET01121 0.597 0.004 DB03091 0.499 0.008 DB00130 0.575 0.004 DB00142 | ||
| 0.575 | 0.005 | 0.735 | Interleukin agonist | 0.445 0.013 DBMET00033 0.269 0.066 DBMET00035 0.735 0.003 DBMET03456 0.568 0.005 DBMET03457 0.512 0.008 DBMET03458 0.467 0.011 DBMET01115 0.465 0.011 DBMET01116 0.678 0.004 DBMET01118 0.553 0.006 DBMET00034 0.405 0.018 DBMET03444 0.412 0.017 DBMET01117 0.699 0.003 DBMET01119 0.722 0.003 DBMET01120 0.453 0.013 DB02746 0.462 0.012 DBMET03446 0.586 0.005 DBMET01114 0.659 0.004 DBMET01121 0.654 0.004 DB03091 0.668 0.004 DB00130 0.626 0.004 DB00142 | DBMET03456 | |
| 0.518 | 0.026 | 0.579 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.402 0.099 DBMET00033 0.306 0.204 DBMET00035 0.394 0.106 DBMET03457 0.386 0.114 DBMET03458 0.342 0.16 DBMET01115 0.342 0.16 DBMET01116 0.568 0.012 DBMET01118 0.382 0.117 DBMET00034 0.299 0.214 DBMET03444 0.343 0.158 DBMET01117 0.337 0.166 DBMET01119 0.337 0.166 DBMET01120 0.579 0.01 DB02746 0.514 0.028 DBMET03446 0.382 0.117 DBMET01114 0.341 0.161 DBMET01121 0.328 0.176 DB03091 0.328 0.176 DB00130 0.321 0.186 DB00142 | DB02746 | |
| 0.486 | 0.004 | 0.486 | Cytokine production inhibitor | 0.168 0.05 DBMET00033 0.14 0.07 DBMET03456 0.468 0.005 DBMET03458 0.139 0.071 DBMET01118 0.429 0.005 DBMET00034 0.16 0.055 DBMET03444 0.176 0.046 DBMET03446 0.424 0.005 DBMET01114 | ||
| 0.487 | 0.033 | 0.618 | Calcium channel L-type activator | 0.244 0.212 DBMET00033 0.231 0.228 DBMET00035 0.313 0.146 DBMET03456 0.475 0.038 DBMET03458 0.231 0.228 DBMET01115 0.231 0.228 DBMET01116 0.602 0.005 DBMET01118 0.501 0.027 DBMET00034 0.301 0.157 DBMET03444 0.253 0.202 DBMET01119 0.253 0.202 DBMET01120 0.542 0.015 DB02746 0.618 0.005 DBMET03446 0.47 0.041 DBMET01114 0.253 0.202 DBMET01121 | DBMET03446 | |
| 0.427 | 0.003 | 0.427 | Interleukin 2 antagonist | 0.235 0.005 DBMET00033 0.165 0.013 DBMET00035 0.178 0.01 DBMET03456 0.136 0.027 DBMET03457 0.315 0.004 DBMET03458 0.114 0.056 DBMET01118 0.331 0.004 DBMET00034 0.2 0.008 DBMET03444 0.111 0.062 DBMET03446 0.338 0.004 DBMET01114 | ||
| 0.42 | 0.005 | 0.436 | Tumour necrosis factor antagonist | 0.348 0.011 DBMET00033 0.163 0.085 DBMET00035 0.214 0.046 DBMET03456 0.168 0.078 DBMET03457 0.366 0.009 DBMET03458 0.214 0.046 DBMET01115 0.292 0.019 DBMET01116 0.436 0.005 DBMET00034 0.382 0.008 DBMET03444 0.3 0.018 DBMET01117 0.164 0.083 DB02746 0.173 0.073 DBMET03446 0.421 0.005 DBMET01114 | DBMET00034 | |
| 0.417 | 0.025 | 0.476 | DNA damaging | 0.296 0.059 DBMET00033 0.476 0.016 DBMET03456 0.227 0.095 DBMET03457 0.398 0.029 DBMET03458 0.172 0.143 DBMET01115 0.25 0.08 DBMET01116 0.445 0.02 DBMET00034 0.322 0.049 DBMET03444 0.296 0.059 DBMET01117 0.214 0.104 DB02746 0.206 0.111 DBMET03446 0.464 0.018 DBMET01114 0.259 0.075 DB03091 0.233 0.09 DB00130 0.307 0.054 DB00142 | DBMET03456 | |
| 0.407 | 0.02 | 0.514 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.352 0.035 DBMET00033 0.34 0.04 DBMET03458 0.289 0.072 DBMET01118 0.352 0.035 DBMET00034 0.323 0.049 DBMET03444 0.514 0.006 DBMET03446 0.381 0.026 DBMET01114 | DBMET03446 | |
| 0.479 | 0.097 | 0.787 | Antiinflammatory | 0.467 0.102 DBMET00033 0.787 0.017 DBMET03456 0.552 0.068 DBMET03458 0.263 0.252 DBMET01118 0.524 0.078 DBMET00034 0.486 0.094 DBMET03444 0.422 0.126 DB02746 0.584 0.058 DBMET01114 0.318 0.198 DB00142 | DBMET03456 | |
| 0.384 | 0.004 | 0.833 | Interleukin 12 antagonist | 0.164 0.009 DBMET00033 0.255 0.005 DBMET03456 0.45 0.003 DBMET03457 0.284 0.004 DBMET03458 0.633 0.002 DBMET01115 0.791 0.002 DBMET01116 0.23 0.005 DBMET01118 0.336 0.004 DBMET00034 0.171 0.008 DBMET03444 0.833 0.001 DBMET01117 0.129 0.022 DBMET01119 0.124 0.026 DBMET01120 0.121 0.028 DB02746 0.161 0.01 DBMET03446 0.311 0.004 DBMET01114 0.103 0.049 DBMET01121 0.153 0.011 DB03091 0.133 0.019 DB00130 0.099 0.055 DB00142 | DBMET01117 | |
| 0.432 | 0.093 | 0.521 | Caspase 9 stimulant | 0.394 0.115 DBMET00033 0.385 0.12 DBMET00035 0.495 0.062 DBMET03456 0.27 0.229 DBMET03457 0.47 0.073 DBMET03458 0.309 0.184 DBMET01115 0.266 0.234 DBMET01118 0.521 0.052 DBMET00034 0.462 0.077 DBMET03444 0.414 0.103 DBMET01117 0.462 0.077 DB02746 0.342 0.152 DBMET03446 0.519 0.053 DBMET01114 0.348 0.147 DB03091 0.273 0.225 DB00130 0.41 0.105 DB00142 | DBMET00034 | |
| 0.386 | 0.06 | 0.515 | Vasodilator, peripheral | 0.294 0.1 DBMET00033 0.371 0.065 DBMET03456 0.312 0.091 DBMET03458 0.289 0.103 DBMET01115 0.391 0.058 DBMET00034 0.272 0.112 DBMET03444 0.373 0.064 DBMET01117 0.305 0.095 DBMET01119 0.261 0.119 DBMET01120 0.515 0.025 DB02746 0.253 0.125 DBMET03446 0.425 0.048 DBMET01114 0.484 0.031 DBMET01121 0.379 0.062 DB03091 0.302 0.096 DB00130 0.491 0.03 DB00142 | DB02746 | |
| 0.332 | 0.015 | 0.349 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.279 0.037 DBMET00033 0.28 0.036 DBMET03458 0.228 0.099 DBMET01118 0.273 0.042 DBMET00034 0.249 0.067 DBMET03444 0.349 0.011 DBMET03446 0.275 0.04 DBMET01114 | DBMET03446 | |
| 0.337 | 0.036 | 0.76 | Angiogenesis stimulant | 0.367 0.028 DBMET00033 0.244 0.072 DBMET00035 0.76 0.004 DBMET03456 0.214 0.087 DBMET03457 0.341 0.035 DBMET03458 0.311 0.045 DBMET01115 0.324 0.041 DBMET01116 0.207 0.091 DBMET01118 0.353 0.032 DBMET00034 0.368 0.028 DBMET03444 0.27 0.061 DBMET01117 0.397 0.022 DBMET01119 0.415 0.019 DBMET01120 0.192 0.099 DB02746 0.419 0.019 DBMET03446 0.37 0.027 DBMET01114 0.386 0.024 DBMET01121 0.667 0.005 DB03091 0.604 0.007 DB00130 0.585 0.007 DB00142 | DBMET03456 | |
| 0.328 | 0.033 | 0.575 | 5 Hydroxytryptamine uptake stimulant | 0.324 0.034 DBMET00033 0.228 0.106 DBMET00035 0.223 0.113 DBMET03457 0.294 0.048 DBMET03458 0.33 0.032 DBMET01115 0.246 0.085 DBMET01116 0.253 0.078 DBMET01118 0.318 0.036 DBMET00034 0.314 0.038 DBMET03444 0.349 0.026 DBMET01117 0.395 0.015 DBMET01119 0.297 0.046 DBMET01120 0.522 0.004 DB02746 0.301 0.044 DBMET03446 0.363 0.022 DBMET01114 0.42 0.011 DBMET01121 0.515 0.004 DB03091 0.424 0.01 DB00130 0.575 0.003 DB00142 | DB00142 | |
| 0.354 | 0.069 | 0.643 | Angiogenesis inhibitor | 0.643 0.013 DBMET00033 0.415 0.049 DBMET03456 0.592 0.017 DBMET03457 0.293 0.097 DBMET03458 0.332 0.078 DBMET00034 0.622 0.014 DBMET03444 0.365 0.065 DBMET01114 | DBMET00033 | |
| 0.303 | 0.02 | 0.369 | Lipocortins synthesis antagonist | 0.235 0.039 DBMET00033 0.246 0.035 DBMET03456 0.262 0.03 DBMET03458 0.184 0.067 DBMET01115 0.295 0.022 DBMET01118 0.296 0.022 DBMET00034 0.228 0.041 DBMET03444 0.218 0.046 DBMET01117 0.174 0.077 DBMET01119 0.308 0.02 DB02746 0.369 0.011 DBMET03446 0.309 0.019 DBMET01114 0.199 0.057 DBMET01121 0.2 0.056 DB03091 0.241 0.037 DB00142 | DBMET03446 | |
| 0.362 | 0.08 | 0.573 | GABA C receptor rho-3 antagonist | 0.245 0.159 DBMET00033 0.366 0.077 DBMET03458 0.251 0.153 DBMET01115 0.251 0.153 DBMET01116 0.357 0.082 DBMET00034 0.246 0.158 DBMET03444 0.353 0.084 DBMET01117 0.573 0.011 DB02746 0.445 0.044 DBMET03446 0.272 0.136 DBMET01114 0.28 0.13 DBMET01121 0.305 0.112 DB03091 0.305 0.112 DB00130 0.38 0.071 DB00142 | DB02746 | |
| 0.304 | 0.032 | 0.469 | Anesthetic general | 0.317 0.029 DBMET00033 0.287 0.036 DBMET03456 0.138 0.128 DBMET03457 0.257 0.047 DBMET03458 0.293 0.035 DBMET01115 0.198 0.075 DBMET01116 0.136 0.13 DBMET01118 0.311 0.03 DBMET00034 0.283 0.038 DBMET03444 0.275 0.04 DBMET01117 0.209 0.069 DBMET01119 0.469 0.01 DB02746 0.219 0.065 DBMET03446 0.328 0.027 DBMET01114 0.168 0.096 DBMET01121 0.37 0.02 DB03091 0.258 0.047 DB00130 0.367 0.021 DB00142 | DB02746 | |
| 0.312 | 0.04 | 0.49 | DNA synthesis inhibitor | 0.313 0.039 DBMET00033 0.245 0.07 DBMET00035 0.49 0.014 DBMET03456 0.269 0.056 DBMET03457 0.351 0.03 DBMET03458 0.228 0.085 DBMET01115 0.215 0.101 DBMET01116 0.313 0.039 DBMET01118 0.332 0.034 DBMET00034 0.299 0.044 DBMET03444 0.233 0.08 DBMET01117 0.312 0.04 DBMET01119 0.366 0.027 DBMET01120 0.386 0.023 DB02746 0.392 0.023 DBMET03446 0.339 0.033 DBMET01114 0.39 0.023 DBMET01121 0.385 0.024 DB03091 0.405 0.021 DB00130 0.459 0.016 DB00142 | DBMET03456 | |
| 0.303 | 0.057 | 0.481 | Insulysin inhibitor | 0.197 0.161 DBMET00033 0.192 0.17 DBMET03457 0.265 0.083 DBMET03458 0.362 0.03 DBMET01115 0.348 0.035 DBMET01116 0.326 0.044 DBMET01118 0.308 0.054 DBMET00034 0.194 0.166 DBMET03444 0.323 0.046 DBMET01117 0.467 0.013 DBMET01119 0.44 0.016 DBMET01120 0.364 0.03 DB02746 0.356 0.032 DBMET03446 0.315 0.05 DBMET01114 0.422 0.019 DBMET01121 0.481 0.011 DB03091 0.439 0.016 DB00130 0.431 0.017 DB00142 | DB03091 | |
| 0.248 | 0.004 | 0.363 | Phosphodiesterase 6D inhibitor | 0.173 0.006 DBMET00033 0.111 0.034 DBMET00035 0.363 0.002 DBMET03456 0.098 0.056 DBMET03457 0.253 0.004 DBMET03458 0.087 0.085 DBMET01118 0.256 0.003 DBMET00034 0.177 0.005 DBMET03444 0.107 0.04 DB02746 0.11 0.036 DBMET03446 0.259 0.003 DBMET01114 | DBMET03456 | |
| 0.245 | 0.006 | 0.245 | 5 Hydroxytryptamine 3A agonist | 0.136 0.044 DBMET00033 0.093 0.084 DBMET00035 0.152 0.034 DBMET03457 0.178 0.023 DBMET03458 0.233 0.008 DBMET00034 0.148 0.036 DBMET03444 0.113 0.062 DB02746 0.159 0.031 DBMET03446 0.21 0.012 DBMET01114 | ||
| 0.311 | 0.081 | 0.429 | Calcium channel activator | 0.216 0.19 DBMET00033 0.246 0.151 DBMET03458 0.296 0.096 DBMET01118 0.285 0.107 DBMET00034 0.208 0.202 DBMET01117 0.429 0.016 DB02746 0.372 0.037 DBMET03446 0.261 0.134 DBMET01114 0.245 0.154 DB00142 | DB02746 | |
| 0.276 | 0.047 | 0.74 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 DBMET00033 0.231 0.088 DBMET03457 0.285 0.041 DBMET03458 0.367 0.013 DBMET01115 0.327 0.022 DBMET01116 0.192 0.151 DBMET01118 0.319 0.025 DBMET00034 0.261 0.058 DBMET03444 0.364 0.013 DBMET01117 0.355 0.015 DBMET01119 0.356 0.015 DBMET01120 0.418 0.006 DB02746 0.274 0.048 DBMET03446 0.312 0.028 DBMET01114 0.404 0.008 DBMET01121 0.569 0.003 DB03091 0.572 0.003 DB00130 0.74 0.002 DB00142 | DB00142 | |
| 0.274 | 0.05 | 0.682 | Psychostimulant | 0.139 0.126 DBMET00033 0.251 0.058 DBMET03456 0.225 0.068 DBMET03458 0.368 0.028 DBMET01115 0.305 0.041 DBMET01116 0.243 0.061 DBMET00034 0.326 0.036 DBMET01117 0.265 0.053 DBMET01119 0.376 0.026 DBMET01120 0.196 0.082 DB02746 0.385 0.025 DBMET03446 0.244 0.061 DBMET01114 0.4 0.022 DBMET01121 0.529 0.009 DB03091 0.593 0.006 DB00130 0.682 0.005 DB00142 | DB00142 | |
| 0.269 | 0.055 | 0.656 | Interleukin antagonist | 0.135 0.13 DBMET00033 0.168 0.105 DBMET03456 0.14 0.126 DBMET03457 0.238 0.066 DBMET03458 0.532 0.017 DBMET01115 0.656 0.007 DBMET01116 0.373 0.035 DBMET01118 0.321 0.043 DBMET00034 0.186 0.092 DBMET03444 0.576 0.014 DBMET01117 0.565 0.014 DBMET01119 0.531 0.017 DBMET01120 0.145 0.122 DB02746 0.211 0.078 DBMET03446 0.292 0.05 DBMET01114 0.358 0.037 DBMET01121 0.654 0.007 DB03091 0.653 0.008 DB00130 0.521 0.018 DB00142 | DBMET01116 | |
| 0.225 | 0.011 | 0.225 | Polo-like kinase-4 inhibitor | 0.126 0.051 DBMET00033 0.159 0.03 DBMET03458 0.18 0.021 DBMET00034 0.117 0.059 DBMET03444 0.117 0.059 DBMET03446 0.185 0.019 DBMET01114 | ||
| 0.337 | 0.127 | 0.779 | 5 Hydroxytryptamine release inhibitor | 0.32 0.144 DBMET00033 0.425 0.064 DBMET03456 0.286 0.182 DBMET03458 0.293 0.173 DBMET01115 0.293 0.173 DBMET01116 0.582 0.013 DBMET01118 0.362 0.105 DBMET00034 0.339 0.125 DBMET03444 0.334 0.13 DBMET01117 0.476 0.041 DBMET01119 0.476 0.041 DBMET01120 0.779 0.003 DB02746 0.389 0.085 DBMET03446 0.318 0.146 DBMET01114 0.526 0.025 DBMET01121 0.446 0.053 DB03091 0.446 0.053 DB00130 0.482 0.039 DB00142 | DB02746 | |
| 0.222 | 0.015 | 0.222 | MAP kinase kinase 5 inhibitor | 0.188 0.048 DBMET00033 0.188 0.048 DBMET00035 0.184 0.055 DBMET03457 0.188 0.049 DBMET03458 0.187 0.051 DBMET00034 0.165 0.1 DBMET03444 0.203 0.029 DBMET03446 0.192 0.043 DBMET01114 | ||
| 0.254 | 0.05 | 0.417 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.159 0.116 DBMET00033 0.182 0.092 DBMET03458 0.168 0.106 DBMET01118 0.201 0.076 DBMET00034 0.148 0.13 DBMET03444 0.417 0.014 DBMET03446 0.208 0.07 DBMET01114 | DBMET03446 | |
| 0.226 | 0.027 | 0.834 | Alpha-N-acetylglucosaminidase inhibitor | 0.379 0.01 DBMET00033 0.201 0.034 DBMET00035 0.304 0.016 DBMET03456 0.163 0.048 DBMET03457 0.154 0.053 DBMET03458 0.276 0.019 DBMET01115 0.276 0.019 DBMET01116 0.413 0.008 DBMET01118 0.175 0.043 DBMET00034 0.235 0.025 DBMET03444 0.36 0.011 DBMET01117 0.467 0.006 DBMET01119 0.467 0.006 DBMET01120 0.834 0.002 DB02746 0.349 0.012 DBMET03446 0.226 0.027 DBMET01114 0.58 0.004 DBMET01121 0.629 0.004 DB03091 0.629 0.004 DB00130 0.635 0.004 DB00142 | DB02746 | |
| 0.293 | 0.098 | 0.724 | Transcription factor NF kappa B inhibitor | 0.268 0.114 DBMET00033 0.234 0.139 DBMET00035 0.724 0.018 DBMET03456 0.426 0.058 DBMET03458 0.43 0.057 DBMET00034 0.343 0.079 DBMET03444 0.229 0.143 DBMET01119 0.215 0.155 DBMET01120 0.323 0.085 DB02746 0.192 0.177 DBMET03446 0.436 0.056 DBMET01114 0.243 0.133 DBMET01121 0.308 0.09 DB03091 0.366 0.072 DB00130 0.402 0.063 DB00142 | DBMET03456 | |
| 0.313 | 0.123 | 0.498 | MAP kinase kinase 6 inhibitor | 0.266 0.171 DBMET00033 0.301 0.135 DBMET03458 0.344 0.097 DBMET01118 0.239 0.205 DBMET00034 0.498 0.019 DBMET03446 0.232 0.215 DBMET01114 | DBMET03446 | |
| 0.247 | 0.061 | 0.313 | MAP-kinase-activated kinase 5 inhibitor | 0.166 0.154 DBMET00033 0.219 0.083 DBMET03458 0.207 0.095 DBMET01118 0.24 0.066 DBMET00034 0.179 0.133 DBMET03444 0.313 0.023 DBMET03446 0.253 0.058 DBMET01114 | DBMET03446 | |
| 0.267 | 0.09 | 0.567 | Immunostimulant | 0.261 0.092 DBMET00033 0.567 0.021 DBMET03456 0.264 0.091 DBMET03458 0.291 0.081 DBMET01115 0.293 0.08 DBMET01116 0.295 0.08 DBMET01118 0.299 0.079 DBMET00034 0.255 0.094 DBMET03444 0.227 0.106 DBMET01117 0.504 0.029 DBMET01119 0.509 0.028 DBMET01120 0.296 0.079 DB02746 0.365 0.06 DBMET03446 0.306 0.077 DBMET01114 0.457 0.036 DBMET01121 0.548 0.023 DB03091 0.548 0.023 DB00130 0.524 0.026 DB00142 | DBMET03456 | |
| 0.298 | 0.125 | 0.696 | Histamine release inhibitor | 0.217 0.183 DBMET00033 0.495 0.03 DBMET03456 0.359 0.096 DBMET03458 0.357 0.096 DBMET01115 0.259 0.149 DBMET01116 0.36 0.095 DBMET01118 0.399 0.076 DBMET00034 0.266 0.144 DBMET03444 0.425 0.063 DBMET01117 0.51 0.025 DBMET01119 0.509 0.026 DBMET01120 0.696 0.005 DB02746 0.41 0.07 DBMET01114 0.63 0.008 DBMET01121 0.485 0.034 DB03091 0.526 0.021 DB00130 0.63 0.008 DB00142 | DB02746 | |
| 0.177 | 0.009 | 0.2 | Cyclin B3 inhibitor | 0.165 0.01 DBMET03458 0.07 0.045 DBMET01118 0.162 0.011 DBMET00034 0.2 0.006 DBMET03446 0.171 0.01 DBMET01114 | DBMET03446 | |
| 0.163 | 0.006 | 0.21 | CDK4/cyclin D1 inhibitor | 0.084 0.022 DBMET00033 0.105 0.013 DBMET03458 0.118 0.011 DBMET00034 0.075 0.027 DBMET03444 0.21 0.005 DBMET03446 0.143 0.008 DBMET01114 | DBMET03446 | |
| 0.191 | 0.034 | 0.191 | Cholinergic antagonist | 0.127 0.067 DBMET00033 0.103 0.092 DBMET00035 0.134 0.062 DBMET03458 0.17 0.043 DBMET00034 0.117 0.076 DBMET03444 0.157 0.049 DBMET03446 0.166 0.044 DBMET01114 | ||
| 0.189 | 0.034 | 0.189 | Acetylcholine antagonist | 0.124 0.067 DBMET00033 0.099 0.093 DBMET00035 0.132 0.061 DBMET03458 0.168 0.041 DBMET00034 0.115 0.075 DBMET03444 0.155 0.047 DBMET03446 0.163 0.044 DBMET01114 | ||
| 0.198 | 0.042 | 0.718 | Interleukin 6 antagonist | 0.161 0.073 DBMET00033 0.278 0.018 DBMET03456 0.184 0.051 DBMET03458 0.635 0.004 DBMET01115 0.699 0.003 DBMET01116 0.205 0.038 DBMET00034 0.162 0.073 DBMET03444 0.718 0.003 DBMET01117 0.218 0.032 DBMET01114 0.243 0.024 DB03091 0.232 0.027 DB00130 0.19 0.047 DB00142 | DBMET01117 | |
| 0.185 | 0.031 | 0.406 | Alkylator | 0.159 0.042 DBMET00033 0.406 0.007 DBMET03456 0.222 0.021 DBMET03458 0.18 0.033 DBMET01115 0.211 0.023 DBMET01116 0.213 0.023 DBMET00034 0.172 0.036 DBMET03444 0.236 0.018 DBMET01117 0.112 0.075 DBMET01119 0.135 0.055 DBMET01120 0.144 0.05 DB02746 0.159 0.042 DBMET03446 0.219 0.021 DBMET01114 0.157 0.043 DBMET01121 0.21 0.024 DB03091 0.244 0.017 DB00130 0.313 0.012 DB00142 | DBMET03456 | |
| 0.16 | 0.006 | 0.16 | Bromodomain-containing protein 2 inhibitor | 0.1 0.04 DBMET03458 0.131 0.017 DBMET00034 0.085 0.064 DB02746 0.096 0.045 DBMET03446 0.131 0.017 DBMET01114 | ||
| 0.293 | 0.141 | 0.666 | Antibacterial | 0.407 0.073 DBMET00033 0.38 0.086 DBMET00035 0.666 0.012 DBMET03456 0.518 0.036 DBMET03457 0.382 0.085 DBMET03458 0.334 0.111 DBMET01116 0.39 0.081 DBMET01118 0.349 0.102 DBMET00034 0.418 0.069 DBMET03444 0.279 0.151 DBMET01117 0.385 0.084 DBMET01119 0.392 0.08 DBMET01120 0.448 0.058 DB02746 0.447 0.058 DBMET03446 0.385 0.084 DBMET01114 0.334 0.112 DBMET01121 0.444 0.059 DB03091 0.431 0.064 DB00130 0.402 0.076 DB00142 | DBMET03456 | |
| 0.157 | 0.006 | 0.177 | Phosphodiesterase VI inhibitor | 0.094 0.024 DBMET00033 0.177 0.005 DBMET03456 0.14 0.008 DBMET03458 0.153 0.006 DBMET00034 0.096 0.023 DBMET03444 0.152 0.006 DBMET01114 | DBMET03456 | |
| 0.185 | 0.037 | 0.39 | Cell wall synthesis inhibitor | 0.225 0.022 DBMET00033 0.39 0.006 DBMET03456 0.177 0.042 DBMET03457 0.197 0.031 DBMET03458 0.229 0.021 DBMET01115 0.335 0.008 DBMET01116 0.225 0.022 DBMET01118 0.195 0.032 DBMET00034 0.221 0.023 DBMET03444 0.296 0.01 DBMET01117 0.225 0.022 DBMET01119 0.258 0.014 DBMET01120 0.259 0.014 DB02746 0.217 0.024 DBMET03446 0.216 0.024 DBMET01114 0.228 0.021 DBMET01121 0.316 0.009 DB03091 0.367 0.007 DB00130 0.346 0.008 DB00142 | DBMET03456 | |
| 0.173 | 0.026 | 0.273 | Nav1.4 sodium channel blocker | 0.154 0.032 DBMET00033 0.117 0.055 DBMET03457 0.151 0.033 DBMET03458 0.121 0.051 DBMET01115 0.149 0.034 DBMET01116 0.103 0.071 DBMET01118 0.169 0.027 DBMET00034 0.154 0.032 DBMET03444 0.12 0.052 DBMET01117 0.204 0.018 DBMET01119 0.157 0.031 DBMET01120 0.176 0.025 DBMET03446 0.155 0.032 DBMET01114 0.132 0.043 DBMET01121 0.273 0.005 DB03091 0.22 0.015 DB00130 0.216 0.016 DB00142 | DB03091 | |
| 0.216 | 0.078 | 0.333 | RNA-directed DNA polymerase inhibitor | 0.25 0.049 DBMET00033 0.185 0.123 DBMET00035 0.191 0.114 DBMET03456 0.218 0.076 DBMET03458 0.196 0.105 DBMET01115 0.191 0.113 DBMET01116 0.226 0.067 DBMET00034 0.243 0.054 DBMET03444 0.194 0.109 DBMET01117 0.333 0.026 DB02746 0.25 0.049 DBMET03446 0.26 0.044 DBMET01114 0.229 0.065 DB03091 0.224 0.07 DB00130 0.232 0.062 DB00142 | DB02746 | |
| 0.146 | 0.012 | 0.146 | Cyclin-dependent kinase 4 inhibitor | 0.059 0.053 DBMET00033 0.094 0.028 DBMET03458 0.102 0.025 DBMET00034 0.085 0.032 DBMET03446 0.118 0.019 DBMET01114 | ||
| 0.163 | 0.029 | 0.798 | GABA C receptor agonist | 0.14 0.038 DBMET00033 0.117 0.052 DBMET00035 0.092 0.076 DBMET03457 0.119 0.05 DBMET03458 0.482 0.004 DBMET01115 0.315 0.008 DBMET01116 0.404 0.005 DBMET01118 0.136 0.04 DBMET00034 0.092 0.076 DBMET03444 0.475 0.004 DBMET01117 0.547 0.003 DBMET01119 0.38 0.005 DBMET01120 0.721 0.002 DB02746 0.634 0.002 DBMET03446 0.178 0.025 DBMET01114 0.561 0.003 DBMET01121 0.735 0.002 DB03091 0.6 0.003 DB00130 0.798 0.001 DB00142 | DB00142 | |
| 0.231 | 0.099 | 0.63 | 5 Hydroxytryptamine release stimulant | 0.216 0.109 DBMET00033 0.166 0.158 DBMET03458 0.167 0.157 DBMET01115 0.167 0.157 DBMET01116 0.25 0.089 DBMET00034 0.239 0.095 DBMET03444 0.193 0.127 DBMET01117 0.483 0.03 DB02746 0.427 0.04 DBMET03446 0.197 0.124 DBMET01114 0.47 0.032 DB03091 0.47 0.032 DB00130 0.63 0.012 DB00142 | DB00142 | |
| 0.18 | 0.05 | 0.328 | Neurotensin receptor agonist | 0.19 0.041 DBMET03458 0.168 0.064 DBMET01115 0.181 0.049 DBMET01116 0.166 0.069 DBMET01118 0.212 0.03 DBMET00034 0.139 0.132 DBMET03444 0.156 0.089 DBMET01117 0.282 0.016 DBMET01119 0.31 0.013 DBMET01120 0.202 0.033 DB02746 0.23 0.025 DBMET03446 0.185 0.045 DBMET01114 0.279 0.017 DBMET01121 0.328 0.011 DB03091 0.326 0.011 DB00130 0.308 0.013 DB00142 | DB03091 | |
| 0.22 | 0.095 | 0.352 | Calpain inhibitor | 0.182 0.133 DBMET01116 0.258 0.058 DBMET01118 0.173 0.144 DBMET00034 0.342 0.018 DBMET01119 0.352 0.016 DBMET01120 0.222 0.092 DB02746 0.227 0.088 DBMET03446 0.179 0.136 DBMET01114 0.296 0.032 DBMET01121 0.262 0.054 DB03091 0.284 0.039 DB00130 0.227 0.087 DB00142 | DBMET01120 | |
| 0.133 | 0.009 | 0.217 | Protein kinase C eta inhibitor | 0.125 0.011 DBMET00033 0.078 0.025 DBMET03456 0.109 0.015 DBMET03458 0.204 0.004 DBMET01118 0.129 0.01 DBMET00034 0.125 0.011 DBMET03444 0.072 0.028 DBMET01119 0.072 0.027 DBMET01120 0.217 0.004 DB02746 0.188 0.005 DBMET03446 0.126 0.011 DBMET01114 0.083 0.022 DBMET01121 | DB02746 | |
| 0.183 | 0.062 | 0.23 | Antipruritic | 0.131 0.122 DBMET03458 0.182 0.063 DBMET00034 0.158 0.085 DBMET01119 0.165 0.079 DB02746 0.146 0.099 DBMET03446 0.172 0.072 DBMET01114 0.15 0.094 DBMET01121 0.211 0.042 DB03091 0.2 0.049 DB00130 0.23 0.032 DB00142 | DB00142 | |
| 0.135 | 0.014 | 0.135 | Phosphodiesterase 11A inhibitor | 0.081 0.057 DBMET00033 0.078 0.063 DBMET03457 0.09 0.042 DBMET03458 0.1 0.032 DBMET00034 0.077 0.066 DBMET03444 0.092 0.04 DBMET01114 | ||
| 0.135 | 0.014 | 0.135 | Phosphodiesterase XI inhibitor | 0.081 0.057 DBMET00033 0.078 0.063 DBMET03457 0.09 0.042 DBMET03458 0.1 0.032 DBMET00034 0.077 0.066 DBMET03444 0.092 0.04 DBMET01114 | ||
| 0.137 | 0.017 | 0.226 | Somatostatin 1 agonist | 0.121 0.023 DBMET00033 0.074 0.059 DBMET03456 0.122 0.023 DBMET03458 0.157 0.012 DBMET01118 0.136 0.017 DBMET00034 0.124 0.022 DBMET03444 0.124 0.022 DBMET01119 0.093 0.039 DBMET01120 0.083 0.048 DB02746 0.226 0.005 DBMET03446 0.124 0.022 DBMET01114 0.16 0.011 DB03091 0.125 0.021 DB00130 0.106 0.03 DB00142 | DBMET03446 | |
| 0.142 | 0.023 | 0.162 | Anabolic | 0.147 0.019 DBMET00033 0.103 0.059 DBMET00035 0.101 0.061 DBMET03456 0.102 0.06 DBMET03457 0.149 0.019 DBMET03458 0.162 0.012 DBMET00034 0.159 0.014 DBMET03444 0.104 0.056 DBMET01117 0.155 0.015 DB02746 0.107 0.053 DBMET03446 0.159 0.014 DBMET01114 0.097 0.067 DBMET01121 0.135 0.027 DB03091 0.148 0.019 DB00130 0.162 0.013 DB00142 | DB00142 | |
| 0.188 | 0.069 | 0.445 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.137 0.099 DBMET01118 0.139 0.096 DBMET00034 0.445 0.01 DBMET03446 0.14 0.096 DBMET01114 | DBMET03446 | |
| 0.126 | 0.009 | 0.168 | CDK4/cyclin D inhibitor | 0.06 0.039 DBMET00033 0.076 0.023 DBMET03458 0.086 0.019 DBMET00034 0.054 0.048 DBMET03444 0.168 0.005 DBMET03446 0.103 0.013 DBMET01114 | DBMET03446 | |
| 0.14 | 0.023 | 0.527 | Triose-phosphate isomerase inhibitor | 0.164 0.016 DBMET00033 0.092 0.057 DBMET00035 0.233 0.008 DBMET03456 0.11 0.039 DBMET03457 0.114 0.036 DBMET03458 0.278 0.005 DBMET01115 0.174 0.014 DBMET01116 0.114 0.036 DBMET01118 0.118 0.033 DBMET00034 0.12 0.032 DBMET03444 0.263 0.006 DBMET01117 0.288 0.005 DBMET01119 0.181 0.013 DBMET01120 0.527 0.002 DB02746 0.101 0.047 DBMET03446 0.131 0.027 DBMET01114 0.259 0.006 DBMET01121 0.431 0.003 DB03091 0.296 0.005 DB00130 0.406 0.003 DB00142 | DB02746 | |
| 0.14 | 0.025 | 0.14 | Acetylcholine M3 receptor agonist | 0.079 0.062 DBMET03446 0.076 0.064 DBMET01114 | ||
| 0.128 | 0.015 | 0.237 | CXC chemokine receptor antagonist | 0.07 0.05 DBMET03458 0.177 0.008 DBMET01118 0.087 0.032 DBMET00034 0.237 0.005 DBMET03446 0.085 0.033 DBMET01114 | DBMET03446 | |
| 0.193 | 0.079 | 0.452 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.304 0.042 DBMET01118 0.148 0.114 DBMET00034 0.171 0.095 DB02746 0.452 0.012 DBMET03446 0.154 0.108 DBMET01114 | DBMET03446 | |
| 0.214 | 0.109 | 0.376 | Spasmolytic | 0.165 0.15 DBMET00033 0.355 0.051 DBMET03456 0.231 0.1 DBMET03458 0.376 0.045 DBMET01118 0.249 0.091 DBMET00034 0.177 0.139 DBMET03444 0.201 0.119 DBMET01119 0.164 0.15 DBMET01120 0.332 0.058 DB02746 0.271 0.082 DBMET03446 0.27 0.083 DBMET01114 0.2 0.119 DBMET01121 0.291 0.074 DB03091 0.233 0.099 DB00130 0.296 0.072 DB00142 | DBMET01118 | |
| 0.133 | 0.027 | 0.333 | Electrolyte absorption antagonist | 0.092 0.071 DBMET00033 0.091 0.073 DBMET03458 0.11 0.045 DBMET01115 0.098 0.06 DBMET01116 0.107 0.048 DBMET01118 0.097 0.062 DBMET00034 0.14 0.024 DBMET01117 0.113 0.042 DBMET01119 0.101 0.057 DBMET01120 0.333 0.004 DB02746 0.114 0.041 DBMET03446 0.107 0.049 DBMET01114 0.146 0.021 DBMET01121 0.127 0.031 DB03091 0.114 0.042 DB00130 0.157 0.017 DB00142 | DB02746 | |
| 0.111 | 0.007 | 0.111 | Poly(ADP-ribose) polymerase inhibitor | 0.047 0.028 DBMET03458 0.048 0.026 DBMET00034 0.041 0.039 DBMET03446 0.05 0.023 DBMET01114 | ||
| 0.11 | 0.009 | 0.114 | Oxytocin antagonist | 0.114 0.009 DBMET00033 0.043 0.022 DBMET03458 0.058 0.015 DBMET00034 0.086 0.011 DBMET03444 0.071 0.013 DBMET03446 0.049 0.018 DBMET01114 | DBMET00033 | |
| 0.126 | 0.028 | 0.126 | Acetylcholine nicotinic antagonist | 0.072 0.066 DBMET00033 0.097 0.041 DBMET00034 0.111 0.033 DBMET03446 0.095 0.043 DBMET01114 | ||
| 0.12 | 0.022 | 0.565 | Hematopoietic | 0.097 0.039 DBMET03458 0.096 0.04 DBMET01115 0.094 0.044 DBMET01116 0.127 0.019 DBMET01118 0.105 0.031 DBMET00034 0.085 0.059 DBMET01117 0.189 0.011 DBMET01119 0.286 0.005 DBMET01120 0.09 0.05 DB02746 0.154 0.014 DBMET03446 0.104 0.032 DBMET01114 0.291 0.005 DBMET01121 0.319 0.005 DB03091 0.516 0.004 DB00130 0.565 0.004 DB00142 | DB00142 | |
| 0.139 | 0.042 | 0.555 | Ferrochelatase inhibitor | 0.096 0.075 DBMET00033 0.42 0.003 DBMET01115 0.367 0.004 DBMET01116 0.212 0.02 DBMET01118 0.352 0.005 DBMET01117 0.385 0.004 DBMET01119 0.331 0.005 DBMET01120 0.555 0.002 DB02746 0.22 0.018 DBMET03446 0.087 0.086 DBMET01114 0.318 0.006 DBMET01121 0.503 0.002 DB03091 0.449 0.003 DB00130 0.455 0.003 DB00142 | DB02746 | |
| 0.128 | 0.033 | 0.247 | Prolactin inhibitor | 0.089 0.067 DBMET00033 0.143 0.025 DBMET03458 0.149 0.023 DBMET01115 0.1 0.056 DBMET01116 0.161 0.018 DBMET00034 0.105 0.051 DBMET03444 0.145 0.024 DBMET01117 0.101 0.054 DBMET01119 0.153 0.021 DB02746 0.116 0.041 DBMET03446 0.148 0.023 DBMET01114 0.119 0.039 DBMET01121 0.219 0.006 DB03091 0.187 0.011 DB00130 0.247 0.004 DB00142 | DB00142 | |
| 0.155 | 0.062 | 0.368 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.106 0.097 DBMET01118 0.368 0.009 DBMET03446 | DBMET03446 | |
| 0.185 | 0.092 | 0.215 | 5 Hydroxytryptamine 3E antagonist | 0.215 0.041 DB02746 0.204 0.056 DBMET03446 0.172 0.13 DB00142 | DB02746 | |
| 0.21 | 0.119 | 0.216 | 5 Hydroxytryptamine 1E antagonist | 0.169 0.167 DBMET03458 0.208 0.122 DBMET00034 0.216 0.113 DB02746 0.206 0.124 DBMET03446 0.199 0.132 DBMET01114 | DB02746 | |
| 0.128 | 0.038 | 0.44 | UDP-glucose 4-epimerase inhibitor | 0.205 0.017 DBMET00033 0.098 0.062 DBMET00035 0.287 0.011 DBMET03456 0.118 0.045 DBMET03458 0.163 0.025 DBMET01118 0.125 0.04 DBMET00034 0.163 0.025 DBMET03444 0.111 0.05 DBMET01117 0.44 0.004 DB02746 0.195 0.019 DBMET03446 0.143 0.031 DBMET01114 0.096 0.065 DBMET01121 0.11 0.051 DB03091 0.11 0.051 DB00130 0.128 0.038 DB00142 | DB02746 | |
| 0.16 | 0.07 | 0.175 | Cyclin-dependent kinase 8 inhibitor | 0.124 0.111 DBMET00034 0.175 0.056 DBMET03446 0.129 0.104 DBMET01114 | DBMET03446 | |
| 0.151 | 0.063 | 0.164 | Neuropeptide Y1 antagonist | 0.129 0.101 DBMET01118 0.154 0.059 DBMET00034 0.146 0.071 DBMET01119 0.124 0.115 DBMET01120 0.141 0.08 DB02746 0.158 0.053 DBMET03446 0.129 0.103 DBMET01114 0.162 0.048 DB03091 0.164 0.045 DB00130 0.146 0.071 DB00142 | DB00130 | |
| 0.114 | 0.027 | 0.181 | Factor XII inhibitor | 0.083 0.061 DBMET00033 0.091 0.047 DBMET03458 0.091 0.048 DBMET01116 0.099 0.038 DBMET00034 0.078 0.071 DBMET03444 0.1 0.037 DBMET01119 0.133 0.018 DBMET01120 0.103 0.035 DBMET03446 0.096 0.041 DBMET01114 0.097 0.041 DBMET01121 0.16 0.01 DB03091 0.181 0.008 DB00130 0.128 0.02 DB00142 | DB00130 | |
| 0.128 | 0.043 | 0.165 | Nav1.1 sodium channel blocker | 0.087 0.085 DBMET00033 0.1 0.066 DBMET00035 0.115 0.052 DBMET03458 0.121 0.047 DBMET01116 0.12 0.048 DBMET00034 0.087 0.086 DBMET03444 0.108 0.057 DBMET01117 0.165 0.028 DB02746 0.094 0.074 DBMET01114 0.096 0.071 DB03091 | DB02746 | |
| 0.098 | 0.013 | 0.098 | Antidiuretic hormone antagonist | 0.053 0.022 DBMET00033 0.039 0.028 DBMET00034 0.036 0.03 DBMET03444 0.044 0.025 DBMET03446 | ||
| 0.135 | 0.052 | 0.135 | Glycogen synthase kinase-3 inhibitor | 0.128 0.056 DBMET03446 | ||
| 0.129 | 0.046 | 0.213 | Protein kinase C gamma inhibitor | 0.105 0.069 DBMET00033 0.104 0.069 DBMET03458 0.201 0.014 DBMET01118 0.14 0.038 DBMET00034 0.112 0.06 DBMET03444 0.213 0.012 DB02746 0.175 0.02 DBMET03446 0.131 0.044 DBMET01114 0.103 0.072 DB03091 0.099 0.079 DB00142 | DB02746 | |
| 0.09 | 0.008 | 0.09 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.029 DBMET00034 0.037 0.026 DBMET01114 | ||
| 0.152 | 0.071 | 0.282 | GABA C receptor rho-2 antagonist | 0.138 0.092 DBMET03458 0.145 0.081 DBMET00034 0.14 0.089 DBMET01117 0.282 0.007 DB02746 0.175 0.046 DBMET03446 0.125 0.115 DBMET01121 0.148 0.076 DB00142 | DB02746 | |
| 0.114 | 0.034 | 0.114 | Polo-like kinase-1 inhibitor | 0.1 0.045 DBMET01118 0.084 0.075 DBMET00034 0.086 0.069 DBMET01120 0.086 0.07 DB02746 0.088 0.066 DBMET03446 0.092 0.057 DBMET01114 0.102 0.043 DB00130 0.082 0.079 DB00142 | ||
| 0.134 | 0.055 | 0.191 | Proteasome inhibitor | 0.111 0.074 DBMET03458 0.097 0.091 DBMET01116 0.137 0.054 DBMET01118 0.119 0.066 DBMET00034 0.183 0.031 DBMET01119 0.191 0.028 DBMET01120 0.105 0.081 DB02746 0.108 0.076 DBMET03446 0.129 0.059 DBMET01114 0.175 0.034 DBMET01121 0.165 0.038 DB03091 0.173 0.035 DB00130 0.143 0.051 DB00142 | DBMET01120 | |
| 0.142 | 0.066 | 0.217 | Ca2+-transporting ATPase inhibitor | 0.156 0.031 DBMET00033 0.146 0.052 DBMET00035 0.133 0.106 DBMET03456 0.135 0.094 DBMET03457 0.135 0.092 DBMET03458 0.147 0.05 DBMET01115 0.139 0.078 DBMET01116 0.146 0.055 DBMET01118 0.137 0.085 DBMET00034 0.144 0.06 DBMET03444 0.166 0.017 DBMET01117 0.143 0.063 DBMET01119 0.135 0.096 DBMET01120 0.217 0.002 DB02746 0.163 0.02 DBMET03446 0.142 0.065 DBMET01114 0.158 0.027 DBMET01121 0.165 0.017 DB03091 0.156 0.03 DB00130 0.179 0.008 DB00142 | DB02746 | |
| 0.083 | 0.008 | 0.083 | Antiviral (Hepatitis D) | 0.069 0.014 DBMET00033 0.06 0.022 DBMET03458 0.071 0.013 DBMET00034 0.064 0.018 DBMET03444 0.073 0.012 DBMET01114 | ||
| 0.092 | 0.018 | 0.092 | 5 Hydroxytryptamine 2A agonist | 0.089 0.02 DBMET03458 0.089 0.02 DBMET00034 0.072 0.035 DBMET01114 | ||
| 0.096 | 0.024 | 0.21 | Protein kinase C alpha inhibitor | 0.067 0.048 DBMET00033 0.062 0.057 DBMET03458 0.139 0.012 DBMET01118 0.074 0.04 DBMET00034 0.1 0.022 DB02746 0.21 0.005 DBMET03446 0.074 0.04 DBMET01114 | DBMET03446 | |
| 0.079 | 0.008 | 0.079 | Vasopressin 2 antagonist | 0.045 0.016 DBMET00033 0.035 0.021 DBMET03458 0.039 0.018 DBMET01118 0.043 0.017 DBMET00034 0.032 0.024 DBMET03444 0.035 0.021 DBMET01119 0.032 0.024 DBMET01120 0.036 0.02 DBMET03446 0.041 0.018 DBMET01114 | ||
| 0.085 | 0.015 | 0.177 | MDM2 inhibitor | 0.073 0.031 DBMET00033 0.067 0.048 DBMET03458 0.122 0.004 DBMET01115 0.142 0.003 DBMET01116 0.067 0.047 DBMET00034 0.177 0.002 DBMET01117 0.071 0.036 DBMET01119 0.1 0.007 DB02746 0.069 0.04 DBMET01114 0.069 0.04 DBMET01121 0.104 0.005 DB03091 0.08 0.02 DB00130 0.09 0.012 DB00142 | DBMET01117 | |
| 0.1 | 0.032 | 0.135 | Glycine receptor antagonist | 0.112 0.023 DBMET00033 0.081 0.056 DBMET00035 0.127 0.015 DBMET03456 0.1 0.033 DBMET03458 0.079 0.059 DBMET00034 0.081 0.055 DBMET03444 0.089 0.043 DBMET01117 0.135 0.011 DB02746 0.112 0.023 DBMET03446 0.085 0.049 DBMET01114 0.101 0.031 DB03091 0.088 0.045 DB00130 0.116 0.02 DB00142 | DB02746 | |
| 0.108 | 0.04 | 0.108 | Alpha 1 adrenoreceptor antagonist | 0.077 0.055 DBMET00034 0.074 0.056 DBMET01114 | ||
| 0.088 | 0.021 | 0.088 | Acetylcholine M5 receptor antagonist | 0.061 0.04 DBMET03458 0.068 0.033 DBMET00034 0.055 0.049 DBMET03446 0.067 0.034 DBMET01114 | ||
| 0.181 | 0.114 | 0.207 | ErbB-1 antagonist | 0.161 0.151 DBMET03458 0.207 0.082 DBMET00034 0.177 0.12 DBMET03444 0.19 0.101 DBMET01114 | DBMET00034 | |
| 0.113 | 0.047 | 0.304 | GABA C receptor rho-1 antagonist | 0.094 0.072 DBMET03458 0.118 0.042 DBMET01115 0.136 0.028 DBMET01116 0.16 0.017 DBMET01118 0.098 0.065 DBMET00034 0.122 0.038 DBMET01117 0.142 0.025 DBMET01119 0.164 0.016 DBMET01120 0.304 0.003 DB02746 0.285 0.004 DBMET03446 0.087 0.083 DBMET01114 0.152 0.02 DBMET01121 0.163 0.016 DB03091 0.187 0.01 DB00130 0.201 0.008 DB00142 | DB02746 | |
| 0.113 | 0.047 | 0.125 | Insulin receptor antagonist | 0.125 0.039 DBMET03446 0.093 0.071 DBMET01114 | DBMET03446 | |
| 0.112 | 0.047 | 0.239 | Protein kinase C mu inhibitor | 0.1 0.057 DBMET00033 0.083 0.076 DBMET03458 0.086 0.072 DBMET01118 0.096 0.061 DBMET00034 0.095 0.062 DBMET03444 0.239 0.008 DBMET03446 0.11 0.048 DBMET01114 | DBMET03446 | |
| 0.121 | 0.056 | 0.121 | GABA receptor agonist | 0.111 0.065 DBMET01117 | ||
| 0.139 | 0.077 | 0.229 | Heat shock protein 70 antagonist | 0.147 0.052 DBMET00033 0.152 0.041 DBMET03456 0.141 0.072 DBMET03458 0.141 0.072 DBMET01115 0.136 0.093 DBMET01116 0.134 0.101 DBMET01118 0.148 0.051 DBMET00034 0.151 0.043 DBMET03444 0.147 0.052 DBMET01117 0.164 0.023 DBMET01119 0.159 0.029 DBMET01120 0.229 0.004 DB02746 0.134 0.099 DBMET03446 0.151 0.044 DBMET01114 0.174 0.015 DBMET01121 0.186 0.01 DB03091 0.172 0.016 DB00130 0.191 0.008 DB00142 | DB02746 | |
| 0.117 | 0.054 | 0.133 | Acetylcholine release stimulant | 0.133 0.03 DB02746 0.11 0.066 DBMET03446 0.097 0.095 DB00130 | DB02746 | |
| 0.089 | 0.027 | 0.089 | Acetylcholine M5 receptor agonist | 0.059 0.057 DB02746 0.068 0.046 DBMET03446 | ||
| 0.085 | 0.024 | 0.114 | Protein kinase C beta inhibitor | 0.073 0.041 DBMET00033 0.07 0.047 DBMET03458 0.112 0.009 DBMET01118 0.083 0.026 DBMET00034 0.071 0.045 DBMET03444 0.114 0.009 DB02746 0.093 0.017 DBMET03446 0.081 0.029 DBMET01114 | DB02746 | |
| 0.071 | 0.009 | 0.071 | Vasopressin 1A antagonist | 0.056 0.012 DBMET00033 0.029 0.02 DBMET00034 0.033 0.017 DBMET03444 0.031 0.018 DBMET03446 | ||
| 0.071 | 0.012 | 0.071 | Vasopressin 1 antagonist | 0.048 0.015 DBMET00033 0.031 0.024 DBMET00034 0.034 0.021 DBMET03444 0.033 0.022 DBMET03446 | ||
| 0.12 | 0.061 | 0.137 | Glycogen synthase kinase-3 beta inhibitor | 0.137 0.05 DBMET03446 | DBMET03446 | |
| 0.109 | 0.05 | 0.361 | Creatine kinase inhibitor | 0.12 0.041 DBMET00033 0.089 0.073 DBMET00035 0.164 0.019 DBMET03458 0.176 0.015 DBMET01115 0.176 0.015 DBMET01116 0.194 0.012 DBMET00034 0.171 0.017 DBMET03444 0.161 0.02 DBMET01117 0.124 0.038 DBMET01119 0.124 0.038 DBMET01120 0.361 0.003 DB02746 0.087 0.076 DBMET03446 0.176 0.015 DBMET01114 0.109 0.05 DBMET01121 0.197 0.011 DB03091 0.197 0.011 DB00130 0.194 0.011 DB00142 | DB02746 | |
| 0.117 | 0.058 | 0.117 | Nav1.5 sodium channel blocker | |||
| 0.122 | 0.065 | 0.123 | Acetylcholine muscarinic antagonist | 0.11 0.079 DBMET01116 0.111 0.078 DBMET00034 0.123 0.063 DBMET03446 0.108 0.081 DBMET01114 0.097 0.094 DB00130 | DBMET03446 | |
| 0.084 | 0.027 | 0.084 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.085 | 0.028 | 0.141 | Phospholipase D inhibitor | 0.078 0.037 DBMET00033 0.079 0.036 DBMET01115 0.103 0.013 DBMET01117 0.097 0.016 DBMET01119 0.098 0.016 DBMET01120 0.112 0.009 DB02746 0.076 0.041 DBMET03446 0.141 0.004 DBMET01121 0.089 0.023 DB03091 0.079 0.036 DB00130 0.11 0.01 DB00142 | DBMET01121 | |
| 0.066 | 0.01 | 0.066 | Nicotinic receptor beta4 subunit antagonist | 0.044 0.019 DBMET00033 0.047 0.018 DBMET03458 0.058 0.013 DBMET00034 0.044 0.02 DBMET03444 0.037 0.026 DBMET03446 0.057 0.013 DBMET01114 | ||
| 0.107 | 0.053 | 0.107 | Alpha adrenoreceptor antagonist | 0.087 0.066 DBMET00034 0.09 0.063 DBMET01114 | ||
| 0.059 | 0.005 | 0.08 | Protein kinase C beta II inhibitor | 0.048 0.007 DBMET00033 0.035 0.018 DBMET03456 0.047 0.007 DBMET03458 0.08 0.004 DBMET01118 0.053 0.005 DBMET00034 0.047 0.007 DBMET03444 0.074 0.004 DB02746 0.08 0.004 DBMET03446 0.051 0.006 DBMET01114 | DBMET03446 | |
| 0.259 | 0.205 | 0.575 | Apoptosis agonist | 0.277 0.19 DBMET00033 0.43 0.1 DBMET00035 0.575 0.055 DBMET03456 0.244 0.222 DBMET03457 0.389 0.119 DBMET03458 0.269 0.196 DBMET01116 0.388 0.119 DBMET00034 0.358 0.135 DBMET03444 0.335 0.149 DBMET01117 0.31 0.165 DB02746 0.424 0.103 DBMET01114 0.256 0.207 DB00142 | DBMET03456 | |
| 0.118 | 0.066 | 0.118 | 5 Hydroxytryptamine antagonist | |||
| 0.084 | 0.033 | 0.085 | Neuronal nicotinic receptor antagonist | 0.066 0.048 DBMET00034 0.085 0.032 DBMET03446 0.062 0.052 DBMET01114 | DBMET03446 | |
| 0.089 | 0.038 | 0.308 | Cathepsin G inhibitor | 0.133 0.024 DBMET01115 0.128 0.025 DBMET01116 0.074 0.049 DBMET00034 0.111 0.029 DBMET01117 0.308 0.009 DBMET01119 0.269 0.011 DBMET01120 0.122 0.027 DB02746 0.073 0.05 DBMET01114 0.242 0.013 DBMET01121 0.282 0.01 DB03091 0.241 0.013 DB00130 0.217 0.015 DB00142 | DBMET01119 | |
| 0.185 | 0.135 | 0.793 | Superoxide dismutase inhibitor | 0.173 0.151 DBMET03458 0.244 0.078 DBMET01115 0.332 0.041 DBMET01116 0.225 0.093 DBMET00034 0.173 0.151 DBMET03444 0.197 0.121 DBMET01117 0.555 0.009 DBMET01119 0.653 0.005 DBMET01120 0.635 0.005 DB02746 0.165 0.162 DBMET03446 0.242 0.08 DBMET01114 0.426 0.022 DBMET01121 0.65 0.005 DB03091 0.793 0.003 DB00130 0.736 0.004 DB00142 | DB00130 | |
| 0.062 | 0.011 | 0.062 | Histone deacetylase 9 inhibitor | 0.036 0.035 DBMET03457 0.038 0.03 DBMET03458 0.042 0.023 DBMET00034 0.042 0.023 DBMET01114 | ||
| 0.179 | 0.13 | 0.271 | Nitric-oxide synthase stimulant | 0.202 0.086 DBMET00033 0.202 0.086 DBMET03456 0.183 0.122 DBMET03458 0.169 0.155 DBMET01118 0.206 0.079 DBMET00034 0.223 0.056 DBMET03444 0.271 0.021 DB02746 0.24 0.04 DBMET03446 0.224 0.055 DBMET01114 0.175 0.141 DBMET01121 0.209 0.075 DB03091 0.209 0.075 DB00130 0.233 0.046 DB00142 | DB02746 | |
| 0.09 | 0.04 | 0.09 | Alpha 1a adrenoreceptor antagonist | 0.061 0.057 DBMET00034 | ||
| 0.066 | 0.017 | 0.089 | HCV NS3/NS4A protease inhibitor | 0.063 0.019 DBMET00033 0.046 0.039 DBMET03458 0.05 0.032 DBMET01115 0.06 0.021 DBMET01118 0.05 0.033 DBMET00034 0.053 0.028 DBMET03444 0.047 0.038 DBMET01117 0.083 0.009 DBMET01119 0.076 0.012 DBMET01120 0.051 0.031 DB02746 0.067 0.016 DBMET03446 0.054 0.027 DBMET01114 0.085 0.009 DBMET01121 0.089 0.008 DB03091 0.074 0.013 DB00130 0.08 0.011 DB00142 | DB03091 | |
| 0.074 | 0.027 | 0.074 | Cyclin-dependent kinase 6 inhibitor | 0.055 0.047 DBMET01114 | ||
| 0.17 | 0.123 | 0.337 | Cyclic AMP phosphodiesterase inhibitor | 0.337 0.029 DBMET03456 0.151 0.15 DBMET03458 0.195 0.098 DBMET00034 0.202 0.092 DBMET01117 0.303 0.041 DB02746 0.203 0.091 DBMET03446 0.212 0.085 DBMET01114 0.151 0.15 DB00142 | DBMET03456 | |
| 0.089 | 0.043 | 0.091 | Thioredoxin reductase inhibitor | 0.076 0.074 DBMET00035 0.091 0.04 DBMET03458 0.089 0.042 DBMET00034 0.079 0.064 DB02746 0.088 0.045 DBMET01114 | DBMET03458 | |
| 0.072 | 0.028 | 0.072 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.057 | 0.013 | 0.107 | Dopamine D5 agonist | 0.04 0.027 DBMET00033 0.072 0.008 DBMET03458 0.107 0.004 DBMET00034 0.06 0.012 DBMET03444 0.072 0.008 DB02746 0.094 0.005 DBMET03446 0.102 0.004 DBMET01114 0.038 0.031 DB03091 0.038 0.031 DB00130 0.055 0.014 DB00142 | DBMET00034 | |
| 0.129 | 0.086 | 0.129 | Activin receptor-like kinase 2 inhibitor | 0.112 0.106 DBMET00034 0.113 0.106 DBMET01114 | ||
| 0.097 | 0.054 | 0.201 | CDK/cyclin complex inhibitor | 0.201 0.019 DBMET03446 0.076 0.074 DBMET01114 | DBMET03446 | |
| 0.074 | 0.032 | 0.074 | 5 Hydroxytryptamine 3 agonist | |||
| 0.07 | 0.028 | 0.129 | Corticotropin releasing factor 2 receptor antagonist | 0.058 0.05 DBMET01116 0.088 0.012 DBMET01118 0.059 0.049 DBMET01117 0.129 0.004 DBMET03446 0.068 0.031 DB03091 0.059 0.048 DB00130 0.058 0.051 DB00142 | DBMET03446 | |
| 0.108 | 0.066 | 0.332 | GABA C receptor antagonist | 0.095 0.086 DBMET03458 0.12 0.053 DBMET01115 0.135 0.04 DBMET01116 0.143 0.034 DBMET01118 0.098 0.081 DBMET00034 0.123 0.049 DBMET01117 0.127 0.046 DBMET01119 0.143 0.034 DBMET01120 0.332 0.004 DB02746 0.331 0.004 DBMET03446 0.094 0.087 DBMET01114 0.135 0.039 DBMET01121 0.186 0.016 DB03091 0.208 0.011 DB00130 0.237 0.008 DB00142 | DB02746 | |
| 0.054 | 0.012 | 0.054 | Histone deacetylase class IV inhibitor | 0.033 0.02 DBMET00035 0.037 0.019 DBMET03457 0.035 0.019 DBMET03458 0.038 0.018 DBMET00034 0.039 0.018 DBMET01114 | ||
| 0.054 | 0.012 | 0.054 | Histone deacetylase 11 inhibitor | 0.033 0.02 DBMET00035 0.037 0.019 DBMET03457 0.035 0.019 DBMET03458 0.038 0.018 DBMET00034 0.039 0.018 DBMET01114 | ||
| 0.066 | 0.024 | 0.066 | Nicotinic receptor alpha7 subunit antagonist | 0.061 0.028 DBMET03446 | ||
| 0.046 | 0.005 | 0.062 | Protein kinase C beta I inhibitor | 0.044 0.005 DBMET00033 0.039 0.01 DBMET03456 0.041 0.008 DBMET03458 0.058 0.003 DBMET01118 0.044 0.005 DBMET00034 0.044 0.006 DBMET03444 0.032 0.03 DBMET01119 0.032 0.028 DBMET01120 0.062 0.003 DB02746 0.052 0.004 DBMET03446 0.043 0.006 DBMET01114 0.035 0.019 DBMET01121 | DB02746 | |
| 0.075 | 0.035 | 0.144 | Glutamate (mGluR7) antagonist | 0.07 0.042 DBMET00035 0.068 0.045 DBMET03457 0.091 0.016 DBMET01115 0.091 0.016 DBMET01116 0.068 0.047 DBMET00034 0.103 0.009 DBMET01117 0.132 0.004 DB02746 0.063 0.057 DBMET03446 0.064 0.054 DBMET01121 0.1 0.01 DB03091 0.131 0.004 DB00130 0.144 0.003 DB00142 | DB00142 | |
| 0.052 | 0.012 | 0.052 | 5 Hydroxytryptamine 2B agonist | |||
| 0.054 | 0.014 | 0.084 | Nerve growth factor antagonist | 0.039 0.037 DBMET03457 0.04 0.036 DBMET00034 0.048 0.02 DBMET01117 0.084 0.004 DB02746 0.049 0.02 DBMET01114 0.039 0.038 DB00142 | DB02746 | |
| 0.062 | 0.022 | 0.066 | Prolyl endopeptidase inhibitor | 0.048 0.04 DBMET03458 0.051 0.034 DBMET01120 0.061 0.024 DB02746 0.048 0.039 DBMET03446 0.05 0.036 DBMET01114 0.066 0.019 DBMET01121 0.049 0.037 DB03091 0.049 0.037 DB00130 0.054 0.031 DB00142 | DBMET01121 | |
| 0.092 | 0.054 | 0.108 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.108 0.039 DBMET03446 | DBMET03446 | |
| 0.055 | 0.017 | 0.055 | Histone deacetylase 7 inhibitor | |||
| 0.064 | 0.028 | 0.167 | Protein kinase C epsilon inhibitor | 0.154 0.005 DBMET01118 0.048 0.044 DBMET00034 0.098 0.013 DB02746 0.167 0.005 DBMET03446 0.048 0.044 DBMET01114 | DBMET03446 | |
| 0.064 | 0.029 | 0.064 | Bromodomain-containing protein 4 inhibitor | |||
| 0.156 | 0.121 | 0.217 | Focal adhesion kinase 2 inhibitor | 0.143 0.141 DBMET01118 0.144 0.14 DB02746 0.217 0.057 DBMET03446 | DBMET03446 | |
| 0.205 | 0.171 | 0.646 | Antithrombotic | 0.211 0.164 DBMET00033 0.646 0.012 DBMET03456 0.318 0.077 DBMET01115 0.269 0.112 DBMET01116 0.273 0.109 DBMET01118 0.224 0.15 DBMET00034 0.205 0.171 DBMET03444 0.321 0.076 DBMET01117 0.532 0.025 DBMET01119 0.466 0.034 DBMET01120 0.369 0.058 DB02746 0.266 0.114 DBMET03446 0.242 0.132 DBMET01114 0.536 0.024 DBMET01121 0.555 0.021 DB03091 0.461 0.035 DB00130 0.557 0.021 DB00142 | DBMET03456 | |
| 0.057 | 0.023 | 0.057 | Bromodomain-containing protein 3 inhibitor | |||
| 0.065 | 0.031 | 0.065 | Phosphodiesterase 1A inhibitor | |||
| 0.037 | 0.005 | 0.045 | 1,3-Beta-glucan synthase inhibitor | 0.045 0.003 DBMET00033 0.037 0.005 DBMET03456 0.035 0.006 DBMET03458 0.038 0.004 DBMET01118 0.037 0.005 DBMET00034 0.045 0.003 DBMET03444 0.04 0.004 DBMET03446 0.038 0.005 DBMET01114 0.027 0.024 DB03091 0.033 0.008 DB00130 | DBMET03444 | |
| 0.099 | 0.067 | 0.099 | Alpha 2c adrenoreceptor antagonist | 0.084 0.082 DBMET00034 0.086 0.08 DBMET01114 | ||
| 0.053 | 0.022 | 0.129 | Melanocortin 4 antagonist | 0.056 0.02 DBMET01118 0.05 0.023 DBMET01119 0.037 0.034 DBMET01120 0.129 0.008 DBMET03446 0.059 0.019 DB03091 0.044 0.027 DB00130 | DBMET03446 | |
| 0.088 | 0.057 | 0.152 | Antineoplastic alkaloid | 0.143 0.03 DBMET00033 0.116 0.039 DBMET00035 0.151 0.027 DBMET03457 0.088 0.057 DBMET03458 0.132 0.033 DBMET00034 0.152 0.027 DBMET03444 0.146 0.029 DBMET01114 | DBMET03444 | |
| 0.097 | 0.066 | 0.26 | Glutamate (mGluR7) agonist | 0.107 0.047 DBMET01115 0.108 0.045 DBMET01118 0.109 0.044 DBMET01117 0.111 0.041 DBMET01119 0.102 0.056 DBMET01120 0.128 0.023 DB02746 0.135 0.019 DBMET03446 0.134 0.019 DBMET01121 0.175 0.006 DB03091 0.193 0.005 DB00130 0.26 0.003 DB00142 | DB00142 | |
| 0.055 | 0.024 | 0.135 | Melanocortin antagonist | 0.056 0.024 DBMET01118 0.055 0.025 DBMET01119 0.044 0.037 DBMET01120 0.135 0.009 DBMET03446 0.06 0.021 DB03091 0.049 0.031 DB00130 | DBMET03446 | |
| 0.059 | 0.028 | 0.059 | 5 Hydroxytryptamine 2 agonist | 0.045 0.044 DBMET03458 | ||
| 0.044 | 0.014 | 0.044 | Histone deacetylase 10 inhibitor | 0.03 0.02 DBMET00035 0.03 0.02 DBMET03457 0.026 0.023 DBMET03458 0.03 0.021 DBMET00034 0.03 0.02 DBMET01114 | ||
| 0.061 | 0.031 | 0.082 | Cyclin B2 inhibitor | 0.06 0.033 DBMET03458 0.061 0.031 DBMET00034 0.082 0.014 DBMET03446 0.061 0.031 DBMET01114 | DBMET03446 | |
| 0.053 | 0.023 | 0.053 | Nicotinic receptor alpha3 subunit antagonist | 0.04 0.035 DBMET00034 0.039 0.038 DB02746 0.045 0.029 DB03091 0.045 0.029 DB00130 | ||
| 0.11 | 0.081 | 0.139 | Cyclin-dependent kinase inhibitor | 0.139 0.062 DBMET03446 | DBMET03446 | |
| 0.065 | 0.037 | 0.09 | Cyclin B1 inhibitor | 0.062 0.041 DBMET03458 0.065 0.038 DBMET00034 0.09 0.015 DBMET03446 0.065 0.038 DBMET01114 | DBMET03446 | |
| 0.069 | 0.041 | 0.069 | Histone deacetylase inhibitor | |||
| 0.051 | 0.023 | 0.074 | Oxytocin agonist | 0.048 0.025 DBMET03458 0.039 0.033 DBMET01116 0.059 0.017 DBMET00034 0.062 0.015 DBMET01119 0.06 0.017 DBMET01120 0.042 0.03 DB02746 0.074 0.007 DBMET03446 0.055 0.02 DBMET01114 0.04 0.032 DBMET01121 0.068 0.011 DB03091 0.068 0.011 DB00130 0.062 0.015 DB00142 | DBMET03446 | |
| 0.082 | 0.056 | 0.09 | Caspase 7 inhibitor | 0.083 0.055 DBMET01115 0.09 0.042 DBMET01117 0.087 0.046 DB02746 0.078 0.067 DB00142 | DBMET01117 | |
| 0.057 | 0.031 | 0.087 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.038 DBMET00033 0.087 0.011 DB02746 | DB02746 | |
| 0.085 | 0.06 | 0.085 | Acetylcholine agonist | 0.08 0.066 DBMET03457 | ||
| 0.041 | 0.017 | 0.041 | Histone deacetylase 4 inhibitor | 0.027 0.026 DBMET03457 0.027 0.026 DBMET00034 0.03 0.023 DBMET01114 | ||
| 0.038 | 0.015 | 0.038 | Adenosine uptake inhibitor | 0.034 0.028 DBMET03446 0.034 0.026 DBMET01114 0.036 0.019 DB00130 0.033 0.031 DB00142 | ||
| 0.096 | 0.073 | 0.267 | Topoisomerase I inhibitor | 0.109 0.063 DBMET00033 0.267 0.014 DBMET03456 0.174 0.033 DBMET03457 0.14 0.045 DBMET03458 0.176 0.033 DBMET00034 0.16 0.038 DBMET03444 0.177 0.033 DBMET01114 | DBMET03456 | |
| 0.089 | 0.067 | 0.576 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.114 0.043 DBMET00033 0.096 0.058 DBMET03456 0.3 0.006 DBMET01115 0.244 0.01 DBMET01116 0.154 0.025 DBMET01118 0.26 0.009 DBMET01117 0.436 0.003 DBMET01119 0.446 0.003 DBMET01120 0.475 0.003 DB02746 0.146 0.028 DBMET03446 0.455 0.003 DBMET01121 0.518 0.002 DB03091 0.562 0.002 DB00130 0.576 0.002 DB00142 | DB00142 | |
| 0.036 | 0.014 | 0.036 | Nicotinic alpha3beta4 receptor agonist | 0.027 0.026 DBMET03446 | ||
| 0.045 | 0.023 | 0.095 | DNA gyrase subunit A inhibitor | 0.055 0.013 DBMET03458 0.063 0.009 DBMET01118 0.048 0.019 DBMET00034 0.056 0.013 DB02746 0.095 0.004 DBMET03446 0.048 0.02 DBMET01114 | DBMET03446 | |
| 0.046 | 0.025 | 0.046 | Histone deacetylase 8 inhibitor | 0.04 0.03 DBMET01114 | ||
| 0.081 | 0.06 | 0.092 | CC chemokine 5 receptor agonist | 0.092 0.033 DBMET00034 0.086 0.046 DB02746 0.079 0.068 DBMET03446 0.083 0.054 DBMET01114 | DBMET00034 | |
| 0.077 | 0.056 | 0.11 | MAP kinase kinase 7 inhibitor | 0.082 0.041 DBMET00033 0.086 0.033 DBMET03458 0.078 0.052 DBMET01118 0.102 0.011 DBMET00034 0.1 0.013 DBMET03444 0.104 0.01 DB02746 0.11 0.007 DBMET03446 0.092 0.022 DBMET01114 0.076 0.06 DB03091 0.086 0.033 DB00142 | DBMET03446 | |
| 0.045 | 0.026 | 0.074 | Growth hormone release inhibitor | 0.037 0.036 DBMET00033 0.038 0.035 DBMET03458 0.043 0.028 DBMET01118 0.043 0.028 DBMET00034 0.037 0.035 DBMET03444 0.048 0.023 DBMET01119 0.037 0.036 DBMET01120 0.064 0.014 DBMET03446 0.039 0.032 DBMET01114 0.074 0.011 DB03091 0.059 0.016 DB00130 0.044 0.027 DB00142 | DB03091 | |
| 0.04 | 0.021 | 0.04 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.047 | 0.03 | 0.053 | Glutamate (mGluR5) agonist | 0.053 0.023 DB02746 | DB02746 | |
| 0.042 | 0.026 | 0.265 | Kainate receptor agonist | 0.042 0.026 DBMET00033 0.041 0.029 DBMET00035 0.058 0.008 DBMET01115 0.058 0.008 DBMET01116 0.046 0.019 DBMET01118 0.058 0.008 DBMET01117 0.054 0.01 DBMET01119 0.063 0.006 DBMET01120 0.092 0.003 DB02746 0.06 0.007 DBMET03446 0.041 0.029 DBMET01114 0.065 0.005 DBMET01121 0.119 0.002 DB03091 0.201 0.001 DB00130 0.265 0.001 DB00142 | DB00142 | |
| 0.106 | 0.089 | 0.238 | Glutamate receptor antagonist | 0.234 0.018 DBMET03457 0.186 0.03 DBMET03458 0.104 0.092 DBMET00034 0.111 0.084 DBMET01117 0.178 0.034 DB02746 0.179 0.033 DB00130 0.238 0.017 DB00142 | DB00142 | |
| 0.103 | 0.086 | 0.159 | Microtubule formation inhibitor | 0.113 0.069 DBMET00033 0.136 0.046 DBMET03456 0.101 0.09 DBMET00034 0.101 0.088 DBMET03444 0.12 0.06 DBMET01117 0.157 0.034 DB02746 0.121 0.06 DBMET03446 0.115 0.066 DBMET01114 0.137 0.045 DB03091 0.133 0.048 DB00130 0.159 0.033 DB00142 | DB00142 | |
| 0.07 | 0.054 | 0.242 | Glycine receptor agonist | 0.083 0.034 DBMET00033 0.079 0.04 DBMET00035 0.1 0.021 DBMET01115 0.077 0.043 DBMET01116 0.066 0.063 DBMET03444 0.113 0.015 DBMET01117 0.083 0.035 DBMET01119 0.076 0.045 DBMET01120 0.208 0.004 DB02746 0.085 0.033 DBMET03446 0.069 0.056 DBMET01114 0.107 0.017 DBMET01121 0.173 0.005 DB03091 0.154 0.006 DB00130 0.242 0.003 DB00142 | DB00142 | |
| 0.07 | 0.055 | 0.506 | Catalase inhibitor | 0.479 0.002 DBMET01115 0.347 0.005 DBMET01116 0.08 0.048 DBMET01118 0.402 0.004 DBMET01117 0.407 0.004 DBMET01119 0.302 0.006 DBMET01120 0.25 0.009 DB02746 0.073 0.052 DBMET03446 0.368 0.004 DBMET01121 0.458 0.003 DB03091 0.462 0.003 DB00130 0.506 0.002 DB00142 | DB00142 | |
| 0.071 | 0.056 | 0.071 | Acetylcholine M4 receptor antagonist | 0.066 0.063 DBMET03446 | ||
| 0.033 | 0.019 | 0.038 | CXC chemokine 3 receptor antagonist | 0.038 0.015 DBMET03446 | DBMET03446 | |
| 0.053 | 0.038 | 0.108 | Alpha-mannosidase inhibitor | 0.066 0.02 DBMET00033 0.051 0.043 DBMET00035 0.101 0.006 DBMET03456 0.057 0.032 DBMET01115 0.057 0.032 DBMET01116 0.05 0.045 DBMET03444 0.054 0.036 DBMET01117 0.05 0.043 DBMET01120 0.084 0.01 DB02746 0.089 0.008 DBMET03446 0.052 0.04 DBMET01114 0.091 0.008 DB03091 0.103 0.006 DB00130 0.108 0.005 DB00142 | DB00142 | |
| 0.047 | 0.034 | 0.066 | Glutamate (mGluR group I) agonist | 0.066 0.018 DB02746 0.061 0.022 DB00142 | DB02746 | |
| 0.037 | 0.023 | 0.104 | p53 inhibitor | 0.068 0.005 DBMET01115 0.08 0.004 DBMET01116 0.104 0.004 DBMET01117 | DBMET01117 | |
| 0.036 | 0.022 | 0.128 | Somatostatin 5 agonist | 0.044 0.016 DBMET00033 0.128 0.004 DBMET01115 0.036 0.022 DBMET01116 0.039 0.02 DBMET03444 0.033 0.027 DBMET01119 0.058 0.01 DBMET03446 0.054 0.011 DB03091 0.04 0.019 DB00130 0.033 0.027 DB00142 | DBMET01115 | |
| 0.033 | 0.019 | 0.039 | Acetylcholine M4 receptor agonist | 0.039 0.015 DBMET03446 | DBMET03446 | |
| 0.122 | 0.11 | 0.182 | MAP3K9 inhibitor | 0.144 0.07 DBMET01118 0.13 0.094 DBMET00034 0.124 0.106 DB02746 0.182 0.025 DBMET03446 | DBMET03446 | |
| 0.041 | 0.029 | 0.086 | Neurokinin 2 antagonist | 0.086 0.013 DBMET03446 0.039 0.031 DB03091 | DBMET03446 | |
| 0.067 | 0.054 | 0.181 | NMDA 2 receptor antagonist | 0.096 0.034 DBMET03457 0.12 0.024 DBMET03458 0.117 0.025 DBMET00034 0.099 0.033 DB02746 0.118 0.025 DBMET03446 0.084 0.041 DBMET01114 0.134 0.02 DB03091 0.181 0.011 DB00130 0.176 0.012 DB00142 | DB00130 | |
| 0.044 | 0.032 | 0.044 | 5 Hydroxytryptamine 2C agonist | |||
| 0.041 | 0.029 | 0.064 | Thymidine kinase inhibitor | 0.064 0.012 DBMET00033 0.043 0.025 DBMET03444 0.046 0.023 DB02746 0.039 0.031 DBMET03446 0.04 0.03 DB00142 | DBMET00033 | |
| 0.141 | 0.13 | 0.509 | Succinate dehydrogenase inhibitor | 0.17 0.08 DBMET00035 0.139 0.135 DBMET03458 0.309 0.009 DBMET01115 0.27 0.017 DBMET01116 0.171 0.079 DBMET01118 0.154 0.105 DBMET00034 0.29 0.012 DBMET01117 0.301 0.01 DBMET01119 0.263 0.018 DBMET01120 0.509 0.003 DB02746 0.173 0.077 DBMET03446 0.178 0.071 DBMET01114 0.279 0.014 DBMET01121 0.422 0.004 DB03091 0.36 0.005 DB00130 0.397 0.004 DB00142 | DB02746 | |
| 0.082 | 0.07 | 0.155 | Granulocyte macrophage colony stimulating factor agonist | 0.083 0.068 DBMET00034 0.083 0.068 DBMET01117 0.097 0.04 DBMET01119 0.097 0.04 DBMET01120 0.155 0.005 DB02746 0.106 0.028 DBMET03446 0.091 0.049 DBMET01114 0.114 0.02 DBMET01121 0.099 0.036 DB03091 0.099 0.036 DB00130 0.116 0.018 DB00142 | DB02746 | |
| 0.057 | 0.046 | 0.072 | Cyclin A1 inhibitor | 0.072 0.02 DBMET03446 0.063 0.033 DB03091 0.057 0.046 DB00130 | DBMET03446 | |
| 0.031 | 0.021 | 0.043 | Dipeptidyl peptidase I inhibitor | 0.028 0.025 DBMET01119 0.043 0.011 DB03091 | DB03091 | |
| 0.022 | 0.011 | 0.022 | Baculoviral IAP repeat-containing protein 3 inhibitor | |||
| 0.057 | 0.047 | 0.071 | Cyclin D1 inhibitor | 0.071 0.027 DBMET03446 | DBMET03446 | |
| 0.04 | 0.03 | 0.053 | Factor XIa inhibitor | 0.053 0.017 DBMET01115 0.041 0.028 DBMET01118 0.05 0.019 DB02746 | DBMET01115 | |
| 0.031 | 0.021 | 0.033 | Cyclophilin A inhibitor | 0.033 0.019 DBMET00033 0.03 0.023 DBMET03444 | DBMET00033 | |
| 0.071 | 0.061 | 0.094 | Nicotinic alpha4beta2 receptor antagonist | 0.094 0.036 DB02746 | DB02746 | |
| 0.05 | 0.042 | 0.109 | Dipeptidyl peptidase inhibitor | 0.109 0.008 DBMET03446 0.073 0.016 DB03091 0.06 0.025 DB00130 0.061 0.024 DB00142 | DBMET03446 | |
| 0.054 | 0.046 | 0.054 | Alpha 1d adrenoreceptor antagonist | |||
| 0.051 | 0.044 | 0.074 | Cyclin B inhibitor | 0.05 0.046 DBMET03458 0.052 0.043 DBMET00034 0.074 0.019 DBMET03446 0.051 0.044 DBMET01114 | DBMET03446 | |
| 0.06 | 0.053 | 0.06 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.014 | 0.007 | 0.014 | Cyclin D2 inhibitor | |||
| 0.025 | 0.018 | 0.025 | Histone deacetylase class IIb inhibitor | 0.024 0.02 DBMET03457 | ||
| 0.016 | 0.009 | 0.022 | CXC chemokine 4 receptor agonist | 0.018 0.007 DBMET03446 0.016 0.01 DB03091 0.022 0.005 DB00130 0.018 0.007 DB00142 | DB00130 | |
| 0.025 | 0.018 | 0.025 | Histone deacetylase 6 inhibitor | 0.024 0.019 DBMET03457 | ||
| 0.035 | 0.029 | 0.053 | Melanocortin 1 antagonist | 0.053 0.019 DBMET03446 0.048 0.02 DB03091 0.045 0.022 DB00130 | DBMET03446 | |
| 0.064 | 0.058 | 0.064 | Phosphodiesterase V inhibitor | |||
| 0.034 | 0.029 | 0.106 | 5-Alpha-reductase inhibitor | 0.103 0.01 DBMET01118 0.034 0.03 DBMET00034 0.046 0.02 DBMET01117 0.044 0.021 DBMET01119 0.106 0.009 DB02746 0.035 0.028 DBMET01114 0.099 0.01 DBMET01121 0.034 0.029 DB00142 | DB02746 | |
| 0.019 | 0.013 | 0.207 | Melatonin 3 antagonist | 0.207 0.004 DBMET03446 | DBMET03446 | |
| 0.026 | 0.021 | 0.084 | Melanocortin 3 antagonist | 0.084 0.012 DBMET03446 0.053 0.014 DB03091 | DBMET03446 | |
| 0.049 | 0.044 | 0.049 | Acetylcholine M2 receptor agonist | |||
| 0.049 | 0.044 | 0.066 | Acetylcholine muscarinic agonist | 0.066 0.029 DBMET03457 0.051 0.042 DBMET03446 | DBMET03457 | |
| 0.012 | 0.008 | 0.023 | Melatonin 5 antagonist | 0.023 0.004 DBMET03446 | DBMET03446 | |
| 0.062 | 0.059 | 0.744 | Glutamate (mGluR6) antagonist | 0.062 0.059 DBMET00033 0.109 0.008 DBMET01115 0.086 0.018 DBMET01116 0.077 0.028 DBMET01118 0.107 0.008 DBMET01117 0.136 0.004 DBMET01119 0.123 0.005 DBMET01120 0.199 0.003 DB02746 0.094 0.013 DBMET03446 0.167 0.003 DBMET01121 0.339 0.002 DB03091 0.384 0.002 DB00130 0.744 0.001 DB00142 | DB00142 | |
| 0.037 | 0.034 | 0.054 | Glutamate (mGluR1a) antagonist | 0.054 0.018 DB02746 | DB02746 | |
| 0.048 | 0.045 | 0.048 | Phosphodiesterase 7A inhibitor | |||
| 0.041 | 0.038 | 0.124 | Mannosidase inhibitor | 0.054 0.022 DBMET00033 0.103 0.005 DBMET03456 0.052 0.023 DBMET01115 0.043 0.034 DBMET01116 0.049 0.027 DBMET01117 0.046 0.03 DBMET01119 0.044 0.034 DBMET01120 0.09 0.007 DB02746 0.082 0.008 DBMET03446 0.05 0.025 DBMET01121 0.094 0.006 DB03091 0.089 0.007 DB00130 0.124 0.004 DB00142 | DB00142 | |
| 0.08 | 0.077 | 0.08 | Phosphodiesterase I inhibitor | |||
| 0.025 | 0.023 | 0.025 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.068 | 0.066 | 0.489 | GABA aminotransferase inhibitor | 0.128 0.013 DBMET01115 0.106 0.023 DBMET01116 0.133 0.011 DBMET01118 0.074 0.056 DBMET00034 0.12 0.016 DBMET01117 0.202 0.004 DBMET01119 0.161 0.006 DBMET01120 0.296 0.003 DB02746 0.172 0.005 DBMET03446 0.072 0.059 DBMET01114 0.192 0.004 DBMET01121 0.418 0.003 DB03091 0.288 0.004 DB00130 0.489 0.003 DB00142 | DB00142 | |
| 0.034 | 0.033 | 0.034 | Cyclin D3 inhibitor | |||
| 0.078 | 0.078 | 0.414 | NADH dehydrogenase inhibitor | 0.108 0.036 DBMET00033 0.084 0.066 DBMET00035 0.142 0.02 DBMET03456 0.09 0.056 DBMET01115 0.09 0.056 DBMET01116 0.09 0.057 DBMET01118 0.084 0.067 DBMET00034 0.101 0.043 DBMET03444 0.115 0.032 DBMET01117 0.098 0.046 DBMET01119 0.098 0.046 DBMET01120 0.414 0.004 DB02746 0.128 0.025 DBMET03446 0.092 0.053 DBMET01114 0.124 0.026 DBMET01121 0.165 0.014 DB03091 0.165 0.014 DB00130 0.213 0.009 DB00142 | DB02746 | |
| 0.035 | 0.035 | 0.067 | MAP3K5 inhibitor | 0.038 0.029 DBMET01116 0.067 0.004 DBMET01117 | DBMET01117 | |
| 0.15 | 0.15 | 0.374 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.205 0.068 DBMET00033 0.166 0.115 DBMET03458 0.16 0.127 DBMET01115 0.166 0.115 DBMET01116 0.237 0.049 DBMET01118 0.184 0.088 DBMET00034 0.232 0.051 DBMET03444 0.171 0.107 DBMET01117 0.178 0.095 DBMET01119 0.186 0.086 DBMET01120 0.374 0.01 DB02746 0.183 0.089 DBMET03446 0.182 0.09 DBMET01114 0.192 0.08 DBMET01121 0.235 0.05 DB03091 0.246 0.044 DB00130 0.253 0.041 DB00142 | DB02746 | |
| 0.043 | 0.043 | 0.045 | Baculoviral IAP repeat-containing protein inhibitor | 0.044 0.039 DBMET01118 0.045 0.035 DB03091 | DB03091 | |
| 0.044 | 0.044 | 0.046 | Neurokinin antagonist | 0.046 0.041 DBMET03446 | DBMET03446 | |
| 0.054 | 0.055 | 0.067 | Gonadotropin-releasing hormone receptor agonist | 0.056 0.047 DBMET00034 0.06 0.04 DBMET01119 0.058 0.044 DBMET01120 0.062 0.037 DBMET03446 0.059 0.041 DB03091 0.067 0.029 DB00130 | DB00130 | |
| 0.052 | 0.053 | 0.66 | Carbamoyl phosphate synthetase inhibitor | 0.083 0.027 DBMET00033 0.187 0.008 DBMET01115 0.125 0.015 DBMET01116 0.055 0.049 DBMET03444 0.194 0.008 DBMET01117 0.139 0.012 DBMET01119 0.138 0.013 DBMET01120 0.169 0.009 DB02746 0.126 0.015 DBMET03446 0.055 0.049 DBMET01114 0.217 0.006 DBMET01121 0.544 0.002 DB03091 0.543 0.002 DB00130 0.66 0.001 DB00142 | DB00142 | |
| 0.022 | 0.023 | 0.078 | Melanocortin 5 antagonist | 0.078 0.009 DBMET03446 | DBMET03446 | |
| 0.025 | 0.027 | 0.039 | Baculoviral IAP repeat-containing protein 4 inhibitor | 0.029 0.016 DBMET01119 0.033 0.011 DBMET01120 0.027 0.02 DBMET01121 0.037 0.009 DB03091 0.039 0.008 DB00130 0.032 0.012 DB00142 | DB00130 | |
| 0.135 | 0.138 | 0.225 | Antimitotic | 0.209 0.079 DBMET00035 0.17 0.104 DBMET03457 0.176 0.099 DBMET00034 0.225 0.071 DBMET01114 | DBMET01114 | |
| 0.134 | 0.137 | 0.214 | MAP kinase kinase 2 inhibitor | 0.183 0.093 DB02746 0.214 0.073 DBMET03446 | DBMET03446 | |
| 0.024 | 0.028 | 0.026 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.024 DBMET03446 | DBMET03446 | |
| 0.051 | 0.055 | 0.169 | Bombesin 1 receptor agonist | 0.074 0.029 DBMET01116 0.095 0.019 DBMET01119 0.096 0.019 DBMET01120 0.129 0.011 DB03091 0.169 0.006 DB00130 0.055 0.047 DB00142 | DB00130 | |
| 0.196 | 0.201 | 0.489 | Immunosuppressant | 0.308 0.11 DBMET00033 0.329 0.098 DBMET00035 0.489 0.036 DBMET03456 0.219 0.177 DBMET03458 0.239 0.157 DBMET00034 0.294 0.119 DBMET03444 0.321 0.102 DBMET01119 0.301 0.114 DBMET01120 0.365 0.079 DB02746 0.258 0.142 DBMET01114 0.344 0.09 DBMET01121 0.442 0.049 DB03091 0.38 0.072 DB00130 0.453 0.046 DB00142 | DBMET03456 | |
| 0.05 | 0.055 | 0.056 | 5 Hydroxytryptamine 7 agonist | 0.056 0.039 DBMET03446 | DBMET03446 | |
| 0.018 | 0.024 | 0.305 | Glutamate (mGluR1a) agonist | 0.047 0.005 DBMET01115 0.024 0.013 DBMET01116 0.045 0.005 DBMET01117 0.075 0.004 DBMET01119 0.052 0.005 DBMET01120 0.109 0.004 DB02746 0.124 0.003 DBMET01121 0.187 0.002 DB03091 0.207 0.002 DB00130 0.305 0.001 DB00142 | DB00142 | |
| 0.08 | 0.087 | 0.123 | Protein kinase C zeta inhibitor | 0.085 0.074 DBMET03458 0.101 0.049 DBMET00034 0.093 0.061 DBMET03444 0.111 0.039 DB02746 0.123 0.03 DBMET03446 0.094 0.059 DBMET01114 0.085 0.076 DB00142 | DBMET03446 | |
| 0.029 | 0.036 | 0.057 | Factor XI inhibitor | 0.047 0.011 DBMET01115 0.046 0.012 DBMET01118 0.036 0.02 DB02746 0.057 0.008 DBMET03446 | DBMET03446 | |
| 0.099 | 0.107 | 0.14 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.098 DBMET00034 0.14 0.032 DBMET03446 | DBMET03446 | |
| 0.085 | 0.093 | 0.189 | DNA intercalator | 0.16 0.038 DBMET03456 0.108 0.066 DBMET01115 0.154 0.04 DBMET01116 0.097 0.077 DBMET00034 0.189 0.029 DBMET01117 0.093 0.081 DBMET01114 | DBMET01117 | |
| 0.011 | 0.019 | 0.079 | 5-Alpha-reductase 1 inhibitor | 0.04 0.008 DBMET01118 0.017 0.012 DBMET01117 0.079 0.005 DB02746 0.022 0.01 DBMET01121 | DB02746 | |
| 0.03 | 0.038 | 0.049 | Growth factor receptor-bound protein 2 antagonist | 0.035 0.025 DBMET01116 0.041 0.013 DBMET01119 0.041 0.013 DBMET01120 0.032 0.031 DBMET03446 0.033 0.03 DBMET01121 0.048 0.005 DB03091 0.049 0.005 DB00130 0.04 0.014 DB00142 | DB00130 | |
| 0.048 | 0.056 | 0.38 | Biliverdin reductase inhibitor | 0.068 0.034 DBMET00033 0.193 0.006 DBMET01115 0.154 0.009 DBMET01116 0.087 0.023 DBMET01118 0.147 0.01 DBMET01117 0.205 0.005 DBMET01119 0.165 0.008 DBMET01120 0.38 0.002 DB02746 0.096 0.02 DBMET03446 0.156 0.009 DBMET01121 0.278 0.004 DB03091 0.232 0.004 DB00130 0.243 0.004 DB00142 | DB02746 | |
| 0.014 | 0.023 | 0.08 | 5-Alpha-reductase 2 inhibitor | 0.052 0.007 DBMET01118 0.02 0.013 DBMET01117 0.08 0.006 DB02746 0.027 0.01 DBMET01121 | DB02746 | |
| 0.029 | 0.039 | 0.087 | Kinesin antagonist | 0.033 0.031 DBMET00034 0.077 0.011 DB00130 0.087 0.009 DB00142 | DB00142 | |
| 0.029 | 0.039 | 0.087 | Kinesin-like protein 1 inhibitor | 0.033 0.031 DBMET00034 0.077 0.011 DB00130 0.087 0.009 DB00142 | DB00142 | |
| 0.043 | 0.053 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.039 DB02746 | DB02746 | |
| 0.043 | 0.053 | 0.054 | Histamine agonist | 0.054 0.034 DBMET03446 | DBMET03446 | |
| 0.031 | 0.041 | 0.22 | Erythropoietin receptor agonist | 0.036 0.033 DBMET01116 0.035 0.034 DBMET00034 0.077 0.013 DBMET01119 0.095 0.011 DBMET01120 0.063 0.016 DBMET01121 0.083 0.012 DB03091 0.22 0.006 DB00130 0.08 0.013 DB00142 | DB00130 | |
| 0.041 | 0.051 | 0.046 | Potassium channel (ATP-sensitive) activator | 0.046 0.037 DB02746 | DB02746 | |
| 0.07 | 0.08 | 0.269 | NMDA receptor antagonist | 0.109 0.041 DBMET03457 0.136 0.029 DBMET03458 0.091 0.053 DBMET01115 0.197 0.015 DBMET01116 0.111 0.04 DBMET00034 0.202 0.014 DBMET01117 0.077 0.069 DBMET01119 0.083 0.062 DBMET01120 0.19 0.016 DB02746 0.112 0.04 DBMET03446 0.084 0.061 DBMET01114 0.088 0.056 DBMET01121 0.164 0.02 DB03091 0.215 0.012 DB00130 0.269 0.008 DB00142 | DB00142 | |
| 0.034 | 0.044 | 0.078 | Guanylate cyclase inhibitor | 0.039 0.035 DBMET01117 0.078 0.003 DB02746 0.045 0.027 DB00142 | DB02746 | |
| 0.042 | 0.052 | 0.116 | Topoisomerase II beta inhibitor | 0.055 0.027 DBMET00034 0.116 0.007 DB02746 0.049 0.034 DBMET03446 0.059 0.022 DBMET01114 | DB02746 | |
| 0.055 | 0.066 | 0.077 | Histone deacetylase SIRT3 inhibitor | 0.061 0.047 DBMET01118 0.064 0.037 DBMET01119 0.064 0.039 DBMET01120 0.077 0.02 DBMET03446 0.075 0.022 DB03091 0.073 0.025 DB00130 | DBMET03446 | |
| 0.031 | 0.042 | 0.081 | Tryptophan 5 hydroxylase inhibitor | 0.042 0.012 DBMET01119 0.047 0.007 DBMET01120 0.056 0.004 DB02746 0.039 0.017 DBMET03446 0.051 0.005 DBMET01121 0.056 0.004 DB03091 0.064 0.004 DB00130 0.081 0.003 DB00142 | DB00142 | |
| 0.036 | 0.048 | 0.177 | AICAR transformylase inhibitor | 0.045 0.029 DBMET00033 0.061 0.014 DBMET01115 0.048 0.024 DBMET01116 0.067 0.011 DBMET01117 0.125 0.004 DBMET01119 0.138 0.003 DBMET01120 0.073 0.009 DB02746 0.04 0.038 DBMET03446 0.177 0.002 DBMET01121 0.108 0.004 DB03091 0.104 0.005 DB00130 0.144 0.003 DB00142 | DBMET01121 | |
| 0.049 | 0.062 | 0.39 | NMDA 2C receptor antagonist | 0.071 0.032 DBMET03457 0.065 0.039 DBMET03458 0.075 0.028 DBMET01115 0.073 0.031 DBMET01116 0.055 0.053 DBMET01118 0.061 0.043 DBMET00034 0.061 0.044 DBMET01117 0.131 0.009 DBMET01119 0.112 0.012 DBMET01120 0.103 0.015 DB02746 0.139 0.008 DBMET03446 0.098 0.016 DBMET01121 0.261 0.004 DB03091 0.367 0.004 DB00130 0.39 0.003 DB00142 | DB00142 | |
| 0.023 | 0.036 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.03 0.01 DBMET00033 0.028 0.014 DB02746 | DBMET00033 | |
| 0.037 | 0.051 | 0.32 | Glutamate (mGluR group III) antagonist | 0.046 0.026 DBMET03457 0.071 0.009 DBMET01115 0.061 0.013 DBMET01116 0.073 0.009 DBMET01117 0.056 0.015 DBMET01119 0.063 0.012 DBMET01120 0.146 0.004 DB02746 0.046 0.026 DBMET03446 0.077 0.008 DBMET01121 0.152 0.004 DB03091 0.206 0.003 DB00130 0.32 0.002 DB00142 | DB00142 | |
| 0.007 | 0.02 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET00033 0.01 0.008 DBMET03456 | DBMET03456 | |
| 0.031 | 0.045 | 0.082 | Dopamine D2 agonist | 0.055 0.024 DBMET03458 0.052 0.025 DBMET00034 0.082 0.014 DBMET03446 0.064 0.019 DBMET01114 | DBMET03446 | |
| 0.019 | 0.033 | 0.073 | Uridine phosphorylase inhibitor | 0.031 0.017 DBMET00033 0.073 0.004 DB02746 0.027 0.021 DBMET03446 0.031 0.017 DB03091 0.032 0.016 DB00142 | DB02746 | |
| 0.047 | 0.062 | 0.084 | Androgen agonist | 0.071 0.03 DBMET00033 0.066 0.034 DBMET00034 0.083 0.022 DBMET03444 0.084 0.022 DB02746 0.062 0.039 DBMET01114 | DB02746 | |
| 0.047 | 0.062 | 0.103 | CDK1/cyclin B inhibitor | 0.103 0.023 DBMET03446 | DBMET03446 | |
| 0.026 | 0.041 | 0.131 | Somatostatin 1 antagonist | 0.054 0.018 DBMET01118 0.042 0.024 DBMET01119 0.131 0.005 DBMET03446 0.07 0.011 DB03091 0.05 0.02 DB00130 0.034 0.03 DB00142 | DBMET03446 | |
| 0.031 | 0.046 | 0.121 | Membrane dipeptidase inhibitor | 0.078 0.005 DBMET01115 0.08 0.005 DBMET01116 0.085 0.005 DBMET01117 0.076 0.006 DBMET01119 0.084 0.005 DBMET01120 0.07 0.007 DB02746 0.045 0.02 DBMET03446 0.091 0.004 DBMET01121 0.109 0.003 DB03091 0.109 0.003 DB00130 0.121 0.003 DB00142 | DB00142 | |
| 0.117 | 0.133 | 0.265 | Adenylate cyclase stimulant | 0.147 0.068 DBMET00033 0.155 0.055 DBMET01115 0.134 0.092 DBMET01116 0.141 0.079 DBMET00034 0.156 0.054 DBMET03444 0.16 0.048 DBMET01117 0.163 0.044 DBMET01119 0.127 0.109 DBMET01120 0.186 0.022 DB02746 0.175 0.03 DBMET03446 0.156 0.053 DBMET01114 0.153 0.058 DBMET01121 0.265 0.004 DB03091 0.208 0.01 DB00130 0.252 0.004 DB00142 | DB03091 | |
| 0.177 | 0.193 | 0.259 | Nootropic | 0.259 0.1 DBMET01115 0.187 0.177 DBMET03446 | DBMET01115 | |
| 0.016 | 0.033 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 DBMET00033 0.021 0.013 DB02746 | DB02746 | |
| 0.038 | 0.055 | 0.089 | Dipeptidyl peptidase IV inhibitor | 0.089 0.006 DBMET03446 0.051 0.019 DB03091 0.049 0.022 DB00130 0.051 0.02 DB00142 | DBMET03446 | |
| 0.066 | 0.084 | 0.118 | Androgen antagonist | 0.101 0.046 DBMET00033 0.095 0.05 DBMET00034 0.118 0.034 DBMET03444 0.102 0.045 DB02746 0.091 0.054 DBMET01114 | DBMET03444 | |
| 0.113 | 0.131 | 0.314 | NOS3 expression enhancer | 0.314 0.016 DBMET03456 0.153 0.069 DBMET03458 0.313 0.016 DBMET01118 0.18 0.05 DBMET00034 0.149 0.073 DBMET03444 0.203 0.04 DB02746 0.18 0.05 DBMET01114 | DBMET03456 | |
| 0.103 | 0.121 | 0.127 | Nav1.6 sodium channel blocker | 0.122 0.093 DBMET03446 0.127 0.085 DB03091 | DB03091 | |
| 0.046 | 0.064 | 0.123 | Dihydroorotate oxidase inhibitor | 0.061 0.027 DBMET01118 0.123 0.004 DB02746 0.055 0.038 DBMET03446 0.053 0.044 DBMET01114 | DB02746 | |
| 0.047 | 0.065 | 0.07 | Kallikrein 1 inhibitor | 0.054 0.044 DBMET01119 0.054 0.043 DBMET01120 0.07 0.024 DBMET03446 0.057 0.038 DB03091 0.062 0.031 DB00130 0.052 0.049 DB00142 | DBMET03446 | |
| 0.073 | 0.092 | 0.094 | mTOR complex 2 inhibitor | 0.094 0.041 DB02746 0.077 0.076 DBMET03446 | DB02746 | |
| 0.042 | 0.061 | 0.068 | NMDA 2B receptor antagonist | 0.068 0.026 DBMET00034 0.048 0.046 DBMET01114 | DBMET00034 | |
| 0.041 | 0.061 | 0.605 | Argininosuccinate synthase inhibitor | 0.064 0.034 DBMET00033 0.122 0.015 DBMET01115 0.092 0.021 DBMET01116 0.056 0.041 DBMET01118 0.126 0.014 DBMET01117 0.207 0.007 DBMET01119 0.253 0.005 DBMET01120 0.28 0.004 DB02746 0.098 0.019 DBMET03446 0.306 0.004 DBMET01121 0.361 0.003 DB03091 0.421 0.002 DB00130 0.605 0.001 DB00142 | DB00142 | |
| 0.102 | 0.122 | 0.714 | Peroxidase inhibitor | 0.187 0.063 DBMET03458 0.21 0.056 DBMET01115 0.296 0.038 DBMET01116 0.263 0.045 DBMET00034 0.167 0.07 DBMET03444 0.226 0.053 DBMET01117 0.161 0.072 DBMET01119 0.336 0.031 DBMET01120 0.542 0.007 DB02746 0.205 0.058 DBMET03446 0.26 0.045 DBMET01114 0.282 0.041 DBMET01121 0.54 0.007 DB03091 0.705 0.003 DB00130 0.714 0.003 DB00142 | DB00142 | |
| 0.004 | 0.024 | 0.008 | DNA topoisomerase III inhibitor | 0.008 0.005 DB02746 | DB02746 | |
| 0.064 | 0.084 | 0.098 | Vanilloid 4 agonist | 0.081 0.038 DBMET01117 0.085 0.033 DBMET01119 0.091 0.025 DB02746 0.072 0.059 DBMET03446 0.088 0.028 DBMET01121 0.096 0.02 DB03091 0.076 0.049 DB00130 0.098 0.018 DB00142 | DB00142 | |
| 0.015 | 0.036 | 0.044 | Vasopressin 1B antagonist | 0.044 0.008 DBMET03446 | DBMET03446 | |
| 0.11 | 0.131 | 0.235 | Sigma receptor agonist | 0.133 0.099 DBMET00034 0.235 0.052 DB02746 | DB02746 | |
| 0.036 | 0.058 | 0.131 | Aldose reductase inhibitor | 0.094 0.019 DBMET03456 0.072 0.026 DBMET03458 0.049 0.039 DBMET01115 0.06 0.032 DBMET01116 0.067 0.028 DBMET00034 0.131 0.013 DBMET01117 0.047 0.042 DB02746 0.075 0.025 DBMET01114 | DBMET01117 | |
| 0.032 | 0.054 | 0.202 | Neurotensin receptor antagonist | 0.059 0.024 DBMET01119 0.137 0.011 DBMET01120 0.116 0.012 DBMET01121 0.202 0.007 DB03091 0.182 0.008 DB00130 0.178 0.008 DB00142 | DB03091 | |
| 0.078 | 0.1 | 0.097 | Cyclin-dependent kinase 5 inhibitor | 0.097 0.078 DBMET03446 | DBMET03446 | |
| 0.013 | 0.035 | 0.038 | Integrin beta5 antagonist | 0.019 0.016 DBMET01120 0.021 0.014 DBMET03446 0.02 0.015 DBMET01121 0.026 0.01 DB03091 0.029 0.009 DB00130 0.038 0.007 DB00142 | DB00142 | |
| 0.055 | 0.077 | 0.075 | Kallikrein 7 inhibitor | 0.075 0.02 DBMET01115 0.063 0.046 DBMET01116 0.062 0.05 DBMET01120 | DBMET01115 | |
| 0.02 | 0.042 | 0.134 | Caspase 2 inhibitor | 0.037 0.018 DBMET01115 0.028 0.026 DBMET01118 0.038 0.017 DBMET01117 0.065 0.008 DBMET01119 0.055 0.01 DBMET01120 0.077 0.006 DBMET01121 0.134 0.004 DB03091 0.084 0.005 DB00130 0.134 0.004 DB00142 | DB00142 | |
| 0.005 | 0.028 | 0.04 | Melanocortin 5 agonist | 0.04 0.013 DB03091 | DB03091 | |
| 0.07 | 0.094 | 0.427 | Aminopeptidase B inhibitor | 0.175 0.028 DBMET01115 0.176 0.028 DBMET01116 0.128 0.048 DBMET01118 0.162 0.033 DBMET01117 0.248 0.013 DBMET01119 0.295 0.009 DBMET01120 0.255 0.012 DB02746 0.198 0.022 DBMET03446 0.28 0.01 DBMET01121 0.314 0.008 DB03091 0.404 0.004 DB00130 0.427 0.004 DB00142 | DB00142 | |
| 0.016 | 0.039 | 0.036 | Vasopressin 1 agonist | 0.021 0.018 DBMET01119 0.021 0.016 DBMET01120 0.036 0.004 DBMET03446 0.024 0.011 DB00130 | DBMET03446 | |
| 0.131 | 0.154 | 0.54 | Anticonvulsant | 0.54 0.01 DBMET01115 0.329 0.033 DBMET03446 0.263 0.052 DB03091 0.255 0.055 DB00130 0.274 0.048 DB00142 | DBMET01115 | |
| 0.07 | 0.093 | 0.183 | Protein kinase C delta inhibitor | 0.155 0.019 DBMET01118 0.183 0.011 DB02746 0.16 0.017 DBMET03446 | DB02746 | |
| 0.014 | 0.038 | 0.043 | Caspase 8 inhibitor | 0.032 0.004 DBMET01115 0.024 0.008 DBMET01116 0.027 0.006 DBMET01118 0.03 0.005 DBMET01117 0.038 0.004 DBMET01119 0.035 0.004 DBMET01120 0.021 0.012 DB02746 0.043 0.003 DBMET01121 0.032 0.004 DB03091 0.028 0.005 DB00130 0.03 0.005 DB00142 | DBMET01121 | |
| 0.077 | 0.101 | 0.202 | Interleukin 1 beta converting enzyme inhibitor | 0.181 0.009 DBMET01115 0.126 0.03 DBMET01116 0.13 0.027 DBMET01118 0.172 0.01 DBMET01117 0.185 0.008 DBMET01119 0.164 0.013 DBMET01120 0.121 0.035 DB02746 0.202 0.005 DBMET01121 0.157 0.014 DB03091 0.144 0.02 DB00130 0.172 0.01 DB00142 | DBMET01121 | |
| 0.088 | 0.113 | 0.218 | Caspase 3 inhibitor | 0.197 0.01 DBMET01115 0.142 0.034 DBMET01116 0.128 0.049 DBMET01118 0.194 0.01 DBMET01117 0.194 0.01 DBMET01119 0.16 0.022 DBMET01120 0.153 0.026 DB02746 0.218 0.007 DBMET01121 0.174 0.016 DB03091 0.161 0.021 DB00130 0.188 0.012 DB00142 | DBMET01121 | |
| 0.008 | 0.033 | 0.048 | Melanocortin 1 agonist | 0.048 0.014 DB03091 | DB03091 | |
| 0.166 | 0.191 | 0.305 | Neuropeptide Y2 antagonist | 0.187 0.145 DBMET01115 0.211 0.101 DBMET01116 0.255 0.052 DBMET01119 0.237 0.069 DBMET01120 0.213 0.098 DB02746 0.188 0.142 DBMET01121 0.305 0.017 DB03091 0.297 0.02 DB00130 0.266 0.042 DB00142 | DB03091 | |
| 0.051 | 0.075 | 0.09 | Ryanodine receptor antagonist | 0.059 0.041 DBMET00034 0.09 0.005 DB02746 0.055 0.053 DBMET03446 0.058 0.043 DBMET01114 0.056 0.051 DB00142 | DB02746 | |
| 0.014 | 0.038 | 0.039 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DBMET01117 0.039 0.013 DB02746 0.035 0.015 DBMET03446 0.03 0.018 DB03091 0.024 0.023 DB00130 0.037 0.013 DB00142 | DB02746 | |
| 0.012 | 0.037 | 0.033 | Dopamine autoreceptor agonist | 0.033 0.012 DBMET03446 | DBMET03446 | |
| 0.019 | 0.044 | 0.044 | Gonadotropin-releasing hormone receptor antagonist | 0.044 0.019 DBMET03458 | DBMET03458 | |
| 0.054 | 0.081 | 0.322 | Aminopeptidase I inhibitor | 0.158 0.011 DBMET01115 0.139 0.015 DBMET01116 0.067 0.057 DBMET01118 0.126 0.018 DBMET01117 0.268 0.004 DBMET01119 0.268 0.004 DBMET01120 0.205 0.006 DB02746 0.074 0.049 DBMET03446 0.248 0.004 DBMET01121 0.322 0.003 DB03091 0.285 0.003 DB00130 0.294 0.003 DB00142 | DB03091 | |
| 0.051 | 0.077 | 0.149 | Protease 3C (Human rhinovirus) inhibitor | 0.092 0.019 DBMET01115 0.096 0.017 DBMET01116 0.059 0.055 DBMET01117 0.127 0.009 DBMET01119 0.132 0.008 DBMET01120 0.08 0.027 DB02746 0.072 0.035 DBMET03446 0.086 0.023 DBMET01121 0.132 0.008 DB03091 0.149 0.007 DB00130 0.102 0.015 DB00142 | DB00130 | |
| 0.053 | 0.081 | 0.128 | Histone deacetylase SIRT2 inhibitor | 0.071 0.054 DBMET01118 0.097 0.032 DBMET01119 0.103 0.026 DBMET03446 0.128 0.013 DB03091 0.085 0.041 DB00130 | DB03091 | |
| 0.018 | 0.046 | 0.329 | Glutamate (mGluR1) agonist | 0.031 0.009 DBMET01115 0.024 0.019 DBMET01116 0.028 0.011 DBMET01117 0.065 0.004 DBMET01119 0.064 0.004 DBMET01120 0.091 0.004 DB02746 0.107 0.004 DBMET01121 0.15 0.003 DB03091 0.226 0.002 DB00130 0.329 0.002 DB00142 | DB00142 | |
| 0.01 | 0.038 | 0.033 | Neurokinin 1 agonist | 0.023 0.012 DBMET01119 0.02 0.015 DBMET01120 0.033 0.009 DB03091 0.027 0.011 DB00130 0.02 0.015 DB00142 | DB03091 | |
| 0.021 | 0.049 | 0.048 | Lysophosphatidic acid 2 receptor antagonist | 0.048 0.009 DB02746 0.03 0.021 DBMET01121 0.029 0.023 DB00130 0.044 0.01 DB00142 | DB02746 | |
| 0.011 | 0.039 | 0.035 | Melanocortin agonist | 0.035 0.016 DB03091 | DB03091 | |
| 0.093 | 0.122 | 0.32 | Cathepsin H inhibitor | 0.128 0.066 DBMET01115 0.131 0.062 DBMET01116 0.318 0.009 DBMET01119 0.314 0.009 DBMET01120 0.21 0.02 DB02746 0.263 0.012 DBMET01121 0.32 0.009 DB03091 0.274 0.011 DB00130 0.246 0.014 DB00142 | DB03091 | |
| 0.041 | 0.07 | 0.107 | CC chemokine 2 receptor antagonist | 0.107 0.012 DBMET01118 0.061 0.032 DB02746 0.06 0.033 DBMET03446 | DBMET01118 | |
| 0.104 | 0.133 | 0.162 | Acetylcholine M1 receptor antagonist | 0.148 0.076 DBMET01116 0.129 0.096 DBMET01117 0.132 0.093 DB02746 0.162 0.064 DBMET03446 0.162 0.064 DB00130 0.15 0.075 DB00142 | DB00130 | |
| 0.041 | 0.071 | 0.128 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.064 0.031 DBMET00033 0.058 0.036 DBMET01117 0.128 0.01 DB02746 0.065 0.03 DBMET03446 0.061 0.033 DB03091 0.061 0.033 DB00130 0.08 0.02 DB00142 | DB02746 | |
| 0.056 | 0.086 | 0.825 | Glutamate dehydrogenase inhibitor | 0.074 0.051 DBMET00033 0.277 0.006 DBMET01115 0.26 0.007 DBMET01116 0.084 0.041 DBMET01118 0.205 0.01 DBMET01117 0.507 0.003 DBMET01119 0.677 0.002 DBMET01120 0.406 0.004 DB02746 0.107 0.027 DBMET03446 0.584 0.003 DBMET01121 0.759 0.002 DB03091 0.825 0.001 DB00130 0.823 0.001 DB00142 | DB00130 | |
| 0.038 | 0.068 | 0.149 | Bombesin 2 receptor antagonist | 0.066 0.021 DBMET01115 0.136 0.011 DBMET01116 0.081 0.017 DBMET01117 0.139 0.011 DBMET01119 0.149 0.01 DBMET01120 0.062 0.023 DB02746 0.089 0.015 DBMET01121 0.124 0.012 DB03091 0.14 0.011 DB00130 0.094 0.015 DB00142 | DBMET01120 | |
| 0.081 | 0.112 | 0.46 | Adenylate kinase inhibitor | 0.108 0.055 DBMET00033 0.191 0.016 DBMET01115 0.135 0.033 DBMET01116 0.203 0.015 DBMET01117 0.216 0.013 DBMET01119 0.176 0.019 DBMET01120 0.362 0.004 DB02746 0.128 0.037 DBMET03446 0.268 0.009 DBMET01121 0.373 0.004 DB03091 0.375 0.004 DB00130 0.46 0.002 DB00142 | DB00142 | |
| 0.083 | 0.114 | 0.231 | Cholesterol synthesis inhibitor | 0.097 0.091 DBMET00033 0.109 0.077 DBMET00034 0.109 0.076 DBMET03444 0.099 0.088 DBMET01117 0.231 0.02 DB02746 0.113 0.072 DBMET01114 0.1 0.087 DBMET01121 0.097 0.092 DB03091 0.129 0.058 DB00142 | DB02746 | |
| 0.019 | 0.05 | 0.024 | Acid ceramidase inhibitor | 0.024 0.023 DBMET03446 | DBMET03446 | |
| 0.038 | 0.069 | 0.08 | Glutamate (mGluR1) antagonist | 0.067 0.033 DB02746 0.08 0.023 DB00130 0.071 0.029 DB00142 | DB00130 | |
| 0.096 | 0.128 | 0.414 | Histone deacetylase SIRT1 inhibitor | 0.121 0.09 DBMET01115 0.124 0.087 DBMET01116 0.178 0.041 DBMET01118 0.29 0.009 DBMET01119 0.256 0.016 DBMET01120 0.184 0.037 DBMET03446 0.209 0.027 DBMET01121 0.414 0.004 DB03091 0.31 0.006 DB00130 0.292 0.009 DB00142 | DB03091 | |
| 0.037 | 0.069 | 0.879 | Alcohol oxidase inhibitor | 0.065 0.032 DBMET00033 0.167 0.009 DBMET01115 0.167 0.009 DBMET01116 0.053 0.042 DBMET01118 0.057 0.038 DBMET00034 0.074 0.027 DBMET03444 0.103 0.017 DBMET01117 0.137 0.012 DBMET01119 0.137 0.012 DBMET01120 0.879 0.002 DB02746 0.069 0.029 DBMET03446 0.086 0.022 DBMET01121 0.488 0.004 DB03091 0.488 0.004 DB00130 0.436 0.004 DB00142 | DB02746 | |
| 0.005 | 0.037 | 0.045 | Melanocortin 3 agonist | 0.045 0.013 DB03091 | DB03091 | |
| 0.048 | 0.08 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 DBMET03458 0.056 0.054 DBMET01114 | DBMET03458 | |
| 0.129 | 0.161 | 0.778 | Aldehyde oxidase inhibitor | 0.174 0.12 DBMET00033 0.206 0.101 DBMET03458 0.159 0.131 DBMET01115 0.159 0.131 DBMET01116 0.284 0.071 DBMET00034 0.278 0.073 DBMET03444 0.265 0.077 DBMET01117 0.197 0.106 DBMET01119 0.197 0.106 DBMET01120 0.778 0.005 DB02746 0.255 0.08 DBMET01114 0.32 0.061 DBMET01121 0.402 0.047 DB03091 0.402 0.047 DB00130 0.584 0.021 DB00142 | DB02746 | |
| 0.033 | 0.066 | 0.053 | Histamine H1 receptor agonist | 0.042 0.034 DB02746 0.053 0.014 DBMET03446 | DBMET03446 | |
| 0.071 | 0.105 | 0.124 | Estrogen-related receptor beta agonist | 0.077 0.076 DBMET00033 0.078 0.074 DBMET03458 0.079 0.071 DBMET01115 0.091 0.038 DBMET00034 0.09 0.041 DBMET03444 0.094 0.033 DBMET01117 0.084 0.055 DBMET01119 0.124 0.009 DB02746 0.082 0.062 DBMET01114 0.099 0.026 DBMET01121 0.089 0.042 DB03091 0.081 0.065 DB00130 0.097 0.029 DB00142 | DB02746 | |
| 0.003 | 0.039 | 0.015 | Integrin alphaVbeta5 antagonist | 0.009 0.008 DBMET01121 0.009 0.008 DB00130 0.015 0.005 DB00142 | DB00142 | |
| 0.127 | 0.163 | 0.651 | Phospholipase C inhibitor | 0.16 0.088 DBMET00033 0.196 0.046 DBMET01115 0.163 0.082 DBMET01116 0.154 0.098 DBMET01118 0.147 0.112 DBMET00034 0.165 0.08 DBMET03444 0.186 0.055 DBMET01117 0.39 0.011 DBMET01119 0.3 0.018 DBMET01120 0.358 0.014 DB02746 0.191 0.051 DBMET03446 0.151 0.105 DBMET01114 0.388 0.011 DBMET01121 0.616 0.004 DB03091 0.542 0.005 DB00130 0.651 0.003 DB00142 | DB00142 | |
| 0.049 | 0.085 | 0.692 | Porphobilinogen synthase inhibitor | 0.377 0.004 DBMET01115 0.213 0.011 DBMET01116 0.066 0.06 DBMET01118 0.286 0.005 DBMET01117 0.305 0.005 DBMET01119 0.176 0.016 DBMET01120 0.692 0.002 DB02746 0.07 0.056 DBMET03446 0.233 0.009 DBMET01121 0.58 0.003 DB03091 0.331 0.005 DB00130 0.526 0.003 DB00142 | DB02746 | |
| 0.135 | 0.171 | 0.207 | Histone acetyltransferase inhibitor | 0.207 0.059 DB02746 | DB02746 | |
| 0.027 | 0.063 | 0.115 | Integrin alpha5beta1 antagonist | 0.073 0.008 DBMET01119 0.074 0.008 DBMET01120 0.083 0.006 DBMET01121 0.094 0.005 DB03091 0.089 0.006 DB00130 0.115 0.005 DB00142 | DB00142 | |
| 0.009 | 0.046 | 0.169 | VLA-4 antagonist | 0.093 0.006 DBMET01119 0.114 0.005 DBMET01120 0.145 0.004 DBMET01121 0.094 0.006 DB03091 0.121 0.005 DB00130 0.169 0.004 DB00142 | DB00142 | |
| 0.165 | 0.202 | 0.486 | Gastrin inhibitor | 0.253 0.075 DBMET01115 0.224 0.114 DBMET01116 0.269 0.059 DBMET01118 0.272 0.055 DBMET01117 0.486 0.004 DBMET01119 0.396 0.005 DBMET01120 0.366 0.007 DB02746 0.203 0.144 DBMET03446 0.464 0.004 DBMET01121 0.373 0.006 DB03091 0.345 0.012 DB00130 0.369 0.007 DB00142 | DBMET01119 | |
| 0.012 | 0.049 | 0.052 | NMDA receptor glycine site antagonist | 0.052 0.005 DB02746 0.024 0.017 DBMET03446 0.025 0.016 DB00130 0.023 0.018 DB00142 | DB02746 | |
| 0.015 | 0.053 | 0.059 | Urotensin II agonist | 0.026 0.019 DBMET01119 0.025 0.021 DBMET01121 0.059 0.005 DB03091 0.038 0.01 DB00130 0.047 0.007 DB00142 | DB03091 | |
| 0.032 | 0.071 | 0.37 | Glutamate (mGluR4) antagonist | 0.044 0.029 DBMET03457 0.061 0.013 DBMET01115 0.05 0.02 DBMET01116 0.06 0.014 DBMET01117 0.088 0.007 DBMET01119 0.092 0.006 DBMET01120 0.146 0.004 DB02746 0.043 0.031 DBMET03446 0.113 0.005 DBMET01121 0.195 0.003 DB03091 0.253 0.003 DB00130 0.37 0.002 DB00142 | DB00142 | |
| 0.036 | 0.075 | 0.648 | Aconitate hydratase inhibitor | 0.128 0.005 DBMET01115 0.08 0.014 DBMET01116 0.073 0.017 DBMET01118 0.158 0.004 DBMET01117 0.24 0.003 DBMET01119 0.147 0.004 DBMET01120 0.648 0.001 DB02746 0.283 0.002 DBMET01121 0.215 0.003 DB03091 0.131 0.005 DB00130 0.313 0.002 DB00142 | DB02746 | |
| 0.011 | 0.049 | 0.019 | Complement factor D inhibitor | 0.019 0.01 DB02746 0.018 0.013 DBMET03446 | DB02746 | |
| 0.019 | 0.058 | 0.028 | Thymidine phosphorylase inhibitor | 0.027 0.016 DB02746 0.028 0.015 DBMET03446 | DBMET03446 | |
| 0.019 | 0.059 | 0.107 | Calcitonin receptor agonist | 0.031 0.026 DBMET01115 0.031 0.026 DBMET01116 0.081 0.012 DBMET01119 0.081 0.012 DBMET01120 0.029 0.028 DB02746 0.031 0.026 DBMET03446 0.066 0.014 DBMET01121 0.107 0.008 DB03091 0.097 0.01 DB00130 0.09 0.011 DB00142 | DB03091 | |
| 0.04 | 0.081 | 0.073 | Cyclin A2 inhibitor | 0.073 0.036 DBMET03446 | DBMET03446 | |
| 0.033 | 0.075 | 0.049 | Purinergic P2X4 antagonist | 0.049 0.025 DB02746 | DB02746 | |
| 0.005 | 0.046 | 0.149 | Integrin alpha4beta1 antagonist | 0.054 0.005 DBMET01119 0.033 0.007 DBMET01120 0.149 0.003 DBMET01121 0.02 0.01 DB03091 0.031 0.007 DB00142 | DBMET01121 | |
| 0.045 | 0.087 | 0.541 | Phenylalanine 4-hydroxylase inhibitor | 0.148 0.012 DBMET01115 0.114 0.02 DBMET01116 0.062 0.055 DBMET00034 0.144 0.013 DBMET01117 0.141 0.013 DBMET01119 0.145 0.013 DBMET01120 0.362 0.003 DB02746 0.077 0.04 DBMET03446 0.067 0.049 DBMET01114 0.19 0.008 DBMET01121 0.354 0.003 DB03091 0.363 0.003 DB00130 0.541 0.002 DB00142 | DB00142 | |
| 0.127 | 0.169 | 0.155 | Cyclin-dependent kinase 3 inhibitor | 0.138 0.128 DBMET00034 0.155 0.086 DBMET03446 | DBMET03446 | |
| 0.045 | 0.088 | 0.09 | Pregnane X receptor antagonist | 0.09 0.004 DB02746 0.057 0.038 DB00142 | DB02746 | |
| 0.029 | 0.072 | 0.077 | Kallikrein inhibitor | 0.071 0.018 DBMET01115 0.047 0.032 DBMET01119 0.047 0.033 DBMET01120 0.077 0.015 DBMET03446 | DBMET03446 | |
| 0.029 | 0.073 | 0.046 | Plasmepsin II inhibitor | 0.039 0.032 DBMET01115 0.046 0.022 DBMET01119 0.041 0.029 DB03091 | DBMET01119 | |
| 0.013 | 0.058 | 0.042 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET01118 0.025 0.008 DBMET01119 0.025 0.008 DBMET01120 0.042 0.003 DB02746 0.03 0.005 DBMET03446 0.023 0.011 DBMET01121 0.028 0.005 DB03091 0.028 0.005 DB00130 0.028 0.005 DB00142 | DB02746 | |
| 0.014 | 0.059 | 0.021 | Histone-lysine N-methyltransferase EZH2 inhibitor | 0.021 0.014 DBMET01118 | DBMET01118 | |
| 0.008 | 0.053 | 0.027 | Melanocortin 4 agonist | 0.027 0.016 DB03091 | DB03091 | |
| 0.027 | 0.073 | 0.136 | AMPA receptor antagonist | 0.051 0.03 DBMET01116 0.042 0.041 DBMET01117 0.055 0.028 DBMET01120 0.112 0.01 DB02746 0.044 0.038 DBMET01121 0.066 0.022 DB03091 0.136 0.007 DB00130 0.114 0.009 DB00142 | DB00130 | |
| 0.112 | 0.157 | 0.335 | Interferon gamma antagonist | 0.262 0.026 DBMET03456 0.14 0.092 DBMET01115 0.137 0.098 DBMET01116 0.142 0.089 DBMET00034 0.135 0.102 DBMET03444 0.155 0.071 DBMET01117 0.185 0.048 DBMET01119 0.187 0.046 DBMET01120 0.295 0.021 DB02746 0.147 0.081 DBMET01114 0.214 0.036 DBMET01121 0.315 0.018 DB03091 0.312 0.018 DB00130 0.335 0.015 DB00142 | DB00142 | |
| 0.039 | 0.085 | 0.084 | Dopamine agonist | 0.062 0.05 DBMET00034 0.065 0.048 DBMET03446 0.084 0.034 DBMET01114 | DBMET01114 | |
| 0.11 | 0.157 | 0.216 | Sphingosine 1-phosphate receptor 5 antagonist | 0.216 0.006 DB02746 0.122 0.121 DBMET01121 0.185 0.02 DB03091 0.165 0.039 DB00130 0.184 0.02 DB00142 | DB02746 | |
| 0.017 | 0.065 | 0.056 | Antidiuretic hormone agonist | 0.027 0.02 DBMET01119 0.028 0.017 DBMET01120 0.056 0.005 DBMET03446 0.029 0.015 DB00130 | DBMET03446 | |
| 0.006 | 0.053 | 0.019 | Human herpes virus 5 capsid protein P40 inhibitor | 0.019 0.005 DB02746 | DB02746 | |
| 0.036 | 0.084 | 0.142 | CXC chemokine 4 receptor antagonist | 0.142 0.017 DBMET03446 0.07 0.036 DB03091 | DBMET03446 | |
| 0.024 | 0.072 | 0.076 | Protein kinase (CK2) beta inhibitor | 0.051 0.007 DBMET01118 0.076 0.004 DB02746 0.058 0.005 DBMET03446 | DB02746 | |
| 0.065 | 0.114 | 0.094 | Breast cancer-resistant protein inhibitor | 0.094 0.061 DBMET00034 0.083 0.075 DBMET01114 | DBMET00034 | |
| 0.017 | 0.066 | 0.594 | Fumarate hydratase inhibitor | 0.128 0.004 DBMET01115 0.07 0.008 DBMET01116 0.099 0.005 DBMET01117 0.159 0.004 DBMET01119 0.107 0.005 DBMET01120 0.368 0.002 DB02746 0.035 0.023 DBMET03446 0.155 0.004 DBMET01121 0.531 0.002 DB03091 0.397 0.002 DB00130 0.594 0.002 DB00142 | DB00142 | |
| 0.134 | 0.183 | 0.366 | Vasodilator | 0.229 0.083 DBMET00033 0.329 0.039 DBMET03456 0.175 0.127 DBMET03458 0.178 0.124 DBMET00034 0.244 0.073 DBMET03444 0.226 0.085 DB02746 0.204 0.101 DBMET01114 0.191 0.112 DBMET01121 0.221 0.088 DB03091 0.257 0.065 DB00130 0.366 0.029 DB00142 | DB00142 | |
| 0.008 | 0.058 | 0.025 | Thromboxane A2 agonist | 0.018 0.008 DBMET01117 0.021 0.005 DB02746 0.02 0.005 DB03091 0.025 0.004 DB00142 | DB00142 | |
| 0.009 | 0.06 | 0.034 | Somatostatin 3 antagonist | 0.034 0.009 DBMET03446 0.019 0.015 DB03091 | DBMET03446 | |
| 0.072 | 0.122 | 0.364 | Cystathionine beta-synthase inhibitor | 0.112 0.064 DBMET03456 0.118 0.06 DBMET03458 0.114 0.063 DBMET01115 0.114 0.063 DBMET01116 0.148 0.041 DBMET00034 0.136 0.047 DBMET03444 0.162 0.036 DBMET01117 0.108 0.068 DBMET01119 0.139 0.046 DBMET01120 0.364 0.006 DB02746 0.138 0.046 DBMET01114 0.188 0.028 DBMET01121 0.244 0.016 DB03091 0.291 0.01 DB00130 0.362 0.006 DB00142 | DB02746 | |
| 0.075 | 0.126 | 0.395 | Histone deacetylase class III inhibitor | 0.1 0.09 DBMET01115 0.144 0.049 DBMET01118 0.269 0.008 DBMET01119 0.186 0.024 DBMET01120 0.145 0.048 DBMET03446 0.163 0.035 DBMET01121 0.395 0.004 DB03091 0.233 0.011 DB00130 0.229 0.012 DB00142 | DB03091 | |
| 0.012 | 0.064 | 0.03 | Protease (Human cytomegalovirus) inhibitor | 0.03 0.008 DB02746 | DB02746 | |
| 0.064 | 0.115 | 0.129 | Chemokine receptor antagonist | 0.129 0.042 DBMET01118 0.109 0.055 DBMET03446 | DBMET01118 | |
| 0.096 | 0.147 | 0.176 | DNA repair enzyme inhibitor | 0.116 0.081 DBMET00033 0.176 0.015 DBMET03456 0.121 0.07 DBMET03457 0.123 0.066 DBMET01115 0.125 0.063 DBMET01116 0.108 0.102 DBMET03444 0.129 0.056 DBMET01117 0.141 0.04 DB02746 0.118 0.077 DBMET03446 0.147 0.034 DB03091 0.153 0.029 DB00130 0.16 0.024 DB00142 | DBMET03456 | |
| 0.079 | 0.131 | 0.253 | DOPA decarboxylase inhibitor | 0.104 0.068 DBMET03458 0.115 0.051 DBMET01115 0.115 0.051 DBMET01116 0.124 0.041 DBMET00034 0.098 0.08 DBMET03444 0.121 0.044 DBMET01117 0.129 0.035 DBMET01119 0.147 0.023 DBMET01120 0.249 0.004 DB02746 0.112 0.055 DBMET03446 0.123 0.042 DBMET01114 0.152 0.02 DBMET01121 0.2 0.007 DB03091 0.225 0.004 DB00130 0.253 0.004 DB00142 | DB00142 | |
| 0.058 | 0.11 | 0.162 | Chymotrypsin inhibitor | 0.124 0.024 DBMET01119 0.115 0.028 DBMET01120 0.078 0.056 DB02746 0.072 0.067 DBMET03446 0.113 0.028 DBMET01121 0.162 0.014 DB03091 0.122 0.025 DB00130 0.121 0.025 DB00142 | DB03091 | |
| 0.042 | 0.095 | 0.572 | NMDA receptor agonist | 0.056 0.054 DBMET03457 0.444 0.002 DBMET01115 0.373 0.003 DBMET01116 0.108 0.017 DBMET01118 0.445 0.002 DBMET01117 0.447 0.002 DBMET01119 0.474 0.002 DBMET01120 0.265 0.004 DB02746 0.076 0.031 DBMET03446 0.568 0.002 DBMET01121 0.38 0.003 DB03091 0.427 0.002 DB00130 0.572 0.002 DB00142 | DB00142 | |
| 0.031 | 0.083 | 0.233 | Acyl-CoA dehydrogenase inhibitor | 0.097 0.017 DBMET01115 0.097 0.017 DBMET01116 0.073 0.025 DBMET01117 0.103 0.015 DBMET01119 0.103 0.015 DBMET01120 0.233 0.004 DB02746 0.076 0.024 DBMET03446 0.075 0.024 DBMET01121 0.189 0.006 DB03091 0.189 0.006 DB00130 0.166 0.008 DB00142 | DB02746 | |
| 0.026 | 0.079 | 0.344 | AMPA 4 receptor antagonist | 0.044 0.021 DBMET01115 0.048 0.016 DBMET01116 0.041 0.025 DBMET01117 0.06 0.01 DBMET01119 0.096 0.005 DBMET01120 0.128 0.004 DB02746 0.074 0.007 DBMET01121 0.173 0.004 DB03091 0.344 0.002 DB00130 0.314 0.003 DB00142 | DB00130 | |
| 0.007 | 0.06 | 0.022 | Vasopressin 2 agonist | 0.022 0.007 DBMET03446 | DBMET03446 | |
| 0.012 | 0.066 | 0.022 | Somatostatin 3 agonist | 0.02 0.011 DBMET01118 0.022 0.008 DBMET03446 | DBMET03446 | |
| 0.032 | 0.087 | 0.128 | Glucose-6-phosphate isomerase inhibitor | 0.044 0.041 DBMET00033 0.061 0.018 DBMET01115 0.047 0.035 DBMET01116 0.083 0.008 DBMET01117 0.044 0.04 DBMET01119 0.105 0.004 DB02746 0.045 0.038 DBMET03446 0.057 0.021 DBMET01121 0.108 0.004 DB03091 0.082 0.008 DB00130 0.128 0.003 DB00142 | DB00142 | |
| 0.014 | 0.069 | 0.085 | Nicotinic acid receptor 2 antagonist | 0.085 0.002 DB02746 | DB02746 | |
| 0.012 | 0.067 | 0.026 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET01115 0.02 0.01 DBMET01117 0.018 0.012 DBMET01119 0.026 0.003 DB02746 0.02 0.01 DBMET01121 0.023 0.005 DB03091 0.02 0.009 DB00130 0.024 0.005 DB00142 | DB02746 | |
| 0.017 | 0.073 | 0.04 | Purinergic P2Y15 antagonist | 0.033 0.013 DB02746 0.04 0.007 DBMET03446 0.03 0.017 DB03091 0.034 0.011 DB00130 0.032 0.013 DB00142 | DBMET03446 | |
| 0.023 | 0.079 | 0.035 | Tubulin agonist | 0.035 0.023 DBMET00035 | DBMET00035 | |
| 0.112 | 0.168 | 0.391 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.247 0.006 DBMET01118 0.184 0.029 DBMET01119 0.189 0.025 DBMET01120 0.391 0.004 DB02746 0.151 0.071 DBMET03446 0.18 0.032 DBMET01121 | DB02746 | |
| 0.015 | 0.071 | 0.136 | NMDA 2D receptor antagonist | 0.042 0.009 DBMET01119 0.036 0.012 DBMET01120 0.136 0.003 DB02746 0.043 0.009 DBMET01121 0.044 0.009 DB03091 0.033 0.014 DB00130 0.037 0.011 DB00142 | DB02746 | |
| 0.014 | 0.071 | 0.245 | Kainate receptor 2 antagonist | 0.052 0.015 DBMET01115 0.039 0.022 DBMET01116 0.051 0.016 DBMET01117 0.075 0.007 DBMET01119 0.087 0.005 DBMET01120 0.124 0.004 DB02746 0.105 0.004 DBMET01121 0.11 0.004 DB03091 0.177 0.003 DB00130 0.245 0.003 DB00142 | DB00142 | |
| 0.089 | 0.146 | 0.293 | Protein kinase C nu inhibitor | 0.293 0.026 DBMET03446 | DBMET03446 | |
| 0.02 | 0.077 | 0.031 | Hedgehog signaling activator | 0.03 0.013 DB02746 0.031 0.012 DBMET03446 | DBMET03446 | |
| 0.026 | 0.083 | 0.39 | Glutamate (mGluR8) agonist | 0.061 0.007 DBMET01115 0.046 0.014 DBMET01116 0.039 0.025 DBMET01118 0.059 0.007 DBMET01117 0.104 0.003 DBMET01119 0.094 0.003 DBMET01120 0.133 0.002 DB02746 0.043 0.018 DBMET03446 0.125 0.002 DBMET01121 0.177 0.001 DB03091 0.194 0.001 DB00130 0.39 0.001 DB00142 | DB00142 | |
| 0.043 | 0.1 | 0.12 | Check point kinase 1 inhibitor | 0.12 0.02 DBMET03446 | DBMET03446 | |
| 0.045 | 0.103 | 0.95 | Glutamate decarboxylase inhibitor | 0.23 0.005 DBMET01115 0.172 0.01 DBMET01116 0.076 0.048 DBMET01118 0.19 0.008 DBMET01117 0.547 0.002 DBMET01119 0.357 0.003 DBMET01120 0.408 0.003 DB02746 0.074 0.05 DBMET03446 0.071 0.053 DBMET01114 0.437 0.003 DBMET01121 0.915 0.001 DB03091 0.905 0.001 DB00130 0.95 0.001 DB00142 | DB00142 | |
| 0.03 | 0.088 | 0.107 | Lysophosphatidic acid 3 receptor antagonist | 0.065 0.018 DBMET01115 0.059 0.024 DBMET01116 0.077 0.01 DBMET01117 0.071 0.014 DBMET01119 0.083 0.008 DBMET01120 0.098 0.005 DB02746 0.107 0.004 DBMET01121 0.087 0.007 DB03091 0.091 0.006 DB00130 0.104 0.004 DB00142 | DBMET01121 | |
| 0.005 | 0.063 | 0.021 | Carbonic anhydrase XI inhibitor | 0.012 0.01 DBMET01115 0.018 0.004 DB02746 0.021 0.004 DB03091 0.017 0.005 DB00130 0.017 0.005 DB00142 | DB03091 | |
| 0.163 | 0.222 | 0.403 | Vasodilator, coronary | 0.349 0.056 DBMET03456 0.195 0.186 DBMET01117 0.233 0.151 DBMET01119 0.297 0.09 DBMET01120 0.403 0.034 DB02746 0.209 0.173 DBMET03446 0.327 0.068 DBMET01121 0.27 0.114 DB03091 0.299 0.088 DB00130 0.327 0.068 DB00142 | DB02746 | |
| 0.02 | 0.079 | 0.05 | Vasopressin 1A agonist | 0.029 0.02 DBMET01116 0.028 0.021 DBMET01118 0.031 0.014 DBMET01119 0.032 0.012 DBMET01120 0.05 0.003 DBMET03446 0.029 0.018 DB03091 0.035 0.009 DB00130 | DBMET03446 | |
| 0.012 | 0.071 | 0.069 | Somatostatin 4 antagonist | 0.069 0.006 DBMET03446 0.03 0.012 DB03091 | DBMET03446 | |
| 0.11 | 0.17 | 0.153 | MAP kinase 3 inhibitor | 0.152 0.064 DB02746 0.153 0.063 DBMET03446 | DBMET03446 | |
| 0.067 | 0.127 | 0.192 | Protein kinase (CK2) alpha inhibitor | 0.157 0.038 DBMET01118 0.192 0.026 DB02746 0.142 0.046 DBMET03446 | DB02746 | |
| 0.033 | 0.094 | 0.154 | NMDA receptor glycine site agonist | 0.112 0.011 DBMET01115 0.08 0.028 DBMET01116 0.058 0.048 DBMET01118 0.071 0.036 DBMET01117 0.086 0.024 DBMET01119 0.094 0.02 DBMET01120 0.153 0.004 DB02746 0.079 0.03 DBMET03446 0.089 0.023 DBMET01121 0.125 0.007 DB03091 0.154 0.004 DB00130 0.152 0.004 DB00142 | DB00130 | |
| 0.003 | 0.064 | 0.017 | Thromboxane agonist | 0.017 0.004 DB02746 0.013 0.005 DB00142 | DB02746 | |
| 0.011 | 0.072 | 0.23 | AMPA 3 receptor antagonist | 0.026 0.024 DBMET01115 0.031 0.02 DBMET01116 0.051 0.009 DBMET01119 0.068 0.005 DBMET01120 0.068 0.005 DB02746 0.057 0.007 DBMET01121 0.094 0.004 DB03091 0.23 0.003 DB00130 0.21 0.003 DB00142 | DB00130 | |
| 0.01 | 0.071 | 0.213 | Arginase inhibitor | 0.042 0.021 DBMET03456 0.039 0.023 DBMET01115 0.036 0.025 DBMET01117 0.057 0.011 DBMET01119 0.067 0.008 DBMET01120 0.072 0.007 DB02746 0.051 0.015 DBMET03446 0.08 0.006 DBMET01121 0.138 0.003 DB03091 0.147 0.002 DB00130 0.213 0.002 DB00142 | DB00142 | |
| 0.033 | 0.095 | 0.064 | Cyclin A inhibitor | 0.064 0.041 DBMET03446 | DBMET03446 | |
| 0.011 | 0.074 | 0.022 | Antibiotic Anthracycline-like | 0.02 0.011 DBMET03456 0.022 0.008 DB02746 0.019 0.013 DBMET03446 0.018 0.015 DB03091 0.019 0.013 DB00130 0.02 0.01 DB00142 | DB02746 | |
| 0.012 | 0.075 | 0.343 | Lysine carboxypeptidase inhibitor | 0.032 0.014 DBMET01115 0.024 0.022 DBMET01118 0.032 0.014 DBMET01117 0.066 0.005 DBMET01119 0.071 0.005 DBMET01120 0.043 0.009 DB02746 0.031 0.015 DBMET03446 0.128 0.003 DBMET01121 0.148 0.003 DB03091 0.16 0.003 DB00130 0.343 0.001 DB00142 | DB00142 | |
| 0.055 | 0.118 | 0.093 | Opioid kappa receptor antagonist | 0.093 0.042 DBMET00034 0.08 0.058 DBMET03444 0.088 0.048 DB03091 0.073 0.071 DB00130 | DBMET00034 | |
| 0.016 | 0.079 | 0.056 | Integrin alpha2beta1 antagonist | 0.036 0.008 DBMET01119 0.037 0.007 DBMET01120 0.047 0.005 DB02746 0.056 0.004 DBMET01121 0.026 0.018 DB03091 0.033 0.01 DB00130 0.039 0.006 DB00142 | DBMET01121 | |
| 0.006 | 0.069 | 0.096 | Aminopeptidase A inhibitor | 0.02 0.011 DBMET01115 0.016 0.015 DBMET01116 0.053 0.003 DBMET01119 0.047 0.004 DBMET01120 0.025 0.008 DB02746 0.046 0.004 DBMET01121 0.096 0.002 DB03091 0.074 0.003 DB00130 0.09 0.002 DB00142 | DB03091 | |
| 0.015 | 0.079 | 0.323 | Somatostatin agonist | 0.323 0.004 DBMET03446 | DBMET03446 | |
| 0.031 | 0.094 | 0.06 | Aldosterone antagonist | 0.06 0.019 DB02746 | DB02746 | |
| 0.042 | 0.106 | 0.269 | Glutamate receptor agonist | 0.147 0.018 DBMET01115 0.14 0.02 DBMET01116 0.087 0.047 DBMET01118 0.209 0.01 DBMET01117 0.071 0.062 DBMET01119 0.11 0.031 DBMET01120 0.197 0.011 DB02746 0.162 0.015 DBMET01121 0.093 0.043 DB03091 0.15 0.017 DB00130 0.269 0.006 DB00142 | DB00142 | |
| 0.123 | 0.188 | 0.251 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.251 0.06 DBMET03446 | DBMET03446 | |
| 0.058 | 0.124 | 0.279 | Glutathione S-transferase inhibitor | 0.159 0.01 DBMET01119 0.181 0.007 DBMET01120 0.147 0.013 DB02746 0.158 0.01 DBMET01121 0.217 0.005 DB03091 0.279 0.003 DB00130 0.266 0.003 DB00142 | DB00130 | |
| 0.071 | 0.137 | 0.244 | Beta glucuronidase inhibitor | 0.093 0.081 DBMET00033 0.244 0.009 DBMET03456 0.092 0.083 DBMET03458 0.104 0.064 DBMET00034 0.116 0.05 DBMET03444 0.133 0.035 DB02746 0.098 0.072 DBMET01114 | DBMET03456 | |
| 0.004 | 0.069 | 0.064 | Prostaglandin EP4 agonist | 0.014 0.011 DBMET01117 0.064 0.004 DB02746 0.017 0.009 DBMET01121 | DB02746 | |
| 0.008 | 0.074 | 0.027 | Telomerase stimulant | 0.021 0.007 DB02746 0.022 0.006 DB03091 0.022 0.006 DB00130 0.027 0.004 DB00142 | DB00142 | |
| 0.09 | 0.156 | 0.207 | Sphingosine 1-phosphate receptor 4 antagonist | 0.111 0.092 DBMET01119 0.107 0.101 DBMET01120 0.207 0.008 DB02746 0.111 0.092 DBMET01121 0.177 0.016 DB03091 0.147 0.036 DB00130 0.16 0.026 DB00142 | DB02746 | |
| 0.062 | 0.128 | 0.192 | Falcipain 3 inhibitor | 0.104 0.067 DBMET01115 0.123 0.051 DBMET01116 0.115 0.057 DBMET01117 0.162 0.031 DBMET01119 0.192 0.02 DBMET01120 0.174 0.027 DB02746 0.103 0.067 DBMET03446 0.187 0.022 DBMET01121 0.105 0.065 DB03091 0.147 0.038 DB00130 0.134 0.045 DB00142 | DBMET01120 | |
| 0.018 | 0.084 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | 0.05 0.008 DB02746 | DB02746 | |
| 0.003 | 0.07 | 0.497 | Glutamate (mGluR6) agonist | 0.014 0.007 DBMET01115 0.013 0.007 DBMET01117 0.034 0.003 DBMET01119 0.028 0.003 DBMET01120 0.063 0.002 DB02746 0.013 0.007 DBMET03446 0.052 0.002 DBMET01121 0.144 0.001 DB03091 0.172 0.001 DB00130 0.497 0.001 DB00142 | DB00142 | |
| 0.079 | 0.147 | 0.35 | Aldehyde dehydrogenase inhibitor | 0.127 0.064 DBMET01115 0.107 0.087 DBMET00034 0.137 0.056 DBMET01117 0.179 0.034 DBMET01119 0.141 0.053 DBMET01120 0.34 0.008 DB02746 0.225 0.022 DBMET01121 0.209 0.026 DB03091 0.214 0.025 DB00130 0.35 0.008 DB00142 | DB00142 | |
| 0.006 | 0.074 | 0.031 | Cyclin T1 inhibitor | 0.031 0.005 DBMET03446 | DBMET03446 | |
| 0.023 | 0.091 | 0.752 | Ornithine carbamoyltransferase inhibitor | 0.089 0.019 DBMET01115 0.134 0.011 DBMET01116 0.065 0.028 DBMET01117 0.153 0.009 DBMET01119 0.309 0.004 DBMET01120 0.177 0.008 DB02746 0.061 0.031 DBMET03446 0.147 0.01 DBMET01121 0.405 0.003 DB03091 0.752 0.001 DB00130 0.59 0.002 DB00142 | DB00130 | |
| 0.019 | 0.088 | 0.052 | Alpha 1d adrenoreceptor agonist | 0.052 0.015 DB02746 | DB02746 | |
| 0.006 | 0.074 | 0.064 | Carbonic anhydrase X inhibitor | 0.024 0.006 DBMET01115 0.019 0.009 DBMET01116 0.018 0.01 DBMET01117 0.028 0.005 DBMET01119 0.022 0.007 DBMET01120 0.041 0.003 DB02746 0.021 0.008 DBMET01121 0.064 0.002 DB03091 0.052 0.002 DB00130 0.052 0.003 DB00142 | DB03091 | |
| 0.006 | 0.074 | 0.064 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 DBMET01115 0.019 0.009 DBMET01116 0.018 0.01 DBMET01117 0.028 0.005 DBMET01119 0.022 0.007 DBMET01120 0.041 0.003 DB02746 0.021 0.008 DBMET01121 0.064 0.002 DB03091 0.052 0.002 DB00130 0.052 0.003 DB00142 | DB03091 | |
| 0.002 | 0.072 | 0.008 | Integrin alpha5beta6 antagonist | 0.006 0.005 DB02746 0.007 0.005 DB03091 0.006 0.005 DB00130 0.008 0.004 DB00142 | DB00142 | |
| 0.067 | 0.136 | 0.116 | MAP kinase kinase 1 inhibitor | 0.116 0.038 DB02746 0.084 0.079 DBMET03446 | DB02746 | |
| 0.014 | 0.083 | 0.043 | Lysophosphatidic acid receptor 1 agonist | 0.025 0.018 DBMET01117 0.024 0.02 DBMET01119 0.024 0.02 DBMET01120 0.043 0.005 DB02746 0.028 0.013 DBMET01121 0.037 0.007 DB03091 0.037 0.007 DB00130 0.04 0.005 DB00142 | DB02746 | |
| 0.039 | 0.109 | 0.567 | Histidine decarboxylase inhibitor | 0.071 0.049 DBMET01115 0.091 0.036 DBMET01116 0.08 0.042 DBMET01118 0.069 0.051 DBMET00034 0.075 0.046 DBMET03444 0.068 0.053 DBMET01117 0.197 0.013 DBMET01119 0.33 0.005 DBMET01120 0.402 0.004 DB02746 0.069 0.051 DBMET03446 0.073 0.048 DBMET01114 0.273 0.008 DBMET01121 0.38 0.004 DB03091 0.554 0.002 DB00130 0.567 0.002 DB00142 | DB00142 | |
| 0.051 | 0.122 | 0.105 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.105 0.01 DB02746 0.076 0.044 DBMET03446 0.073 0.052 DB03091 0.08 0.037 DB00130 0.091 0.021 DB00142 | DB02746 | |
| 0.004 | 0.075 | 0.268 | Kainate receptor 1 antagonist | 0.024 0.013 DBMET01115 0.025 0.012 DBMET01116 0.021 0.015 DBMET01118 0.087 0.004 DBMET01119 0.117 0.004 DBMET01120 0.122 0.003 DB02746 0.087 0.004 DBMET01121 0.159 0.003 DB03091 0.268 0.002 DB00130 0.26 0.002 DB00142 | DB00130 | |
| 0.005 | 0.076 | 0.27 | AMPA 1 receptor antagonist | 0.026 0.022 DBMET01116 0.055 0.01 DBMET01119 0.102 0.005 DBMET01120 0.079 0.007 DB02746 0.051 0.011 DBMET01121 0.127 0.004 DB03091 0.27 0.003 DB00130 0.183 0.004 DB00142 | DB00130 | |
| 0.034 | 0.105 | 0.532 | Phosphofructokinase-1 inhibitor | 0.064 0.053 DBMET00033 0.084 0.039 DBMET03456 0.148 0.018 DBMET01115 0.092 0.035 DBMET01116 0.173 0.014 DBMET01117 0.17 0.015 DBMET01119 0.131 0.022 DBMET01120 0.29 0.006 DB02746 0.122 0.025 DBMET03446 0.216 0.01 DBMET01121 0.343 0.004 DB03091 0.332 0.004 DB00130 0.532 0.002 DB00142 | DB00142 | |
| 0.012 | 0.083 | 0.065 | Sirtuin 2 inhibitor | 0.061 0.009 DB03091 0.065 0.008 DB00130 0.041 0.017 DB00142 | DB00130 | |
| 0.008 | 0.079 | 0.021 | Purinergic P2Y1 agonist | 0.014 0.013 DB02746 0.015 0.012 DB03091 0.017 0.009 DB00130 0.021 0.006 DB00142 | DB00142 | |
| 0.016 | 0.087 | 0.051 | Carnitine palmitoyltransferase inhibitor | 0.051 0.008 DB02746 | DB02746 | |
| 0.07 | 0.142 | 0.135 | Nav1.3 sodium channel blocker | 0.103 0.093 DBMET01115 0.135 0.059 DB02746 | DB02746 | |
| 0.095 | 0.167 | 0.296 | Hexokinase inhibitor | 0.222 0.025 DBMET03456 0.132 0.101 DBMET03458 0.19 0.042 DBMET01118 0.296 0.011 DB02746 0.121 0.117 DBMET03446 | DB02746 | |
| 0.037 | 0.109 | 0.056 | Dopamine D1 antagonist | 0.056 0.055 DBMET01114 | DBMET01114 | |
| 0.02 | 0.093 | 0.349 | Glutamate (mGluR3) antagonist | 0.059 0.009 DBMET01115 0.063 0.008 DBMET01116 0.054 0.01 DBMET01117 0.06 0.008 DBMET01119 0.081 0.005 DBMET01120 0.2 0.003 DB02746 0.045 0.016 DBMET03446 0.069 0.006 DBMET01121 0.255 0.003 DB03091 0.333 0.002 DB00130 0.349 0.002 DB00142 | DB00142 | |
| 0.049 | 0.123 | 0.091 | Exportin-1 inhibitor | 0.091 0.014 DB02746 0.072 0.04 DB03091 0.074 0.034 DB00130 0.064 0.058 DB00142 | DB02746 | |
| 0.112 | 0.185 | 0.16 | MAP kinase kinase 4 inhibitor | 0.13 0.114 DBMET03458 0.131 0.11 DBMET01118 0.15 0.062 DBMET00034 0.147 0.068 DBMET03444 0.14 0.084 DB02746 0.16 0.045 DBMET03446 0.129 0.117 DBMET01114 | DBMET03446 | |
| 0.082 | 0.156 | 0.544 | Thrombolytic | 0.314 0.022 DBMET03456 0.211 0.047 DBMET01115 0.371 0.014 DBMET01116 0.126 0.104 DBMET01118 0.122 0.108 DBMET00034 0.116 0.115 DBMET03444 0.399 0.011 DBMET01117 0.347 0.017 DBMET01119 0.406 0.011 DBMET01120 0.224 0.041 DB02746 0.141 0.089 DBMET01114 0.429 0.009 DBMET01121 0.465 0.006 DB03091 0.473 0.006 DB00130 0.544 0.005 DB00142 | DB00142 | |
| 0.011 | 0.085 | 0.074 | Plasma kallikrein inhibitor | 0.05 0.012 DBMET01115 0.074 0.006 DBMET03446 | DBMET03446 | |
| 0.113 | 0.187 | 0.277 | 3C-like protease (Human coronavirus) inhibitor | 0.187 0.06 DBMET01119 0.189 0.059 DBMET01120 0.277 0.017 DB02746 0.141 0.117 DBMET01121 0.15 0.102 DB00130 | DB02746 | |
| 0.034 | 0.108 | 0.099 | Heparanase inhibitor | 0.099 0.004 DBMET03456 0.049 0.047 DBMET01117 0.05 0.046 DBMET01120 0.087 0.005 DB02746 0.063 0.019 DBMET01121 0.054 0.036 DB00142 | DBMET03456 | |
| 0.021 | 0.095 | 0.164 | DNA topoisomerase IV inhibitor | 0.164 0.003 DBMET03457 | DBMET03457 | |
| 0.052 | 0.128 | 0.186 | Protein kinase (CK2) inhibitor | 0.156 0.03 DBMET01118 0.186 0.022 DB02746 0.139 0.038 DBMET03446 | DB02746 | |
| 0.033 | 0.108 | 0.186 | Opioid mu receptor antagonist | 0.077 0.041 DBMET00034 0.097 0.033 DBMET01119 0.068 0.048 DBMET01120 0.186 0.011 DB03091 0.143 0.019 DB00130 0.126 0.023 DB00142 | DB03091 | |
| 0.004 | 0.079 | 0.024 | Lysophosphatidic acid receptor 3 agonist | 0.024 0.004 DB02746 0.018 0.006 DB03091 0.017 0.007 DB00130 0.022 0.005 DB00142 | DB02746 | |
| 0.069 | 0.145 | 0.387 | Amylase inhibitor | 0.387 0.01 DBMET03456 0.101 0.095 DBMET03458 0.107 0.09 DBMET01116 0.143 0.068 DBMET00034 0.148 0.065 DBMET03444 0.201 0.044 DBMET01117 0.278 0.022 DB02746 0.175 0.053 DBMET03446 0.149 0.065 DBMET01114 0.164 0.058 DBMET01121 0.188 0.048 DB03091 0.209 0.041 DB00130 0.276 0.022 DB00142 | DBMET03456 | |
| 0.05 | 0.127 | 0.107 | Cyclin-dependent kinase 1 inhibitor | 0.107 0.062 DBMET03446 | DBMET03446 | |
| 0.009 | 0.087 | 0.034 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.034 0.014 DB02746 | DB02746 | |
| 0.043 | 0.121 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.056 0.035 DBMET01119 0.07 0.011 DB02746 0.071 0.01 DB03091 0.062 0.02 DB00130 0.057 0.033 DB00142 | DB03091 | |
| 0.004 | 0.082 | 0.041 | Integrin beta2 antagonist | 0.013 0.008 DBMET01119 0.041 0.004 DBMET01120 0.014 0.007 DB02746 0.039 0.004 DBMET01121 0.015 0.006 DB00130 0.011 0.01 DB00142 | DBMET01120 | |
| 0.003 | 0.082 | 0.032 | Angiotensin AT1B receptor antagonist | 0.017 0.007 DBMET01117 0.014 0.01 DBMET01119 0.012 0.011 DBMET01120 0.032 0.004 DB02746 0.021 0.005 DBMET01121 | DB02746 | |
| 0.024 | 0.103 | 0.073 | Plasmin inhibitor | 0.046 0.034 DBMET01119 0.047 0.033 DBMET01120 0.073 0.024 DBMET03446 0.04 0.038 DB03091 0.042 0.037 DB00130 0.045 0.034 DB00142 | DBMET03446 | |
| 0.034 | 0.113 | 0.194 | Antineoplastic antibiotic | 0.093 0.049 DBMET00033 0.085 0.054 DBMET00035 0.194 0.022 DBMET03456 0.087 0.053 DBMET03457 0.08 0.057 DBMET03458 0.101 0.046 DBMET03444 | DBMET03456 | |
| 0.019 | 0.099 | 0.075 | Carboxypeptidase B inhibitor | 0.032 0.026 DBMET01115 0.032 0.026 DBMET01116 0.033 0.022 DBMET01117 0.038 0.014 DBMET01119 0.038 0.015 DBMET01120 0.035 0.019 DB02746 0.035 0.019 DBMET03446 0.04 0.012 DBMET01121 0.055 0.005 DB03091 0.057 0.005 DB00130 0.075 0.003 DB00142 | DB00142 | |
| 0.039 | 0.12 | 0.098 | Potassium channel intermediate-conductance Ca-activated blocker | 0.078 0.019 DBMET01115 0.06 0.041 DBMET01116 0.06 0.042 DBMET01117 0.098 0.009 DB02746 | DB02746 | |
| 0.051 | 0.133 | 0.209 | Opioid antagonist | 0.097 0.05 DBMET00034 0.123 0.035 DBMET01119 0.098 0.049 DBMET01120 0.209 0.012 DB03091 0.168 0.021 DB00130 0.142 0.028 DB00142 | DB03091 | |
| 0.037 | 0.118 | 0.079 | Sphingosine kinase inhibitor | 0.059 0.04 DB02746 0.066 0.03 DBMET03446 0.079 0.017 DB03091 0.064 0.032 DB00130 0.078 0.017 DB00142 | DB03091 | |
| 0.018 | 0.099 | 0.063 | Dipeptidyl peptidase II inhibitor | 0.032 0.023 DBMET03446 0.051 0.009 DB03091 0.046 0.011 DB00130 0.063 0.006 DB00142 | DB00142 | |
| 0.049 | 0.13 | 0.148 | Histamine N-methyltransferase inhibitor | 0.142 0.017 DB02746 0.096 0.049 DB03091 0.138 0.019 DB00130 0.148 0.015 DB00142 | DB00142 | |
| 0.021 | 0.102 | 0.109 | Integrin alpha2 antagonist | 0.035 0.028 DBMET01118 0.035 0.029 DBMET01117 0.067 0.005 DBMET01119 0.056 0.009 DBMET01120 0.063 0.006 DB02746 0.109 0.004 DBMET01121 0.046 0.014 DB03091 0.047 0.013 DB00130 0.068 0.005 DB00142 | DBMET01121 | |
| 0.067 | 0.15 | 0.592 | Interleukin 1b antagonist | 0.399 0.005 DBMET01115 0.539 0.004 DBMET01116 0.592 0.004 DBMET01117 0.16 0.033 DB02746 | DBMET01117 | |
| 0.014 | 0.097 | 0.136 | TRPM8 blocker | 0.136 0.005 DB02746 | DB02746 | |
| 0.008 | 0.091 | 0.089 | Somatostatin 2 antagonist | 0.089 0.007 DBMET03446 0.063 0.011 DB03091 0.034 0.019 DB00130 | DBMET03446 | |
| 0.015 | 0.098 | 0.052 | Epoxide hydrolase 1 inhibitor | 0.032 0.02 DBMET01118 0.036 0.015 DBMET01119 0.052 0.005 DB02746 0.04 0.011 DBMET01121 0.028 0.027 DB03091 | DB02746 | |
| 0.005 | 0.089 | 0.263 | Integrin alpha4 antagonist | 0.027 0.017 DBMET01115 0.102 0.006 DBMET01119 0.126 0.005 DBMET01120 0.227 0.004 DBMET01121 0.104 0.005 DB03091 0.127 0.005 DB00130 0.263 0.004 DB00142 | DB00142 | |
| 0.018 | 0.103 | 0.241 | NMDA 2A receptor antagonist | 0.056 0.033 DBMET01115 0.061 0.029 DBMET01116 0.045 0.043 DBMET01117 0.083 0.019 DBMET01119 0.111 0.011 DBMET01120 0.096 0.014 DB02746 0.092 0.015 DBMET01121 0.153 0.007 DB03091 0.241 0.004 DB00130 0.239 0.004 DB00142 | DB00130 | |
| 0.017 | 0.102 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 DB02746 | DB02746 | |
| 0.011 | 0.097 | 0.039 | Growth hormone releasing factor agonist | 0.039 0.019 DB03091 0.036 0.021 DB00130 | DB03091 | |
| 0.002 | 0.088 | 0.031 | Neurokinin 3 agonist | 0.031 0.003 DB03091 0.011 0.008 DB00130 0.01 0.009 DB00142 | DB03091 | |
| 0.004 | 0.09 | 0.035 | Egl nine homolog 3 inhibitor | 0.035 0.003 DB02746 | DB02746 | |
| 0.023 | 0.11 | 0.047 | Sphingosine kinase 1 inhibitor | 0.044 0.024 DBMET03446 0.047 0.019 DB03091 0.041 0.03 DB00130 0.047 0.02 DB00142 | DB00142 | |
| 0.032 | 0.12 | 0.059 | Sphingosine kinase 2 inhibitor | 0.059 0.033 DB02746 0.056 0.037 DBMET03446 0.056 0.037 DB00142 | DB02746 | |
| 0.013 | 0.101 | 0.046 | Vanilloid 2 agonist | 0.044 0.003 DB02746 0.031 0.008 DB03091 0.036 0.005 DB00130 0.046 0.003 DB00142 | DB00142 | |
| 0.021 | 0.109 | 0.049 | Histamine H2 receptor agonist | 0.049 0.022 DBMET03446 0.043 0.03 DB00130 | DBMET03446 | |
| 0.02 | 0.107 | 0.332 | Cholecystokinin B agonist | 0.04 0.023 DBMET01115 0.036 0.028 DBMET01116 0.163 0.005 DBMET01119 0.083 0.007 DBMET01120 0.074 0.008 DBMET01121 0.332 0.003 DB03091 0.161 0.005 DB00130 0.164 0.005 DB00142 | DB03091 | |
| 0.009 | 0.097 | 0.029 | Cyclin E2 inhibitor | 0.029 0.019 DBMET03446 | DBMET03446 | |
| 0.033 | 0.121 | 0.073 | Protein kinase C iota inhibitor | 0.073 0.03 DBMET03446 | DBMET03446 | |
| 0.005 | 0.094 | 0.027 | Integrin alphaVbeta6 antagonist | 0.016 0.008 DBMET01119 0.019 0.006 DBMET01120 0.018 0.007 DBMET01121 0.027 0.004 DB03091 0.025 0.004 DB00130 0.022 0.005 DB00142 | DB03091 | |
| 0.018 | 0.108 | 0.069 | Angiotensin AT1 receptor antagonist | 0.053 0.013 DBMET01116 0.043 0.027 DBMET01118 0.06 0.006 DBMET01117 0.048 0.021 DBMET01119 0.053 0.014 DBMET01120 0.069 0.004 DB02746 0.06 0.006 DBMET01121 0.043 0.027 DB00142 | DB02746 | |
| 0.024 | 0.114 | 0.208 | Opioid delta receptor antagonist | 0.067 0.042 DBMET00034 0.107 0.029 DBMET01119 0.075 0.038 DBMET01120 0.208 0.01 DB03091 0.166 0.017 DB00130 0.151 0.019 DB00142 | DB03091 | |
| 0.038 | 0.128 | 0.13 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.13 0.024 DBMET03446 | DBMET03446 | |
| 0.005 | 0.095 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.015 0.006 DB02746 | DB02746 | |
| 0.013 | 0.104 | 0.055 | Peptide deformylase inhibitor | 0.044 0.012 DBMET01115 0.03 0.021 DBMET01121 0.045 0.012 DB03091 0.05 0.01 DB00130 0.055 0.008 DB00142 | DB00142 | |
| 0.033 | 0.125 | 0.101 | Thromboxane synthase inhibitor | 0.078 0.013 DBMET01115 0.063 0.024 DBMET01116 0.057 0.033 DBMET01118 0.101 0.006 DBMET01117 0.069 0.018 DBMET01119 0.06 0.027 DBMET01120 0.095 0.007 DB02746 0.094 0.008 DBMET01121 0.058 0.031 DB03091 0.051 0.047 DB00130 0.069 0.018 DB00142 | DBMET01117 | |
| 0.025 | 0.117 | 0.066 | Adenylate cyclase 1 inhibitor | 0.066 0.014 DB02746 | DB02746 | |
| 0.061 | 0.155 | 0.265 | Adenylate cyclase inhibitor | 0.197 0.026 DBMET01118 0.204 0.025 DBMET01119 0.199 0.026 DBMET01120 0.173 0.033 DB02746 0.158 0.04 DBMET03446 0.095 0.089 DBMET01114 0.165 0.036 DBMET01121 0.233 0.021 DB03091 0.265 0.017 DB00130 0.226 0.022 DB00142 | DB00130 | |
| 0.035 | 0.129 | 0.063 | Transcription factor AP-1 inhibitor | 0.063 0.04 DB02746 | DB02746 | |
| 0.018 | 0.112 | 0.049 | Chemokine receptor agonist | 0.049 0.036 DBMET01118 | DBMET01118 | |
| 0.113 | 0.207 | 0.259 | Neurotrophic factor enhancer | 0.174 0.106 DBMET03456 0.16 0.124 DBMET01115 0.168 0.112 DBMET00034 0.18 0.098 DBMET03444 0.191 0.086 DBMET01117 0.259 0.034 DB02746 0.159 0.125 DBMET03446 0.168 0.113 DBMET01114 0.207 0.07 DB03091 0.155 0.131 DB00130 0.2 0.076 DB00142 | DB02746 | |
| 0.094 | 0.19 | 0.437 | Hemostatic | 0.36 0.011 DBMET03456 0.153 0.064 DBMET01115 0.284 0.017 DBMET01118 0.437 0.006 DBMET01119 0.375 0.009 DBMET01120 0.222 0.026 DB02746 0.158 0.059 DBMET03446 0.363 0.01 DBMET01121 0.366 0.01 DB03091 0.284 0.017 DB00130 0.317 0.014 DB00142 | DBMET01119 | |
| 0.006 | 0.102 | 0.053 | Nicotinic acid receptor 1 antagonist | 0.053 0.003 DB02746 0.019 0.01 DB03091 0.019 0.01 DB00130 0.02 0.009 DB00142 | DB02746 | |
| 0.046 | 0.143 | 0.148 | Interferon agonist | 0.073 0.065 DBMET01120 0.098 0.031 DB02746 0.085 0.045 DBMET03446 0.082 0.049 DBMET01121 0.125 0.015 DB03091 0.119 0.018 DB00130 0.148 0.01 DB00142 | DB00142 | |
| 0.006 | 0.102 | 0.047 | Growth hormone releasing factor antagonist | 0.021 0.018 DBMET01119 0.047 0.008 DB03091 0.034 0.011 DB00130 0.02 0.019 DB00142 | DB03091 | |
| 0.02 | 0.117 | 0.213 | Thymidylate synthase inhibitor | 0.081 0.007 DBMET01115 0.101 0.004 DBMET01116 0.136 0.003 DBMET01117 0.141 0.003 DBMET01119 0.162 0.003 DBMET01120 0.069 0.012 DB02746 0.213 0.002 DBMET01121 0.1 0.004 DB03091 0.119 0.004 DB00130 0.153 0.003 DB00142 | DBMET01121 | |
| 0.091 | 0.188 | 0.24 | Vanilloid 1 agonist | 0.119 0.091 DBMET01115 0.123 0.081 DBMET01116 0.115 0.1 DBMET01117 0.12 0.087 DBMET01119 0.15 0.039 DBMET01120 0.141 0.048 DB02746 0.113 0.106 DBMET01114 0.141 0.049 DBMET01121 0.212 0.009 DB03091 0.24 0.006 DB00130 0.222 0.008 DB00142 | DB00130 | |
| 0.026 | 0.124 | 0.155 | Aminopeptidase microsomal inhibitor | 0.075 0.028 DBMET01119 0.084 0.023 DBMET01120 0.155 0.007 DBMET03446 0.073 0.029 DBMET01121 0.144 0.009 DB03091 0.143 0.009 DB00130 0.148 0.008 DB00142 | DBMET03446 | |
| 0.037 | 0.135 | 0.176 | Sirtuin 1 inhibitor | 0.118 0.015 DBMET01119 0.114 0.016 DBMET01120 0.102 0.022 DBMET01121 0.176 0.005 DB03091 0.16 0.005 DB00130 0.159 0.005 DB00142 | DB03091 | |
| 0.031 | 0.129 | 0.107 | Matrix metalloproteinase inhibitor | 0.063 0.05 DBMET03457 0.076 0.04 DBMET01115 0.08 0.037 DBMET01116 0.079 0.037 DBMET01117 0.09 0.031 DBMET01119 0.08 0.037 DBMET01120 0.08 0.037 DBMET01121 0.107 0.024 DB03091 0.097 0.028 DB00130 0.089 0.032 DB00142 | DB03091 | |
| 0.005 | 0.105 | 0.034 | Bradykinin B2 receptor antagonist | 0.034 0.02 DB03091 | DB03091 | |
| 0.043 | 0.143 | 0.081 | MAO A inhibitor | 0.081 0.079 DBMET03446 | DBMET03446 | |
| 0.025 | 0.125 | 0.041 | Vanilloid 3 antagonist | 0.041 0.019 DB02746 | DB02746 | |
| 0.087 | 0.188 | 0.229 | Arachidonic acid antagonist | 0.134 0.108 DBMET00033 0.126 0.118 DBMET00035 0.139 0.101 DBMET01115 0.145 0.094 DBMET03444 0.185 0.048 DBMET01117 0.229 0.012 DB02746 0.137 0.105 DBMET01114 0.155 0.083 DBMET01121 0.191 0.042 DB03091 0.178 0.056 DB00130 0.209 0.025 DB00142 | DB02746 | |
| 0.044 | 0.145 | 0.074 | Potassium channel (Tandem pore domain) blocker | 0.074 0.049 DB02746 | DB02746 | |
| 0.018 | 0.119 | 0.136 | Aminopeptidase N inhibitor | 0.055 0.027 DBMET01119 0.064 0.022 DBMET01120 0.136 0.007 DBMET03446 0.054 0.028 DBMET01121 0.124 0.009 DB03091 0.124 0.009 DB00130 0.128 0.008 DB00142 | DBMET03446 | |
| 0.002 | 0.104 | 0.021 | Carboxypeptidase B2 inhibitor | 0.016 0.005 DB03091 0.014 0.005 DB00130 0.021 0.004 DB00142 | DB00142 | |
| 0.035 | 0.137 | 0.147 | CDC25B inhibitor | 0.057 0.055 DBMET01116 0.086 0.023 DBMET01117 0.147 0.007 DB02746 0.058 0.054 DBMET01114 0.059 0.051 DBMET01121 | DB02746 | |
| 0.035 | 0.137 | 0.099 | Na+ K+ transporting ATPase inhibitor | 0.082 0.049 DBMET03456 0.098 0.033 DB02746 0.079 0.051 DBMET03446 0.082 0.049 DB03091 0.068 0.062 DB00130 0.099 0.032 DB00142 | DB00142 | |
| 0.026 | 0.129 | 0.087 | Matrix metalloproteinase (membrane-type) inhibitor | 0.052 0.043 DBMET03457 0.056 0.037 DBMET01115 0.071 0.024 DBMET01119 0.064 0.029 DBMET01120 0.05 0.047 DBMET03446 0.066 0.027 DBMET01121 0.087 0.018 DB03091 0.078 0.021 DB00130 0.075 0.022 DB00142 | DB03091 | |
| 0.048 | 0.151 | 0.075 | Calcium channel P-type blocker | 0.075 0.02 DB02746 | DB02746 | |
| 0.02 | 0.123 | 0.092 | Leukocyte elastase inhibitor | 0.092 0.01 DBMET01119 0.059 0.018 DBMET01120 0.058 0.019 DB02746 0.081 0.012 DBMET01121 0.092 0.01 DB03091 0.045 0.028 DB00130 0.049 0.024 DB00142 | DB03091 | |
| 0.016 | 0.12 | 0.074 | Angiotensin II receptor antagonist | 0.041 0.013 DBMET01116 0.033 0.027 DBMET01118 0.052 0.006 DBMET01117 0.04 0.014 DBMET01119 0.045 0.01 DBMET01120 0.074 0.004 DB02746 0.056 0.005 DBMET01121 0.031 0.03 DB00130 0.036 0.021 DB00142 | DB02746 | |
| 0.02 | 0.124 | 0.271 | NMDA receptor subunit 3B antagonist | 0.044 0.03 DBMET01119 0.051 0.024 DBMET01120 0.163 0.005 DB02746 0.077 0.014 DBMET01121 0.117 0.009 DB03091 0.182 0.005 DB00130 0.271 0.004 DB00142 | DB00142 | |
| 0.012 | 0.116 | 0.349 | Kainate receptor antagonist | 0.045 0.025 DBMET01115 0.06 0.016 DBMET01116 0.055 0.019 DBMET01118 0.036 0.033 DBMET01117 0.14 0.005 DBMET01119 0.226 0.004 DBMET01120 0.194 0.004 DB02746 0.152 0.005 DBMET01121 0.199 0.004 DB03091 0.349 0.003 DB00130 0.305 0.003 DB00142 | DB00130 | |
| 0.009 | 0.114 | 0.037 | Calpain 1 inhibitor | 0.037 0.015 DBMET01119 0.035 0.02 DBMET01120 0.032 0.027 DB00130 | DBMET01119 | |
| 0.028 | 0.134 | 0.072 | Dopamine beta hydroxylase inhibitor | 0.072 0.007 DB02746 0.045 0.043 DB00142 | DB02746 | |
| 0.095 | 0.203 | 0.214 | Melanin inhibitor | 0.207 0.038 DBMET03456 0.142 0.094 DBMET00034 0.129 0.116 DBMET03444 0.126 0.122 DBMET01117 0.15 0.082 DBMET01119 0.192 0.044 DB02746 0.138 0.1 DBMET01114 0.15 0.082 DBMET01121 0.214 0.036 DB03091 0.161 0.068 DB00130 0.206 0.038 DB00142 | DB03091 | |
| 0.091 | 0.2 | 0.571 | DNA methyltransferase I inhibitor | 0.232 0.055 DBMET03456 0.361 0.013 DBMET01115 0.462 0.005 DBMET01116 0.571 0.004 DBMET01117 0.237 0.052 DBMET01119 0.29 0.03 DBMET01120 0.321 0.02 DB02746 0.147 0.108 DBMET01114 0.364 0.012 DBMET01121 0.277 0.035 DB03091 0.332 0.017 DB00130 0.426 0.007 DB00142 | DBMET01117 | |
| 0.043 | 0.152 | 0.092 | Trypsin inhibitor | 0.078 0.028 DBMET01119 0.088 0.023 DBMET01120 0.069 0.034 DBMET03446 0.078 0.028 DBMET01121 0.075 0.03 DB03091 0.081 0.026 DB00130 0.092 0.021 DB00142 | DB00142 | |
| 0.018 | 0.128 | 0.194 | Glutamate (mGluR3) agonist | 0.036 0.015 DBMET01115 0.048 0.005 DBMET01118 0.036 0.015 DBMET01117 0.084 0.003 DBMET01119 0.074 0.003 DBMET01120 0.094 0.002 DB02746 0.038 0.012 DBMET03446 0.112 0.002 DBMET01121 0.116 0.002 DB03091 0.101 0.002 DB00130 0.194 0.001 DB00142 | DB00142 | |
| 0.018 | 0.129 | 0.105 | Opioid agonist | 0.105 0.012 DB03091 0.082 0.018 DB00130 0.065 0.026 DB00142 | DB03091 | |
| 0.009 | 0.119 | 0.026 | CXC chemokine 5 receptor antagonist | 0.026 0.005 DB02746 | DB02746 | |
| 0.05 | 0.161 | 0.261 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.066 DBMET01115 0.089 0.066 DBMET01116 0.093 0.062 DBMET01117 0.096 0.059 DBMET01119 0.083 0.074 DBMET01120 0.261 0.004 DB02746 0.086 0.069 DBMET01121 0.133 0.032 DB03091 0.133 0.032 DB00130 0.177 0.017 DB00142 | DB02746 | |
| 0.011 | 0.123 | 0.102 | LFA antagonist | 0.065 0.005 DBMET01119 0.102 0.004 DBMET01120 0.061 0.005 DB02746 0.1 0.004 DBMET01121 0.042 0.007 DB03091 0.044 0.007 DB00130 0.038 0.009 DB00142 | DBMET01120 | |
| 0.047 | 0.16 | 0.386 | Alcohol dehydrogenase inhibitor | 0.167 0.016 DBMET01115 0.217 0.01 DBMET01116 0.086 0.07 DBMET01118 0.08 0.079 DBMET00034 0.187 0.014 DBMET01117 0.181 0.014 DBMET01119 0.204 0.012 DBMET01120 0.275 0.006 DB02746 0.178 0.015 DBMET01121 0.257 0.007 DB03091 0.358 0.004 DB00130 0.386 0.004 DB00142 | DB00142 | |
| 0.013 | 0.126 | 0.257 | NMDA receptor subunit 3A antagonist | 0.034 0.03 DBMET01117 0.035 0.03 DBMET01120 0.133 0.005 DB02746 0.06 0.017 DBMET01121 0.09 0.01 DB03091 0.151 0.005 DB00130 0.257 0.004 DB00142 | DB00142 | |
| 0.025 | 0.139 | 0.068 | GABA B receptor antagonist | 0.039 0.037 DBMET01115 0.057 0.014 DB02746 0.055 0.015 DB03091 0.042 0.032 DB00130 0.068 0.009 DB00142 | DB00142 | |
| 0.009 | 0.123 | 0.088 | HCV NS5B polymerase inhibitor | 0.035 0.018 DBMET01119 0.047 0.011 DBMET01120 0.076 0.006 DB02746 0.088 0.005 DBMET01121 | DBMET01121 | |
| 0.027 | 0.144 | 0.073 | CDC7 inhibitor | 0.073 0.041 DBMET03446 | DBMET03446 | |
| 0.012 | 0.129 | 0.052 | Thyroid hormone agonist | 0.027 0.016 DB02746 0.025 0.021 DBMET01121 0.039 0.006 DB03091 0.033 0.01 DB00130 0.052 0.004 DB00142 | DB00142 | |
| 0.016 | 0.134 | 0.123 | GABA uptake inhibitor | 0.059 0.01 DBMET01115 0.053 0.014 DBMET01117 0.044 0.021 DBMET01119 0.123 0.003 DB02746 0.041 0.025 DBMET01121 0.053 0.013 DB03091 0.037 0.031 DB00130 0.058 0.011 DB00142 | DB02746 | |
| 0.028 | 0.146 | 0.28 | Carbonic anhydrase stimulant | 0.06 0.041 DBMET01115 0.073 0.029 DBMET01116 0.092 0.021 DBMET01119 0.148 0.011 DBMET01120 0.074 0.029 DB02746 0.097 0.019 DBMET01121 0.236 0.006 DB03091 0.28 0.005 DB00130 0.22 0.006 DB00142 | DB00130 | |
| 0.008 | 0.129 | 0.045 | Factor VII inhibitor | 0.045 0.013 DBMET01119 0.04 0.015 DBMET01120 0.027 0.023 DBMET01121 0.035 0.017 DB03091 0.036 0.017 DB00130 0.03 0.02 DB00142 | DBMET01119 | |
| 0.01 | 0.13 | 0.063 | Free fatty acid receptor 1 antagonist | 0.055 0.007 DBMET01117 0.063 0.005 DB02746 0.034 0.024 DB00142 | DB02746 | |
| 0.015 | 0.137 | 0.036 | Motilin receptor antagonist | 0.028 0.018 DBMET01118 0.036 0.009 DBMET03446 0.034 0.01 DB03091 0.028 0.017 DB00130 | DBMET03446 | |
| 0.135 | 0.258 | 0.385 | Calpain 2 inhibitor | 0.273 0.132 DBMET01118 0.367 0.078 DBMET01119 0.385 0.069 DBMET01120 0.298 0.115 DB02746 0.335 0.094 DBMET01121 0.228 0.165 DB00130 | DBMET01120 | |
| 0.015 | 0.138 | 0.151 | Opioid mu receptor agonist | 0.041 0.04 DBMET01115 0.052 0.028 DBMET01119 0.151 0.007 DB03091 0.104 0.012 DB00130 0.089 0.016 DB00142 | DB03091 | |
| 0.019 | 0.144 | 0.098 | Purinergic P2X antagonist | 0.098 0.009 DBMET01115 | DBMET01115 | |
| 0.014 | 0.14 | 0.238 | Antimetabolite | 0.057 0.027 DBMET01115 0.07 0.022 DBMET01116 0.097 0.017 DBMET01117 0.116 0.014 DBMET01119 0.158 0.011 DBMET01120 0.05 0.032 DB02746 0.041 0.039 DBMET03446 0.204 0.009 DBMET01121 0.163 0.011 DB03091 0.19 0.01 DB00130 0.238 0.008 DB00142 | DB00142 | |
| 0.014 | 0.14 | 0.11 | CDK2/cyclin E inhibitor | 0.11 0.02 DBMET03446 | DBMET03446 | |
| 0.011 | 0.138 | 0.561 | Integrin antagonist | 0.136 0.012 DBMET01115 0.066 0.023 DBMET01117 0.212 0.007 DBMET01119 0.269 0.005 DBMET01120 0.423 0.004 DBMET01121 0.278 0.005 DB03091 0.319 0.005 DB00130 0.561 0.004 DB00142 | DB00142 | |
| 0.058 | 0.185 | 0.168 | D-Ala-D-Ala ligase inhibitor | 0.168 0.004 DB02746 0.08 0.068 DBMET01121 0.086 0.053 DB00142 | DB02746 | |
| 0.016 | 0.143 | 0.111 | RNA-directed RNA polymerase inhibitor | 0.032 0.027 DBMET01117 0.039 0.019 DBMET01119 0.058 0.01 DBMET01120 0.093 0.005 DB02746 0.111 0.005 DBMET01121 0.039 0.019 DB00142 | DBMET01121 | |
| 0.016 | 0.144 | 0.035 | Ceramide glucosyltransferase inhibitor | 0.035 0.027 DB02746 | DB02746 | |
| 0.005 | 0.133 | 0.164 | Somatostatin 2 agonist | 0.164 0.003 DBMET03446 | DBMET03446 | |
| 0.006 | 0.134 | 0.074 | Methionyl aminopeptidase 2 inhibitor | 0.074 0.005 DB02746 | DB02746 | |
| 0.009 | 0.14 | 0.032 | Prostaglandin F2 alpha agonist | 0.03 0.009 DB02746 0.026 0.011 DB03091 0.023 0.015 DB00130 0.032 0.008 DB00142 | DB00142 | |
| 0.015 | 0.146 | 0.075 | Factor XIIIa inhibitor | 0.034 0.03 DBMET01119 0.047 0.018 DBMET01120 0.035 0.029 DBMET01121 0.043 0.021 DB03091 0.075 0.009 DB00130 0.05 0.016 DB00142 | DB00130 | |
| 0.008 | 0.139 | 0.204 | AMPA 2 receptor antagonist | 0.035 0.017 DBMET01120 0.062 0.009 DB02746 0.033 0.018 DBMET01121 0.066 0.008 DB03091 0.181 0.004 DB00130 0.204 0.004 DB00142 | DB00142 | |
| 0.009 | 0.14 | 0.032 | Carnitine palmitoyltransferase 1A inhibitor | 0.032 0.016 DB02746 | DB02746 | |
| 0.008 | 0.139 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.012 DB02746 | DB02746 | |
| 0.044 | 0.175 | 0.123 | Pim-3 kinase inhibitor | 0.123 0.029 DBMET03446 | DBMET03446 | |
| 0.014 | 0.145 | 0.142 | Carbonic anhydrase VB inhibitor | 0.142 0.009 DB02746 0.051 0.043 DB00142 | DB02746 | |
| 0.014 | 0.145 | 0.236 | Toll-Like receptor 2 agonist | 0.049 0.024 DBMET01115 0.05 0.023 DBMET01116 0.035 0.034 DBMET01117 0.155 0.011 DBMET01119 0.16 0.01 DBMET01120 0.037 0.032 DB02746 0.108 0.014 DBMET01121 0.233 0.005 DB03091 0.236 0.005 DB00130 0.219 0.006 DB00142 | DB00130 | |
| 0.039 | 0.171 | 0.065 | Phosphodiesterase 1C inhibitor | 0.065 0.037 DB02746 | DB02746 | |
| 0.023 | 0.155 | 0.153 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.042 0.028 DBMET01119 0.042 0.028 DBMET01120 0.153 0.002 DB02746 0.046 0.021 DBMET01121 0.069 0.005 DB03091 0.058 0.008 DB00130 0.072 0.004 DB00142 | DB02746 | |
| 0.029 | 0.161 | 0.057 | Fatty acid synthase inhibitor | 0.057 0.039 DB02746 | DB02746 | |
| 0.019 | 0.151 | 0.198 | Dihydroorotase inhibitor | 0.147 0.004 DBMET01118 0.072 0.011 DBMET01119 0.072 0.011 DBMET01120 0.198 0.003 DB02746 0.106 0.005 DBMET01121 | DB02746 | |
| 0.016 | 0.149 | 0.086 | Adenosine deaminase inhibitor | 0.063 0.018 DBMET01115 0.068 0.015 DBMET01116 0.06 0.021 DBMET01117 0.061 0.02 DBMET01119 0.071 0.013 DBMET01120 0.086 0.008 DB02746 0.063 0.018 DBMET01121 0.071 0.013 DB03091 0.086 0.008 DB00130 0.085 0.008 DB00142 | DB00130 | |
| 0.006 | 0.139 | 0.082 | Somatostatin 5 antagonist | 0.064 0.009 DBMET01118 0.05 0.013 DBMET01119 0.037 0.02 DBMET01120 0.062 0.01 DB02746 0.082 0.008 DBMET03446 0.058 0.01 DB03091 0.033 0.022 DB00130 | DBMET03446 | |
| 0.057 | 0.191 | 0.101 | MAP kinase kinase inhibitor | 0.101 0.093 DB02746 | DB02746 | |
| 0.017 | 0.152 | 0.346 | Glutamate (mGluR4) agonist | 0.043 0.014 DBMET01119 0.041 0.015 DBMET01120 0.085 0.005 DB02746 0.079 0.005 DBMET01121 0.103 0.004 DB03091 0.11 0.004 DB00130 0.346 0.003 DB00142 | DB00142 | |
| 0.076 | 0.21 | 0.442 | Diuretic | 0.155 0.073 DBMET03456 0.162 0.067 DBMET01116 0.346 0.017 DBMET01118 0.187 0.05 DBMET01117 0.442 0.01 DBMET01119 0.341 0.017 DBMET01120 0.22 0.037 DB02746 0.157 0.071 DBMET03446 0.403 0.013 DBMET01121 0.405 0.013 DB03091 0.282 0.026 DB00130 0.331 0.018 DB00142 | DBMET01119 | |
| 0.05 | 0.185 | 0.091 | Cyclin-dependent kinase 9 inhibitor | 0.091 0.074 DBMET03446 | DBMET03446 | |
| 0.038 | 0.173 | 0.304 | Ornithine decarboxylase inhibitor | 0.083 0.064 DBMET01115 0.091 0.055 DBMET01117 0.119 0.027 DBMET01119 0.11 0.034 DBMET01120 0.172 0.007 DB02746 0.081 0.066 DBMET03446 0.141 0.014 DBMET01121 0.157 0.009 DB03091 0.172 0.007 DB00130 0.304 0.003 DB00142 | DB00142 | |
| 0.017 | 0.152 | 0.034 | Melatonin receptor 1A agonist | 0.034 0.022 DB02746 | DB02746 | |
| 0.084 | 0.22 | 0.193 | Sphingosine 1-phosphate receptor 2 antagonist | 0.114 0.112 DBMET01115 0.127 0.081 DBMET01117 0.12 0.096 DBMET01119 0.181 0.014 DB02746 0.134 0.066 DBMET01121 0.193 0.009 DB03091 0.153 0.037 DB00130 0.193 0.009 DB00142 | DB00142 | |
| 0.062 | 0.198 | 0.165 | Glutamate release inhibitor | 0.086 0.072 DBMET01119 0.165 0.007 DB02746 0.109 0.031 DBMET03446 0.163 0.007 DB03091 0.114 0.027 DB00130 0.149 0.01 DB00142 | DB02746 | |
| 0.037 | 0.175 | 0.15 | Protein kinase A inhibitor | 0.098 0.046 DBMET01118 0.071 0.07 DB02746 0.15 0.024 DBMET03446 | DBMET03446 | |
| 0.022 | 0.16 | 0.058 | Pim-2 kinase inhibitor | 0.058 0.033 DBMET03446 | DBMET03446 | |
| 0.004 | 0.142 | 0.041 | Prostaglandin E2 agonist | 0.041 0.007 DB02746 | DB02746 | |
| 0.015 | 0.155 | 0.066 | Metalloproteinase-3 inhibitor | 0.054 0.029 DBMET01119 0.055 0.028 DBMET01120 0.066 0.021 DBMET01121 0.064 0.022 DB03091 0.06 0.024 DB00130 0.063 0.022 DB00142 | DBMET01121 | |
| 0.064 | 0.204 | 0.266 | Photosensitizer | 0.14 0.037 DBMET01115 0.116 0.062 DBMET01116 0.157 0.027 DBMET01117 0.155 0.028 DBMET01119 0.14 0.038 DBMET01120 0.209 0.011 DB02746 0.188 0.015 DBMET01121 0.266 0.005 DB03091 0.183 0.017 DB00130 0.255 0.005 DB00142 | DB03091 | |
| 0.057 | 0.197 | 0.105 | Multidrug resistance-associated protein 1 inhibitor | 0.105 0.07 DBMET03456 | DBMET03456 | |
| 0.014 | 0.155 | 0.029 | Complement factor 1s inhibitor | 0.029 0.009 DB02746 0.026 0.016 DB00142 | DB02746 | |
| 0.024 | 0.166 | 0.069 | Lysine-specific demethylase 1A inhibitor | 0.069 0.018 DBMET03446 | DBMET03446 | |
| 0.008 | 0.15 | 0.048 | Trypsin I inhibitor | 0.038 0.019 DBMET01119 0.045 0.014 DBMET01120 0.042 0.016 DBMET01121 0.035 0.021 DB03091 0.04 0.017 DB00130 0.048 0.013 DB00142 | DB00142 | |
| 0.042 | 0.184 | 0.082 | Potassium channel activator | 0.082 0.072 DB02746 | DB02746 | |
| 0.008 | 0.15 | 0.025 | Geranylgeranyltransferase inhibitor | 0.021 0.017 DBMET01120 0.02 0.018 DB03091 0.025 0.012 DB00130 0.024 0.013 DB00142 | DB00130 | |
| 0.01 | 0.152 | 0.095 | Farnesoid X receptor agonist | 0.095 0.004 DB02746 | DB02746 | |
| 0.056 | 0.198 | 0.289 | Mucolytic | 0.112 0.063 DBMET01115 0.121 0.053 DBMET01118 0.118 0.056 DBMET01117 0.197 0.014 DBMET01119 0.192 0.015 DBMET01120 0.26 0.005 DB02746 0.105 0.071 DBMET03446 0.241 0.007 DBMET01121 0.224 0.009 DB03091 0.219 0.01 DB00130 0.289 0.004 DB00142 | DB00142 | |
| 0.02 | 0.164 | 0.437 | Glutamate (mGluR group III) agonist | 0.061 0.018 DBMET01118 0.094 0.011 DBMET01119 0.093 0.011 DBMET01120 0.153 0.005 DB02746 0.146 0.005 DBMET01121 0.167 0.004 DB03091 0.191 0.004 DB00130 0.437 0.003 DB00142 | DB00142 | |
| 0.029 | 0.172 | 0.062 | CDK1/cyclin B1 inhibitor | 0.062 0.057 DBMET03446 | DBMET03446 | |
| 0.092 | 0.236 | 0.185 | CF transmembrane conductance regulator agonist | 0.185 0.032 DB02746 0.159 0.061 DBMET03446 0.133 0.111 DB00142 | DB02746 | |
| 0.025 | 0.17 | 0.044 | Histamine H4 receptor antagonist | 0.044 0.042 DBMET03446 | DBMET03446 | |
| 0.007 | 0.153 | 0.058 | Prostaglandin agonist | 0.058 0.009 DB02746 0.029 0.025 DB00142 | DB02746 | |
| 0.012 | 0.159 | 0.081 | Cyclin E1 inhibitor | 0.081 0.024 DBMET03446 | DBMET03446 | |
| 0.01 | 0.157 | 0.158 | Nicotinic acid receptor agonist | 0.158 0.004 DB02746 | DB02746 | |
| 0.01 | 0.159 | 0.039 | DNA gyrase subunit B inhibitor | 0.039 0.024 DB02746 | DB02746 | |
| 0.009 | 0.159 | 0.047 | Sodium/glucose cotransporter inhibitor | 0.047 0.005 DBMET03456 | DBMET03456 | |
| 0.048 | 0.197 | 0.183 | GABA B receptor agonist | 0.113 0.01 DBMET01115 0.091 0.024 DBMET01116 0.098 0.018 DBMET01117 0.104 0.014 DBMET01119 0.085 0.033 DBMET01120 0.147 0.004 DB02746 0.092 0.023 DBMET01121 0.183 0.004 DB03091 0.136 0.005 DB00130 0.18 0.004 DB00142 | DB03091 | |
| 0.005 | 0.154 | 0.182 | Integrin beta3 antagonist | 0.018 0.015 DBMET01117 0.023 0.012 DBMET01119 0.023 0.012 DBMET01120 0.036 0.008 DBMET01121 0.075 0.005 DB03091 0.049 0.006 DB00130 0.182 0.004 DB00142 | DB00142 | |
| 0.03 | 0.179 | 0.078 | Phosphodiesterase IV inhibitor | 0.078 0.064 DBMET03457 | DBMET03457 | |
| 0.061 | 0.212 | 0.226 | Cyclooxygenase 3 inhibitor | 0.22 0.013 DBMET03456 0.106 0.094 DBMET03444 0.103 0.099 DBMET01117 0.144 0.053 DBMET01119 0.161 0.04 DBMET01120 0.212 0.015 DB02746 0.18 0.027 DBMET01121 0.189 0.023 DB03091 0.207 0.016 DB00130 0.226 0.012 DB00142 | DB00142 | |
| 0.013 | 0.165 | 0.059 | Matrix metalloproteinase 1 inhibitor | 0.057 0.033 DB03091 0.059 0.032 DB00130 | DB00130 | |
| 0.009 | 0.161 | 0.047 | Retinoid X beta receptor antagonist | 0.047 0.003 DB02746 0.022 0.011 DB00142 | DB02746 | |
| 0.036 | 0.188 | 0.07 | Beta 3 adrenoreceptor antagonist | 0.07 0.034 DB02746 | DB02746 | |
| 0.04 | 0.192 | 0.218 | Carbonic anhydrase VI inhibitor | 0.073 0.067 DBMET01115 0.218 0.011 DB02746 0.092 0.045 DB03091 0.081 0.056 DB00130 0.102 0.038 DB00142 | DB02746 | |
| 0.044 | 0.198 | 0.24 | Topoisomerase II inhibitor | 0.24 0.026 DBMET03456 0.211 0.031 DBMET03457 0.109 0.078 DBMET03458 0.125 0.063 DBMET00034 0.175 0.04 DB02746 0.121 0.066 DBMET01114 | DBMET03456 | |
| 0.12 | 0.275 | 0.283 | Hypoxia-inducible factor 1 alpha inhibitor | 0.217 0.133 DBMET03456 0.259 0.093 DBMET03457 0.204 0.147 DBMET03458 0.191 0.163 DBMET00034 0.186 0.169 DBMET01117 0.283 0.074 DB02746 0.187 0.168 DBMET01114 | DB02746 | |
| 0.041 | 0.196 | 0.291 | Keratolytic | 0.071 0.064 DBMET01118 0.091 0.037 DBMET01119 0.112 0.025 DBMET01120 0.291 0.004 DB02746 0.137 0.017 DBMET01121 0.096 0.033 DB03091 0.113 0.024 DB00130 0.148 0.015 DB00142 | DB02746 | |
| 0.028 | 0.184 | 0.138 | Angiotensin-converting enzyme inhibitor | 0.05 0.048 DBMET01115 0.069 0.02 DBMET01116 0.055 0.038 DBMET01118 0.071 0.019 DBMET01117 0.07 0.019 DBMET01119 0.092 0.01 DBMET01120 0.061 0.029 DB02746 0.098 0.009 DBMET01121 0.101 0.009 DB03091 0.125 0.006 DB00130 0.138 0.005 DB00142 | DB00142 | |
| 0.005 | 0.161 | 0.148 | Vitronectin receptor antagonist | 0.023 0.013 DBMET01119 0.035 0.009 DBMET01120 0.055 0.006 DBMET01121 0.071 0.005 DB03091 0.087 0.005 DB00130 0.148 0.004 DB00142 | DB00142 | |
| 0.004 | 0.16 | 0.091 | Integrin alpha4beta7 antagonist | 0.041 0.006 DBMET01119 0.064 0.005 DBMET01120 0.091 0.004 DBMET01121 0.031 0.009 DB03091 0.055 0.005 DB00130 0.088 0.004 DB00142 | DBMET01121 | |
| 0.03 | 0.187 | 0.191 | Purinergic P2X1 antagonist | 0.054 0.053 DBMET01117 0.191 0.004 DB02746 0.077 0.027 DBMET01121 0.064 0.038 DB03091 0.088 0.021 DB00142 | DB02746 | |
| 0.086 | 0.244 | 0.152 | Papain-like protease (SARS coronavirus) inhibitor | 0.135 0.052 DBMET01118 0.117 0.091 DBMET00034 0.12 0.081 DBMET03444 0.148 0.036 DBMET01119 0.148 0.036 DBMET01120 0.152 0.032 DBMET01121 | DBMET01121 | |
| 0.025 | 0.184 | 0.079 | Histamine H1 receptor antagonist | 0.079 0.058 DBMET01117 0.077 0.061 DB02746 | DBMET01117 | |
| 0.007 | 0.166 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.015 DB02746 | DB02746 | |
| 0.042 | 0.201 | 0.127 | Sphingomyelinase inhibitor | 0.127 0.036 DB02746 0.091 0.07 DB00130 | DB02746 | |
| 0.006 | 0.166 | 0.247 | Cholecystokinin antagonist | 0.219 0.004 DBMET01119 0.089 0.01 DBMET01120 0.125 0.006 DBMET01121 0.247 0.004 DB03091 0.069 0.014 DB00130 0.092 0.009 DB00142 | DB03091 | |
| 0.006 | 0.167 | 0.093 | Endothelial nitric-oxide synthase inhibitor | 0.049 0.01 DB03091 0.063 0.007 DB00130 0.093 0.004 DB00142 | DB00142 | |
| 0.089 | 0.25 | 0.14 | Pregnane X receptor agonist | 0.14 0.074 DB02746 | DB02746 | |
| 0.049 | 0.21 | 0.139 | MAP kinase 13 inhibitor | 0.139 0.042 DBMET03446 | DBMET03446 | |
| 0.002 | 0.163 | 0.008 | Thyroid hormone beta agonist | 0.008 0.007 DB00142 | DB00142 | |
| 0.005 | 0.167 | 0.051 | Prostaglandin EP2 agonist | 0.051 0.005 DB02746 | DB02746 | |
| 0.027 | 0.189 | 0.112 | Autotaxin inhibitor | 0.112 0.011 DB02746 0.05 0.04 DBMET01121 | DB02746 | |
| 0.03 | 0.193 | 0.056 | Glucosylceramidase inhibitor | 0.056 0.036 DB02746 | DB02746 | |
| 0.019 | 0.183 | 0.047 | Benzodiazepine antagonist | 0.047 0.032 DB02746 | DB02746 | |
| 0.007 | 0.171 | 0.031 | Glutamate (mGluR2) antagonist | 0.031 0.019 DB02746 0.031 0.018 DB00142 | DB00142 | |
| 0.016 | 0.18 | 0.063 | Retinoid X alpha receptor antagonist | 0.063 0.004 DB02746 | DB02746 | |
| 0.007 | 0.172 | 0.12 | Kainate receptor 4 antagonist | 0.029 0.014 DBMET03457 0.023 0.019 DBMET01120 0.053 0.006 DB02746 0.031 0.013 DBMET01121 0.034 0.012 DB03091 0.081 0.004 DB00130 0.12 0.004 DB00142 | DB00142 | |
| 0.081 | 0.246 | 0.556 | DNA methylase inhibitor | 0.225 0.063 DBMET03456 0.367 0.014 DBMET01115 0.515 0.005 DBMET01116 0.556 0.005 DBMET01117 0.237 0.056 DBMET01119 0.327 0.021 DBMET01120 0.309 0.025 DB02746 0.356 0.016 DBMET01121 0.279 0.034 DB03091 0.392 0.011 DB00130 0.444 0.008 DB00142 | DBMET01117 | |
| 0.016 | 0.182 | 0.073 | Plasminogen activator inhibitor | 0.06 0.039 DBMET01118 0.064 0.036 DBMET01119 0.054 0.045 DBMET01120 0.056 0.043 DBMET03446 0.05 0.048 DBMET01121 0.054 0.045 DB03091 0.073 0.03 DB00142 | DB00142 | |
| 0.061 | 0.227 | 0.162 | Nav1.2 sodium channel blocker | 0.162 0.05 DBMET01119 0.152 0.056 DBMET01120 0.132 0.071 DB02746 0.126 0.077 DB03091 0.118 0.086 DB00130 | DBMET01119 | |
| 0.04 | 0.207 | 0.066 | Transcription factor RelA inhibitor | 0.066 0.037 DB02746 | DB02746 | |
| 0.009 | 0.176 | 0.066 | Carbonic anhydrase VII inhibitor | 0.066 0.016 DB02746 | DB02746 | |
| 0.061 | 0.228 | 0.24 | TRPA1 agonist | 0.139 0.039 DBMET01118 0.137 0.041 DBMET01119 0.122 0.056 DBMET01120 0.24 0.006 DB02746 0.151 0.03 DBMET01121 0.103 0.082 DB03091 0.113 0.067 DB00130 0.137 0.041 DB00142 | DB02746 | |
| 0.014 | 0.183 | 0.149 | Neutrophil collagenase inhibitor | 0.071 0.039 DBMET01115 0.128 0.015 DBMET01119 0.095 0.024 DBMET01120 0.064 0.046 DB02746 0.091 0.026 DBMET01121 0.149 0.012 DB03091 0.129 0.015 DB00130 0.116 0.018 DB00142 | DB03091 | |
| 0.01 | 0.178 | 0.151 | Retinoid X alpha receptor agonist | 0.045 0.016 DBMET01117 0.151 0.003 DB02746 0.032 0.028 DBMET01121 0.038 0.021 DB00142 | DB02746 | |
| 0.024 | 0.193 | 0.077 | Syk tyrosine kinase inhibitor | 0.077 0.043 DBMET03446 | DBMET03446 | |
| 0.085 | 0.255 | 0.328 | Antiamyloidogenic | 0.213 0.091 DBMET03456 0.187 0.109 DBMET01119 0.164 0.129 DBMET01120 0.184 0.111 DB02746 0.157 0.138 DBMET01114 0.328 0.044 DB03091 0.232 0.08 DB00130 0.209 0.094 DB00142 | DB03091 | |
| 0.011 | 0.182 | 0.105 | Cyclin E inhibitor | 0.105 0.022 DBMET03446 | DBMET03446 | |
| 0.031 | 0.202 | 0.146 | Analgesic, opioid | 0.072 0.058 DBMET01119 0.146 0.016 DB03091 0.108 0.028 DB00130 0.101 0.031 DB00142 | DB03091 | |
| 0.115 | 0.286 | 0.455 | Transcription factor STAT3 inhibitor | 0.188 0.151 DBMET01116 0.222 0.109 DBMET01118 0.407 0.017 DBMET01119 0.455 0.011 DBMET01120 0.315 0.046 DB02746 0.297 0.055 DBMET01121 0.298 0.055 DB03091 0.411 0.017 DB00130 0.264 0.073 DB00142 | DBMET01120 | |
| 0.017 | 0.188 | 0.073 | Retinoid X receptor antagonist | 0.073 0.004 DB02746 0.036 0.029 DB00142 | DB02746 | |
| 0.021 | 0.192 | 0.09 | Collagenase 3 inhibitor | 0.09 0.019 DBMET01119 0.063 0.038 DBMET01120 0.073 0.03 DB02746 0.059 0.043 DBMET03446 0.084 0.022 DBMET01121 0.072 0.03 DB03091 0.063 0.038 DB00130 0.07 0.031 DB00142 | DBMET01119 | |
| 0.003 | 0.175 | 0.036 | Ileal bile acid transport inhibitor | 0.02 0.009 DBMET01121 0.034 0.004 DB03091 0.027 0.005 DB00130 0.036 0.004 DB00142 | DB00142 | |
| 0.01 | 0.182 | 0.09 | Dihydropteroate synthase inhibitor | 0.046 0.02 DBMET01119 0.049 0.017 DBMET01120 0.081 0.006 DB02746 0.09 0.005 DBMET01121 0.048 0.018 DB03091 0.04 0.026 DB00130 0.071 0.008 DB00142 | DBMET01121 | |
| 0.007 | 0.179 | 0.031 | Beta 1 adrenoreceptor agonist | 0.031 0.008 DB02746 | DB02746 | |
| 0.03 | 0.203 | 0.159 | Metalloproteinase-2 inhibitor | 0.09 0.044 DBMET03457 0.106 0.035 DBMET01115 0.086 0.047 DBMET01116 0.093 0.042 DBMET01117 0.115 0.032 DBMET01119 0.1 0.038 DBMET01120 0.112 0.033 DBMET01121 0.159 0.017 DB03091 0.134 0.024 DB00130 0.129 0.025 DB00142 | DB03091 | |
| 0.003 | 0.176 | 0.016 | Thrombopoietin agonist | 0.016 0.005 DB02746 | DB02746 | |
| 0.081 | 0.254 | 0.148 | P-glycoprotein inhibitor | 0.148 0.12 DBMET03456 | DBMET03456 | |
| 0.007 | 0.181 | 0.108 | Prostaglandin EP4 antagonist | 0.024 0.02 DBMET01118 0.058 0.007 DBMET01119 0.024 0.02 DBMET01120 0.1 0.004 DB02746 0.108 0.004 DBMET01121 | DBMET01121 | |
| 0.026 | 0.201 | 0.068 | Bombesin 3 receptor antagonist | 0.051 0.044 DB03091 0.068 0.026 DB00130 | DB00130 | |
| 0.007 | 0.182 | 0.039 | Cathepsin L1 inhibitor | 0.039 0.028 DBMET01119 | DBMET01119 | |
| 0.045 | 0.22 | 0.127 | Tubulin antagonist | 0.103 0.098 DBMET00035 0.125 0.075 DBMET03457 0.101 0.1 DBMET03458 0.103 0.099 DBMET00034 0.127 0.073 DBMET01114 | DBMET01114 | |
| 0.02 | 0.195 | 0.073 | Bombesin antagonist | 0.062 0.017 DBMET01116 0.054 0.025 DBMET01119 0.055 0.023 DBMET01120 0.067 0.014 DB03091 0.073 0.011 DB00130 | DB00130 | |
| 0.01 | 0.186 | 0.073 | Glutamate (mGluR group II) antagonist | 0.051 0.015 DB02746 0.049 0.017 DB00130 0.073 0.008 DB00142 | DB00142 | |
| 0.018 | 0.194 | 0.125 | Neurokinin 2 agonist | 0.069 0.009 DBMET01115 0.043 0.026 DBMET01116 0.061 0.012 DBMET01119 0.044 0.025 DBMET01120 0.125 0.004 DB03091 0.064 0.011 DB00130 0.049 0.02 DB00142 | DB03091 | |
| 0.012 | 0.189 | 0.035 | Caspase 6 inhibitor | 0.028 0.027 DBMET01115 0.032 0.017 DBMET01119 0.033 0.015 DBMET01121 0.033 0.015 DB03091 0.029 0.025 DB00130 0.035 0.012 DB00142 | DB00142 | |
| 0.039 | 0.217 | 0.315 | Expectorant | 0.18 0.025 DBMET03456 0.089 0.082 DBMET01115 0.099 0.07 DBMET01118 0.096 0.073 DBMET01117 0.182 0.024 DBMET01119 0.168 0.029 DBMET01120 0.275 0.01 DB02746 0.242 0.014 DBMET01121 0.223 0.016 DB03091 0.206 0.019 DB00130 0.315 0.008 DB00142 | DB00142 | |
| 0.006 | 0.185 | 0.038 | Isoleucine-tRNA ligase inhibitor | 0.026 0.009 DB02746 0.038 0.003 DB03091 0.029 0.006 DB00130 0.035 0.004 DB00142 | DB03091 | |
| 0.024 | 0.204 | 0.051 | CF transmembrane conductance regulator antagonist | 0.051 0.008 DB02746 | DB02746 | |
| 0.021 | 0.202 | 0.06 | Myc inhibitor | 0.06 0.029 DB02746 | DB02746 | |
| 0.029 | 0.21 | 0.093 | Factor III inhibitor | 0.051 0.032 DBMET03456 0.047 0.042 DBMET01118 0.057 0.022 DBMET01119 0.055 0.024 DBMET01120 0.093 0.005 DB02746 0.056 0.022 DBMET01121 | DB02746 | |
| 0.019 | 0.201 | 0.158 | Glucagon-like peptide 1 agonist | 0.054 0.052 DBMET01116 0.11 0.017 DBMET01119 0.114 0.016 DBMET01120 0.106 0.019 DBMET01121 0.15 0.009 DB03091 0.158 0.007 DB00130 0.147 0.009 DB00142 | DB00130 | |
| 0.012 | 0.196 | 0.329 | Glycine transporter 2 inhibitor | 0.078 0.018 DBMET01119 0.21 0.005 DBMET01120 0.161 0.007 DBMET01121 0.142 0.008 DB03091 0.329 0.004 DB00130 0.301 0.004 DB00142 | DB00130 | |
| 0.005 | 0.189 | 0.336 | GP IIb/IIIa receptor antagonist | 0.075 0.023 DBMET01115 0.132 0.013 DBMET01116 0.164 0.009 DBMET01117 0.113 0.015 DBMET01119 0.106 0.016 DBMET01120 0.124 0.014 DBMET01121 0.248 0.005 DB03091 0.207 0.006 DB00130 0.336 0.004 DB00142 | DB00142 | |
| 0.013 | 0.199 | 0.074 | Cathepsin L inhibitor | 0.074 0.027 DBMET01119 0.062 0.036 DBMET01120 0.052 0.047 DBMET01121 0.054 0.046 DB03091 | DBMET01119 | |
| 0.011 | 0.196 | 0.04 | Bombesin 1 receptor antagonist | 0.04 0.022 DB00130 | DB00130 | |
| 0.008 | 0.194 | 0.065 | Liver X receptor beta antagonist | 0.065 0.005 DB02746 | DB02746 | |
| 0.005 | 0.193 | 0.017 | Vitamin D receptor agonist | 0.017 0.01 DBMET01121 0.016 0.012 DB00142 | DBMET01121 | |
| 0.037 | 0.225 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.026 DB02746 0.058 0.057 DB03091 0.063 0.039 DB00130 | DB02746 | |
| 0.012 | 0.201 | 0.054 | Thrombin receptor antagonist | 0.041 0.011 DBMET01119 0.029 0.019 DBMET01120 0.054 0.008 DB03091 0.039 0.012 DB00130 0.027 0.022 DB00142 | DB03091 | |
| 0.019 | 0.207 | 0.149 | Glutamate (mGluR8) antagonist | 0.047 0.01 DBMET01115 0.041 0.015 DBMET01116 0.034 0.029 DBMET01118 0.044 0.013 DBMET01117 0.055 0.006 DBMET01119 0.056 0.006 DBMET01120 0.075 0.004 DB02746 0.061 0.005 DBMET01121 0.08 0.003 DB03091 0.115 0.002 DB00130 0.149 0.002 DB00142 | DB00142 | |
| 0.021 | 0.21 | 0.047 | Cytokine production stimulant | 0.047 0.038 DB02746 0.046 0.042 DB00130 0.047 0.038 DB00142 | DB00142 | |
| 0.062 | 0.253 | 0.34 | Pyruvate kinase inhibitor | 0.34 0.037 DB02746 0.23 0.068 DB00130 0.312 0.045 DB00142 | DB02746 | |
| 0.047 | 0.239 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | 0.093 0.067 DBMET01117 0.126 0.025 DB02746 0.11 0.041 DB00142 | DB02746 | |
| 0.06 | 0.252 | 0.477 | Anticoagulant | 0.218 0.047 DBMET03456 0.238 0.041 DBMET01115 0.276 0.033 DBMET01116 0.14 0.09 DBMET01118 0.251 0.038 DBMET01117 0.342 0.022 DBMET01119 0.355 0.021 DBMET01120 0.121 0.111 DB02746 0.336 0.023 DBMET01121 0.448 0.013 DB03091 0.424 0.014 DB00130 0.477 0.011 DB00142 | DB00142 | |
| 0.056 | 0.251 | 0.553 | Interleukin 1 antagonist | 0.354 0.008 DBMET01115 0.52 0.005 DBMET01116 0.553 0.004 DBMET01117 0.131 0.075 DB02746 0.114 0.097 DB03091 0.126 0.081 DB00130 | DBMET01117 | |
| 0.005 | 0.199 | 0.033 | CXC chemokine 2 receptor antagonist | 0.033 0.012 DB02746 | DB02746 | |
| 0.034 | 0.228 | 0.12 | Cyclin-dependent kinase 2 inhibitor | 0.12 0.053 DBMET03446 | DBMET03446 | |
| 0.008 | 0.203 | 0.072 | Geranyltranstransferase inhibitor | 0.072 0.007 DB02746 0.051 0.022 DB03091 0.044 0.03 DB00130 0.058 0.015 DB00142 | DB02746 | |
| 0.006 | 0.201 | 0.122 | Integrin alphaVbeta3 antagonist | 0.023 0.014 DBMET01117 0.026 0.011 DBMET01119 0.031 0.008 DBMET01120 0.045 0.005 DBMET01121 0.053 0.005 DB03091 0.052 0.005 DB00130 0.122 0.004 DB00142 | DB00142 | |
| 0.09 | 0.285 | 0.236 | ATPase inhibitor | 0.189 0.048 DBMET03456 0.186 0.05 DBMET03457 0.236 0.017 DB02746 | DB02746 | |
| 0.005 | 0.2 | 0.193 | Kainate receptor 3 antagonist | 0.016 0.013 DBMET01120 0.038 0.005 DB02746 0.02 0.009 DBMET01121 0.022 0.008 DB03091 0.119 0.003 DB00130 0.193 0.003 DB00142 | DB00142 | |
| 0.021 | 0.217 | 0.13 | Carbonic anhydrase VA inhibitor | 0.13 0.015 DB02746 0.067 0.05 DB00142 | DB02746 | |
| 0.006 | 0.202 | 0.129 | Retinoid X receptor agonist | 0.057 0.015 DBMET01117 0.129 0.003 DB02746 0.046 0.019 DBMET01121 0.035 0.025 DB00142 | DB02746 | |
| 0.008 | 0.203 | 0.053 | Opioid delta receptor agonist | 0.053 0.012 DB03091 0.044 0.017 DB00130 0.039 0.02 DB00142 | DB03091 | |
| 0.006 | 0.203 | 0.023 | Dopamine D1 agonist | 0.023 0.015 DBMET03456 0.021 0.018 DBMET01114 | DBMET03456 | |
| 0.014 | 0.211 | 0.165 | Dihydroorotate dehydrogenase inhibitor | 0.108 0.009 DBMET01118 0.165 0.005 DB02746 | DB02746 | |
| 0.005 | 0.202 | 0.023 | Angiotensin-converting enzyme 2 inhibitor | 0.02 0.009 DBMET01120 0.023 0.007 DBMET01121 0.019 0.01 DB00130 0.02 0.009 DB00142 | DBMET01121 | |
| 0.005 | 0.203 | 0.053 | Carbonic anhydrase IV inhibitor | 0.053 0.023 DBMET01120 0.05 0.024 DB02746 0.05 0.025 DBMET01121 0.052 0.023 DB00130 0.049 0.026 DB00142 | DBMET01120 | |
| 0.025 | 0.223 | 0.089 | CYP2A6 inhibitor | 0.089 0.042 DB02746 | DB02746 | |
| 0.06 | 0.258 | 0.199 | Interleukin 8 antagonist | 0.145 0.037 DBMET01119 0.127 0.053 DBMET01120 0.14 0.041 DB02746 0.137 0.043 DBMET01121 0.199 0.013 DB03091 0.164 0.026 DB00130 0.184 0.017 DB00142 | DB03091 | |
| 0.026 | 0.224 | 0.077 | Beta adrenoreceptor antagonist | 0.077 0.03 DB02746 | DB02746 | |
| 0.004 | 0.203 | 0.197 | Cholecystokinin B antagonist | 0.172 0.004 DBMET01119 0.058 0.009 DBMET01120 0.076 0.006 DBMET01121 0.197 0.004 DB03091 0.043 0.013 DB00130 0.059 0.009 DB00142 | DB03091 | |
| 0.007 | 0.207 | 0.062 | Phosphoglycerate kinase inhibitor | 0.062 0.011 DB02746 0.036 0.023 DB03091 0.043 0.018 DB00142 | DB02746 | |
| 0.046 | 0.247 | 0.161 | Alkaline phosphatase inhibitor | 0.161 0.053 DB02746 | DB02746 | |
| 0.041 | 0.242 | 0.079 | Estrogen receptor alpha antagonist | 0.077 0.054 DBMET03444 0.079 0.05 DB02746 | DB02746 | |
| 0.067 | 0.267 | 0.286 | Mannose-6-phosphate isomerase inhibitor | 0.286 0.006 DB02746 0.125 0.092 DB00130 0.152 0.063 DB00142 | DB02746 | |
| 0.02 | 0.222 | 0.219 | Sphingosine 1-phosphate receptor 4 agonist | 0.073 0.042 DBMET01115 0.091 0.03 DBMET01117 0.068 0.047 DBMET01119 0.118 0.017 DB02746 0.126 0.015 DBMET01121 0.153 0.008 DB03091 0.128 0.014 DB00130 0.219 0.004 DB00142 | DB00142 | |
| 0.026 | 0.228 | 0.172 | Calcium antagonist | 0.172 0.018 DB02746 | DB02746 | |
| 0.109 | 0.31 | 0.624 | Cholesterol antagonist | 0.331 0.073 DBMET03456 0.239 0.133 DBMET01115 0.207 0.159 DBMET01118 0.335 0.071 DBMET01117 0.266 0.114 DBMET01119 0.266 0.114 DBMET01120 0.624 0.016 DB02746 0.484 0.035 DBMET01121 0.355 0.062 DB03091 0.312 0.084 DB00130 0.527 0.028 DB00142 | DB02746 | |
| 0.031 | 0.233 | 0.083 | Secretase beta inhibitor | 0.083 0.032 DBMET03446 0.082 0.034 DB03091 0.069 0.051 DB00130 0.073 0.045 DB00142 | DBMET03446 | |
| 0.03 | 0.233 | 0.097 | Calcium channel L-type blocker | 0.097 0.026 DB02746 | DB02746 | |
| 0.025 | 0.228 | 0.081 | Elastase 1 inhibitor | 0.081 0.034 DBMET01119 0.075 0.04 DBMET01121 0.065 0.054 DB03091 0.067 0.051 DB00142 | DBMET01119 | |
| 0.034 | 0.237 | 0.085 | MAP-kinase-activated kinase inhibitor | 0.085 0.055 DBMET03446 | DBMET03446 | |
| 0.027 | 0.231 | 0.142 | Anesthetic local | 0.142 0.053 DB02746 | DB02746 | |
| 0.128 | 0.332 | 0.602 | Apoptosis antagonist | 0.403 0.038 DBMET03456 0.548 0.015 DBMET01115 0.271 0.108 DBMET01116 0.202 0.176 DBMET00034 0.356 0.053 DBMET01117 0.448 0.028 DBMET01119 0.354 0.054 DBMET01120 0.325 0.07 DB02746 0.231 0.146 DBMET01114 0.439 0.029 DBMET01121 0.602 0.009 DB03091 0.395 0.04 DB00130 0.541 0.015 DB00142 | DB03091 | |
| 0.016 | 0.221 | 0.098 | Nicotinic acid receptor 1 agonist | 0.098 0.008 DB02746 | DB02746 | |
| 0.003 | 0.208 | 0.031 | Egl nine homolog 1 inhibitor | 0.031 0.004 DB02746 0.016 0.009 DBMET01121 | DB02746 | |
| 0.027 | 0.234 | 0.114 | Metalloproteinase-9 inhibitor | 0.075 0.048 DBMET03457 0.085 0.041 DBMET01115 0.067 0.063 DBMET01116 0.066 0.065 DBMET01117 0.079 0.045 DBMET01119 0.074 0.049 DBMET01120 0.074 0.049 DBMET01121 0.114 0.026 DB03091 0.103 0.03 DB00130 0.091 0.037 DB00142 | DB03091 | |
| 0.015 | 0.222 | 0.057 | Liver X receptor alpha agonist | 0.057 0.014 DB02746 | DB02746 | |
| 0.008 | 0.215 | 0.166 | Ribonucleotide reductase inhibitor | 0.073 0.03 DBMET01115 0.06 0.036 DBMET01116 0.107 0.019 DBMET01119 0.129 0.015 DBMET01120 0.048 0.044 DB02746 0.096 0.022 DBMET01121 0.163 0.01 DB03091 0.166 0.01 DB00130 0.146 0.013 DB00142 | DB00130 | |
| 0.009 | 0.216 | 0.041 | Liver X receptor alpha antagonist | 0.041 0.009 DB02746 | DB02746 | |
| 0.018 | 0.226 | 0.055 | Cholesterol esterase inhibitor | 0.055 0.022 DB02746 | DB02746 | |
| 0.03 | 0.238 | 0.101 | Interferon inducer | 0.06 0.055 DBMET01120 0.079 0.024 DB02746 0.061 0.051 DBMET01121 0.078 0.026 DB03091 0.092 0.016 DB00130 0.101 0.012 DB00142 | DB00142 | |
| 0.007 | 0.216 | 0.045 | Prostaglandin D2 agonist | 0.036 0.015 DBMET01117 0.041 0.012 DB02746 0.031 0.021 DBMET01121 0.036 0.015 DB03091 0.045 0.01 DB00142 | DB00142 | |
| 0.008 | 0.218 | 0.167 | Ribonucleoside-diphosphate reductase inhibitor | 0.071 0.028 DBMET01115 0.058 0.035 DBMET01116 0.108 0.018 DBMET01119 0.132 0.014 DBMET01120 0.048 0.042 DB02746 0.095 0.02 DBMET01121 0.165 0.009 DB03091 0.167 0.009 DB00130 0.148 0.011 DB00142 | DB00130 | |
| 0.019 | 0.229 | 0.106 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.106 0.009 DB02746 | DB02746 | |
| 0.004 | 0.214 | 0.093 | Integrin beta7 antagonist | 0.039 0.008 DBMET01119 0.052 0.006 DBMET01120 0.075 0.005 DBMET01121 0.057 0.005 DB03091 0.078 0.005 DB00130 0.093 0.004 DB00142 | DB00142 | |
| 0.026 | 0.239 | 0.075 | MAP-kinase-activated kinase 2 inhibitor | 0.075 0.05 DBMET03446 | DBMET03446 | |
| 0.045 | 0.257 | 0.269 | Carbonic anhydrase III inhibitor | 0.111 0.051 DBMET01115 0.096 0.067 DBMET01116 0.102 0.06 DBMET01117 0.119 0.045 DBMET01119 0.103 0.059 DBMET01120 0.269 0.007 DB02746 0.112 0.05 DBMET01121 0.195 0.017 DB03091 0.165 0.024 DB00130 0.195 0.017 DB00142 | DB02746 | |
| 0.03 | 0.243 | 0.104 | Cathepsin E inhibitor | 0.056 0.046 DBMET01116 0.07 0.029 DBMET01119 0.081 0.022 DBMET01120 0.06 0.041 DBMET01121 0.075 0.025 DB03091 0.104 0.012 DB00130 0.069 0.03 DB00142 | DB00130 | |
| 0.053 | 0.266 | 0.299 | Toll-Like receptor 2 antagonist | 0.141 0.059 DBMET01115 0.116 0.082 DBMET01116 0.133 0.065 DBMET01117 0.265 0.007 DBMET01119 0.242 0.01 DBMET01120 0.184 0.032 DB02746 0.256 0.008 DBMET01121 0.299 0.005 DB03091 0.269 0.007 DB00130 0.292 0.005 DB00142 | DB03091 | |
| 0.018 | 0.231 | 0.146 | Carbonic anhydrase V inhibitor | 0.146 0.015 DB02746 0.06 0.054 DB00142 | DB02746 | |
| 0.02 | 0.233 | 0.057 | Cathepsin D inhibitor | 0.057 0.036 DBMET01119 0.05 0.041 DBMET01120 0.057 0.036 DB03091 0.049 0.043 DB00130 | DB03091 | |
| 0.024 | 0.237 | 0.205 | Carbonic anhydrase XIII inhibitor | 0.205 0.013 DB02746 0.065 0.063 DB03091 0.074 0.054 DB00142 | DB02746 | |
| 0.072 | 0.288 | 0.598 | Growth hormone agonist | 0.394 0.017 DBMET01115 0.35 0.023 DBMET01116 0.169 0.074 DBMET01118 0.34 0.025 DBMET01117 0.449 0.01 DBMET01119 0.39 0.017 DBMET01120 0.385 0.018 DBMET01121 0.598 0.004 DB03091 0.534 0.005 DB00130 0.573 0.004 DB00142 | DB03091 | |
| 0.075 | 0.291 | 0.296 | Non-steroidal antiinflammatory agent | 0.218 0.058 DBMET03456 0.252 0.042 DB02746 0.156 0.107 DBMET01121 0.217 0.059 DB03091 0.207 0.065 DB00130 0.296 0.029 DB00142 | DB00142 | |
| 0.107 | 0.324 | 0.469 | Transcription factor STAT inhibitor | 0.177 0.173 DBMET01116 0.19 0.153 DBMET01118 0.422 0.015 DBMET01119 0.469 0.01 DBMET01120 0.31 0.05 DB02746 0.291 0.061 DBMET01121 0.345 0.036 DB03091 0.418 0.015 DB00130 0.267 0.076 DB00142 | DBMET01120 | |
| 0.017 | 0.234 | 0.051 | Beta 1 adrenoreceptor antagonist | 0.051 0.045 DB02746 | DB02746 | |
| 0.024 | 0.243 | 0.163 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.163 0.015 DB02746 | DB02746 | |
| 0.022 | 0.242 | 0.08 | Epithelial sodium channel blocker | 0.062 0.026 DBMET01119 0.059 0.031 DBMET01120 0.055 0.037 DB02746 0.059 0.031 DBMET03446 0.08 0.012 DB03091 0.066 0.022 DB00130 0.06 0.028 DB00142 | DB03091 | |
| 0.147 | 0.366 | 0.725 | Cyclophilin D inhibitor | 0.339 0.13 DBMET00033 0.725 0.012 DBMET03456 0.361 0.115 DBMET01115 0.318 0.147 DBMET01116 0.307 0.157 DBMET01118 0.335 0.134 DBMET03444 0.434 0.074 DBMET01117 0.342 0.128 DBMET01119 0.317 0.148 DBMET01120 0.573 0.032 DB02746 0.293 0.169 DBMET03446 0.405 0.088 DBMET01121 0.457 0.064 DB03091 0.408 0.086 DB00130 0.548 0.038 DB00142 | DBMET03456 | |
| 0.005 | 0.224 | 0.021 | Dipeptidyl peptidase VIII inhibitor | 0.021 0.007 DB03091 0.016 0.01 DB00130 0.018 0.008 DB00142 | DB03091 | |
| 0.001 | 0.222 | 0.016 | Bone morphogenic protein 1 inhibitor | 0.005 0.004 DBMET01119 0.007 0.003 DBMET01120 0.016 0.002 DBMET01121 | DBMET01121 | |
| 0.026 | 0.248 | 0.672 | CD45 antagonist | 0.054 0.028 DBMET01115 0.056 0.026 DBMET01116 0.048 0.04 DBMET01117 0.629 0.002 DBMET01119 0.672 0.002 DBMET01120 0.244 0.004 DB02746 0.621 0.002 DBMET01121 0.145 0.006 DB03091 0.227 0.004 DB00130 0.163 0.005 DB00142 | DBMET01120 | |
| 0.005 | 0.227 | 0.055 | Carbonic anhydrase XII inhibitor | 0.055 0.035 DB02746 | DB02746 | |
| 0.013 | 0.235 | 0.091 | Carbonic anhydrase XIV inhibitor | 0.091 0.013 DB02746 0.045 0.04 DB00142 | DB02746 | |
| 0.004 | 0.227 | 0.084 | Aminopeptidase P inhibitor | 0.021 0.019 DBMET01115 0.084 0.002 DBMET01116 0.077 0.003 DBMET01117 0.038 0.005 DBMET01119 0.026 0.013 DBMET01120 0.067 0.003 DB03091 0.041 0.005 DB00130 0.03 0.01 DB00142 | DBMET01116 | |
| 0.006 | 0.23 | 0.038 | Estradiol 17 beta-dehydrogenase inhibitor | 0.038 0.033 DB02746 | DB02746 | |
| 0.009 | 0.234 | 0.056 | ATP citrate lysase inhibitor | 0.056 0.006 DB02746 0.036 0.016 DB00142 | DB02746 | |
| 0.065 | 0.291 | 0.239 | I kappa B kinase epsilon inhibitor | 0.239 0.043 DB02746 0.178 0.091 DBMET03446 | DB02746 | |
| 0.019 | 0.248 | 0.088 | Sphingosine 1-phosphate receptor 3 antagonist | 0.055 0.046 DBMET01119 0.057 0.043 DBMET01120 0.082 0.016 DB02746 0.071 0.025 DBMET01121 0.081 0.016 DB03091 0.069 0.027 DB00130 0.088 0.012 DB00142 | DB00142 | |
| 0.048 | 0.278 | 0.334 | Carbonic anhydrase XV inhibitor | 0.334 0.006 DB02746 0.095 0.074 DB00142 | DB02746 | |
| 0.045 | 0.275 | 0.258 | Cytidine deaminase inhibitor | 0.258 0.027 DB02746 | DB02746 | |
| 0.026 | 0.257 | 0.046 | Heme oxygenase inhibitor | 0.046 0.019 DB02746 | DB02746 | |
| 0.04 | 0.271 | 0.132 | Bile acid receptor antagonist | 0.101 0.046 DBMET01117 0.094 0.064 DBMET01119 0.086 0.083 DBMET01120 0.132 0.012 DB02746 0.112 0.028 DBMET01121 0.105 0.039 DB03091 0.103 0.043 DB00130 0.121 0.019 DB00142 | DB02746 | |
| 0.004 | 0.236 | 0.021 | Integrin alphaLbeta2 antagonist | 0.013 0.009 DBMET01115 0.021 0.005 DBMET01120 0.021 0.005 DBMET01121 0.014 0.008 DB00130 0.012 0.011 DB00142 | DBMET01121 | |
| 0.004 | 0.236 | 0.028 | Dipeptidyl peptidase IX inhibitor | 0.028 0.006 DB03091 0.017 0.01 DB00130 0.021 0.008 DB00142 | DB03091 | |
| 0.062 | 0.294 | 0.149 | Transcription factor STAT6 inhibitor | 0.149 0.024 DBMET01119 0.128 0.047 DBMET01120 0.134 0.039 DB02746 0.14 0.032 DB03091 0.13 0.043 DB00130 0.111 0.079 DB00142 | DBMET01119 | |
| 0.005 | 0.241 | 0.053 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.023 DBMET01118 0.031 0.024 DBMET01119 0.034 0.019 DBMET01120 0.051 0.006 DB02746 0.033 0.02 DBMET01121 0.053 0.005 DB03091 0.042 0.01 DB00130 0.043 0.01 DB00142 | DB03091 | |
| 0.048 | 0.284 | 0.406 | Mcl-1 antagonist | 0.195 0.058 DBMET01117 0.406 0.01 DB02746 0.133 0.108 DBMET01114 0.128 0.114 DBMET01121 | DB02746 | |
| 0.029 | 0.266 | 0.127 | Myeloperoxidase inhibitor | 0.086 0.055 DBMET01116 0.103 0.031 DB02746 0.127 0.017 DB00130 0.094 0.043 DB00142 | DB00130 | |
| 0.005 | 0.243 | 0.063 | Carbonic anhydrase I inhibitor | 0.063 0.033 DB02746 | DB02746 | |
| 0.009 | 0.248 | 0.068 | ICAM 1 antagonist | 0.025 0.011 DBMET01119 0.068 0.003 DBMET01120 0.026 0.01 DB02746 0.038 0.004 DBMET01121 0.034 0.005 DB00130 0.025 0.011 DB00142 | DBMET01120 | |
| 0.048 | 0.286 | 0.219 | Aryl hydrocarbon receptor agonist | 0.219 0.092 DB02746 | DB02746 | |
| 0.005 | 0.245 | 0.216 | Kainate receptor 5 antagonist | 0.022 0.013 DBMET01119 0.028 0.01 DBMET01120 0.133 0.004 DB02746 0.039 0.007 DBMET01121 0.029 0.01 DB03091 0.12 0.004 DB00130 0.216 0.003 DB00142 | DB00142 | |
| 0.008 | 0.248 | 0.102 | Purinergic P2Y antagonist | 0.054 0.023 DBMET01119 0.077 0.013 DB02746 0.102 0.009 DBMET01121 0.039 0.038 DB03091 0.058 0.02 DB00142 | DBMET01121 | |
| 0.051 | 0.292 | 0.116 | 3C-Like protease (SARS coronavirus) inhibitor | 0.083 0.06 DBMET01118 0.116 0.021 DBMET01119 0.106 0.028 DBMET01120 0.108 0.026 DB02746 0.094 0.039 DBMET01121 0.089 0.048 DB00130 | DBMET01119 | |
| 0.004 | 0.246 | 0.066 | Carbonic anhydrase IX inhibitor | 0.066 0.035 DB02746 | DB02746 | |
| 0.02 | 0.263 | 0.067 | Squalene epoxidase inhibitor | 0.067 0.016 DB02746 | DB02746 | |
| 0.006 | 0.249 | 0.046 | Diamine oxidase inhibitor | 0.046 0.017 DB02746 | DB02746 | |
| 0.03 | 0.274 | 0.08 | Leukotriene C antagonist | 0.056 0.038 DBMET01117 0.08 0.008 DB02746 0.059 0.031 DBMET01121 0.06 0.029 DB03091 0.064 0.021 DB00142 | DB02746 | |
| 0.06 | 0.304 | 0.354 | Thiol protease inhibitor | 0.132 0.093 DBMET01115 0.168 0.056 DBMET01116 0.135 0.087 DBMET01117 0.354 0.015 DBMET01119 0.349 0.015 DBMET01120 0.175 0.051 DB02746 0.297 0.019 DBMET01121 0.27 0.023 DB03091 0.273 0.023 DB00130 0.239 0.029 DB00142 | DBMET01119 | |
| 0.026 | 0.272 | 0.121 | Adrenaline agonist | 0.121 0.025 DB02746 | DB02746 | |
| 0.049 | 0.297 | 0.195 | NADPH oxidase inhibitor | 0.195 0.036 DB02746 | DB02746 | |
| 0.014 | 0.263 | 0.062 | TRPA1 antagonist | 0.062 0.04 DB02746 | DB02746 | |
| 0.12 | 0.37 | 0.274 | Caspase 3 stimulant | 0.274 0.094 DBMET03456 0.219 0.144 DBMET00034 0.198 0.172 DBMET03444 0.223 0.139 DBMET01114 | DBMET03456 | |
| 0.052 | 0.302 | 0.246 | Protein kinase stimulant | 0.137 0.078 DBMET03456 0.121 0.091 DBMET01119 0.246 0.028 DB02746 0.148 0.07 DBMET01121 0.178 0.051 DB03091 0.155 0.065 DB00130 0.236 0.03 DB00142 | DB02746 | |
| 0.007 | 0.258 | 0.094 | Calcium-sensing receptor agonist | 0.057 0.005 DBMET01119 0.075 0.004 DBMET01120 0.071 0.004 DB02746 0.085 0.004 DBMET01121 0.066 0.004 DB03091 0.075 0.004 DB00130 0.094 0.003 DB00142 | DB00142 | |
| 0.026 | 0.278 | 0.159 | Macrophage migration inhibitory factor inhibitor | 0.159 0.013 DB02746 | DB02746 | |
| 0.016 | 0.269 | 0.07 | GHS receptor agonist | 0.07 0.009 DB03091 0.044 0.027 DB00130 | DB03091 | |
| 0.007 | 0.259 | 0.04 | Liver X receptor beta agonist | 0.04 0.015 DB02746 | DB02746 | |
| 0.029 | 0.287 | 0.163 | Urease inhibitor | 0.115 0.05 DBMET01119 0.154 0.021 DBMET01120 0.163 0.018 DB02746 0.114 0.051 DBMET01121 0.085 0.084 DB03091 0.149 0.024 DB00130 0.117 0.048 DB00142 | DB02746 | |
| 0.007 | 0.266 | 0.282 | Phosphorylase inhibitor | 0.213 0.005 DBMET01118 0.194 0.005 DBMET01119 0.243 0.004 DBMET01120 0.144 0.008 DB02746 0.282 0.004 DBMET01121 0.06 0.025 DB03091 0.082 0.016 DB00130 0.088 0.015 DB00142 | DBMET01121 | |
| 0.021 | 0.281 | 0.093 | Botulinum neurotoxin type A inhibitor | 0.054 0.048 DB02746 0.064 0.032 DBMET03446 0.093 0.011 DB03091 0.074 0.022 DB00130 0.08 0.017 DB00142 | DB03091 | |
| 0.016 | 0.277 | 0.051 | Beta 2 adrenoreceptor antagonist | 0.051 0.036 DB02746 | DB02746 | |
| 0.041 | 0.302 | 0.339 | Bone formation stimulant | 0.122 0.084 DBMET01118 0.198 0.036 DBMET01119 0.231 0.029 DBMET01120 0.128 0.078 DB02746 0.139 0.068 DBMET03446 0.267 0.022 DBMET01121 0.281 0.019 DB03091 0.286 0.019 DB00130 0.339 0.013 DB00142 | DB00142 | |
| 0.014 | 0.278 | 0.091 | Diacylglycerol O-acyltransferase inhibitor | 0.046 0.042 DBMET01119 0.056 0.029 DBMET01120 0.082 0.013 DB02746 0.091 0.01 DBMET01121 0.064 0.023 DB00142 | DBMET01121 | |
| 0.028 | 0.292 | 0.151 | Mediator release inhibitor | 0.09 0.082 DBMET03456 0.105 0.064 DBMET01115 0.096 0.075 DBMET01116 0.109 0.06 DBMET01117 0.097 0.074 DBMET01119 0.105 0.064 DBMET01120 0.151 0.028 DB02746 0.117 0.05 DBMET01121 0.139 0.034 DB03091 0.14 0.034 DB00130 0.14 0.033 DB00142 | DB02746 | |
| 0.024 | 0.289 | 0.286 | Inducible nitric-oxide synthase inhibitor | 0.189 0.009 DB03091 0.249 0.005 DB00130 0.286 0.004 DB00142 | DB00142 | |
| 0.019 | 0.285 | 0.055 | Leukotriene C4 antagonist | 0.055 0.007 DB02746 0.038 0.03 DBMET01121 0.038 0.03 DB03091 0.041 0.022 DB00142 | DB02746 | |
| 0.006 | 0.275 | 0.042 | Lysophosphatidic acid 1 receptor antagonist | 0.042 0.004 DB02746 0.025 0.009 DBMET01121 0.021 0.015 DB00142 | DB02746 | |
| 0.007 | 0.277 | 0.043 | Cholesterol ester transfer protein antagonist | 0.043 0.011 DB02746 | DB02746 | |
| 0.039 | 0.308 | 0.264 | DNA polymerase I inhibitor | 0.264 0.015 DBMET00035 0.125 0.064 DBMET03456 0.109 0.077 DBMET03444 0.105 0.081 DBMET01119 0.167 0.041 DB02746 0.113 0.074 DBMET01114 0.117 0.07 DBMET01121 0.186 0.033 DB03091 0.098 0.088 DB00130 0.163 0.042 DB00142 | DBMET00035 | |
| 0.016 | 0.286 | 0.17 | Neuropeptide agonist | 0.073 0.034 DBMET01116 0.132 0.019 DBMET01119 0.125 0.021 DBMET01120 0.17 0.008 DB03091 0.165 0.009 DB00130 0.099 0.027 DB00142 | DB03091 | |
| 0.03 | 0.301 | 0.086 | Histamine H2 receptor antagonist | 0.086 0.054 DB02746 | DB02746 | |
| 0.059 | 0.33 | 0.743 | Platelet antagonist | 0.273 0.063 DBMET03456 0.405 0.026 DBMET01115 0.371 0.033 DBMET01116 0.151 0.144 DBMET01118 0.524 0.011 DBMET01117 0.513 0.013 DBMET01119 0.427 0.022 DBMET01120 0.348 0.039 DB02746 0.548 0.01 DBMET01121 0.664 0.005 DB03091 0.539 0.01 DB00130 0.743 0.005 DB00142 | DB00142 | |
| 0.011 | 0.283 | 0.104 | Dihydrofolate reductase inhibitor | 0.054 0.014 DBMET01117 0.064 0.008 DBMET01119 0.071 0.006 DBMET01120 0.052 0.016 DB02746 0.104 0.004 DBMET01121 0.049 0.021 DB03091 0.046 0.025 DB00130 0.077 0.005 DB00142 | DBMET01121 | |
| 0.005 | 0.279 | 0.034 | Glucagon receptor antagonist | 0.034 0.017 DB03091 0.027 0.023 DB00130 0.029 0.021 DB00142 | DB03091 | |
| 0.005 | 0.28 | 0.056 | Carbonic anhydrase II inhibitor | 0.056 0.038 DB02746 | DB02746 | |
| 0.016 | 0.294 | 0.24 | Monophenol monooxygenase inhibitor | 0.131 0.055 DBMET03456 0.089 0.084 DBMET01120 0.24 0.025 DB02746 0.112 0.067 DBMET01121 0.106 0.072 DB03091 0.137 0.052 DB00130 0.208 0.031 DB00142 | DB02746 | |
| 0.083 | 0.361 | 0.277 | DNA polymerase beta inhibitor | 0.277 0.177 DB02746 | DB02746 | |
| 0.045 | 0.324 | 0.471 | Cell adhesion inhibitor | 0.219 0.02 DBMET03456 0.31 0.009 DBMET01115 0.166 0.037 DBMET01116 0.209 0.022 DBMET01117 0.308 0.009 DBMET01119 0.414 0.005 DBMET01120 0.188 0.028 DB02746 0.462 0.005 DBMET01121 0.305 0.01 DB03091 0.414 0.005 DB00130 0.471 0.004 DB00142 | DB00142 | |
| 0.033 | 0.313 | 0.13 | Cyclooxygenase 1 inhibitor | 0.13 0.071 DB02746 | DB02746 | |
| 0.039 | 0.318 | 0.143 | Beta amyloid protein antagonist | 0.139 0.049 DB03091 0.112 0.076 DB00130 0.143 0.046 DB00142 | DB00142 | |
| 0.009 | 0.288 | 0.054 | Collagenase inhibitor | 0.05 0.033 DBMET01119 0.049 0.034 DBMET01120 0.05 0.033 DBMET01121 0.052 0.028 DB03091 0.054 0.024 DB00130 0.053 0.025 DB00142 | DB00130 | |
| 0.028 | 0.309 | 0.115 | ATPase (Vacuolar H+) inhibitor | 0.096 0.046 DBMET00035 0.115 0.023 DBMET03456 | DBMET03456 | |
| 0.004 | 0.284 | 0.059 | Endothelin receptor antagonist | 0.059 0.009 DB02746 | DB02746 | |
| 0.005 | 0.286 | 0.073 | Carbonic anhydrase inhibitor | 0.073 0.038 DB02746 | DB02746 | |
| 0.03 | 0.31 | 0.256 | Nitric-oxide synthase inhibitor | 0.21 0.008 DB03091 0.239 0.005 DB00130 0.256 0.005 DB00142 | DB00142 | |
| 0.02 | 0.302 | 0.098 | Thrombin inhibitor | 0.078 0.044 DBMET01119 0.08 0.042 DBMET01120 0.073 0.051 DBMET03446 0.066 0.061 DBMET01121 0.091 0.032 DB03091 0.094 0.029 DB00130 0.098 0.027 DB00142 | DB00142 | |
| 0.005 | 0.288 | 0.076 | Fructose-1,6-bisphosphatase inhibitor | 0.076 0.009 DB02746 | DB02746 | |
| 0.019 | 0.303 | 0.053 | Beta adrenoreceptor agonist | 0.053 0.014 DB02746 | DB02746 | |
| 0.002 | 0.285 | 0.011 | Beta 3 adrenoreceptor agonist | 0.011 0.008 DB02746 | DB02746 | |
| 0.004 | 0.289 | 0.03 | Endothelin B receptor antagonist | 0.03 0.009 DB02746 | DB02746 | |
| 0.005 | 0.291 | 0.077 | Sphingosine 1-phosphate receptor 1 agonist | 0.058 0.014 DB02746 0.04 0.033 DBMET01121 0.069 0.009 DB03091 0.049 0.021 DB00130 0.077 0.006 DB00142 | DB00142 | |
| 0.001 | 0.289 | 0.037 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.01 0.004 DBMET01119 0.012 0.003 DBMET01120 0.025 0.002 DBMET01121 0.013 0.003 DB03091 0.011 0.003 DB00130 0.037 0.002 DB00142 | DB00142 | |
| 0.004 | 0.293 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.027 0.011 DB02746 | DB02746 | |
| 0.014 | 0.305 | 0.055 | Acid-sensing ion channel blocker | 0.055 0.013 DB02746 | DB02746 | |
| 0.077 | 0.368 | 0.355 | Alpha-glucosidase inhibitor | 0.355 0.134 DBMET03456 0.266 0.178 DB02746 | DBMET03456 | |
| 0.018 | 0.313 | 0.085 | Epoxide hydrolase inhibitor | 0.085 0.038 DB02746 0.085 0.037 DBMET01121 | DBMET01121 | |
| 0.013 | 0.31 | 0.167 | Purinergic P2 antagonist | 0.167 0.009 DBMET01115 0.055 0.053 DBMET01117 | DBMET01115 | |
| 0.039 | 0.337 | 0.153 | EphB2 antagonist | 0.153 0.127 DBMET03446 | DBMET03446 | |
| 0.016 | 0.314 | 0.085 | DNA gyrase inhibitor | 0.085 0.024 DBMET03457 0.072 0.034 DBMET01118 0.084 0.024 DB02746 0.078 0.029 DBMET03446 | DBMET03457 | |
| 0.024 | 0.323 | 0.195 | Protease inhibitor | 0.105 0.061 DBMET01115 0.132 0.04 DBMET01116 0.09 0.074 DBMET01117 0.155 0.027 DBMET01119 0.161 0.025 DBMET01120 0.134 0.038 DBMET01121 0.168 0.022 DB03091 0.195 0.015 DB00130 0.149 0.03 DB00142 | DB00130 | |
| 0.042 | 0.341 | 0.15 | Estrogen antagonist | 0.12 0.056 DBMET03458 0.146 0.025 DBMET00034 0.15 0.023 DBMET03444 0.102 0.093 DB02746 0.116 0.063 DBMET01114 | DBMET03444 | |
| 0.008 | 0.308 | 0.052 | Potassium channel Kv1.3 blocker | 0.052 0.027 DB02746 | DB02746 | |
| 0.091 | 0.391 | 0.159 | CC chemokine 6 receptor antagonist | 0.139 0.043 DBMET03456 0.123 0.1 DBMET01118 0.159 0.013 DB02746 | DB02746 | |
| 0.043 | 0.343 | 0.374 | Dual specificity phosphatase 3 inhibitor | 0.184 0.07 DBMET01117 0.374 0.017 DB02746 | DB02746 | |
| 0.023 | 0.325 | 0.539 | HIV-1 integrase inhibitor | 0.539 0.003 DBMET03457 0.125 0.014 DBMET03458 0.064 0.06 DBMET01116 0.081 0.037 DBMET01117 0.12 0.015 DB02746 0.077 0.04 DBMET01114 0.07 0.048 DBMET01121 | DBMET03457 | |
| 0.008 | 0.31 | 0.077 | Factor VIIa inhibitor | 0.053 0.019 DBMET01119 0.043 0.023 DBMET01120 0.077 0.014 DB03091 0.055 0.019 DB00130 0.039 0.026 DB00142 | DB03091 | |
| 0.004 | 0.309 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.018 DBMET03456 0.025 0.021 DB02746 | DBMET03456 | |
| 0.019 | 0.324 | 0.121 | Sphingosine 1-phosphate receptor 1 antagonist | 0.071 0.018 DBMET01119 0.058 0.033 DBMET01120 0.071 0.018 DB02746 0.121 0.005 DBMET01121 0.084 0.013 DB03091 0.056 0.037 DB00130 0.113 0.007 DB00142 | DBMET01121 | |
| 0.008 | 0.314 | 0.034 | Tryptase inhibitor | 0.034 0.03 DBMET01120 | DBMET01120 | |
| 0.073 | 0.379 | 0.296 | 12-Lipoxygenase inhibitor | 0.205 0.146 DBMET01116 0.296 0.082 DBMET01117 0.257 0.105 DB02746 | DBMET01117 | |
| 0.01 | 0.321 | 0.242 | Glutamate (mGluR) agonist | 0.116 0.019 DB02746 0.123 0.018 DB00130 0.242 0.007 DB00142 | DB00142 | |
| 0.026 | 0.34 | 0.068 | Adenosine A3 receptor antagonist | 0.068 0.063 DB02746 | DB02746 | |
| 0.015 | 0.329 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 DBMET03456 0.056 0.01 DBMET03446 | DBMET03456 | |
| 0.002 | 0.317 | 0.045 | Prostaglandin H2 antagonist | 0.027 0.016 DBMET01117 0.045 0.004 DB02746 0.025 0.019 DBMET01121 0.031 0.012 DB00142 | DB02746 | |
| 0.004 | 0.321 | 0.023 | Endothelin A receptor antagonist | 0.023 0.013 DB02746 | DB02746 | |
| 0.045 | 0.362 | 0.158 | Heat shock protein 90 alpha antagonist | 0.158 0.079 DB02746 | DB02746 | |
| 0.01 | 0.329 | 0.15 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.15 0.007 DB02746 | DB02746 | |
| 0.038 | 0.358 | 0.132 | Antibacterial (Helicobacter pylori) | 0.132 0.065 DB02746 0.108 0.102 DB03091 0.113 0.093 DB00142 | DB02746 | |
| 0.006 | 0.327 | 0.08 | AMPA receptor agonist | 0.042 0.015 DB03091 0.062 0.005 DB00130 0.08 0.004 DB00142 | DB00142 | |
| 0.009 | 0.33 | 0.081 | Sphingosine 1-phosphate receptor agonist | 0.068 0.012 DB02746 0.049 0.025 DBMET01121 0.067 0.013 DB03091 0.043 0.033 DB00130 0.081 0.008 DB00142 | DB00142 | |
| 0.008 | 0.329 | 0.04 | Tryptophan hydroxylase 1 inhibitor | 0.019 0.008 DBMET01120 0.02 0.007 DBMET01121 0.024 0.004 DB03091 0.031 0.003 DB00130 0.04 0.003 DB00142 | DB00142 | |
| 0.073 | 0.396 | 0.285 | DNA directed DNA polymerase inhibitor | 0.285 0.17 DB02746 | DB02746 | |
| 0.007 | 0.333 | 0.046 | Liver X receptor antagonist | 0.046 0.011 DB02746 | DB02746 | |
| 0.007 | 0.333 | 0.088 | Thromboxane A2 antagonist | 0.044 0.042 DBMET01117 0.088 0.011 DB02746 0.06 0.028 DBMET01121 0.045 0.041 DB03091 0.063 0.026 DB00142 | DB02746 | |
| 0.007 | 0.335 | 0.044 | Urokinase inhibitor | 0.044 0.036 DBMET01120 | DBMET01120 | |
| 0.013 | 0.341 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 DBMET03456 | DBMET03456 | |
| 0.029 | 0.357 | 0.24 | Chelator | 0.187 0.027 DBMET03457 0.101 0.076 DBMET03458 0.1 0.078 DBMET01115 0.178 0.029 DBMET01116 0.196 0.025 DBMET01117 0.125 0.049 DBMET01119 0.151 0.035 DBMET01120 0.178 0.028 DB02746 0.098 0.08 DBMET01114 0.154 0.034 DBMET01121 0.195 0.025 DB03091 0.231 0.019 DB00130 0.24 0.018 DB00142 | DB00142 | |
| 0.003 | 0.331 | 0.057 | Neutral endopeptidase inhibitor | 0.025 0.013 DBMET01117 0.022 0.015 DBMET01119 0.035 0.01 DBMET01120 0.051 0.007 DBMET01121 0.032 0.011 DB03091 0.039 0.009 DB00130 0.057 0.006 DB00142 | DB00142 | |
| 0.01 | 0.338 | 0.123 | Prostaglandin-E synthase inhibitor | 0.072 0.046 DBMET01118 0.123 0.019 DB02746 | DB02746 | |
| 0.009 | 0.339 | 0.165 | Xanthine dehydrogenase inhibitor | 0.165 0.006 DB02746 | DB02746 | |
| 0.002 | 0.335 | 0.029 | Glucagon agonist | 0.015 0.01 DB03091 0.029 0.006 DB00130 0.018 0.009 DB00142 | DB00130 | |
| 0.099 | 0.432 | 0.36 | Peptidyltransferase inhibitor | 0.207 0.091 DBMET00033 0.36 0.011 DBMET03456 0.213 0.083 DBMET01115 0.213 0.083 DBMET01116 0.175 0.138 DBMET01118 0.202 0.096 DBMET03444 0.167 0.154 DBMET01117 0.237 0.061 DBMET01119 0.237 0.061 DBMET01120 0.235 0.062 DB02746 0.165 0.157 DBMET03446 0.208 0.089 DBMET01121 0.305 0.023 DB03091 0.305 0.023 DB00130 0.308 0.022 DB00142 | DBMET03456 | |
| 0.028 | 0.362 | 0.216 | AMP-activated protein kinase stimulant | 0.149 0.029 DBMET03456 0.128 0.042 DBMET01118 0.216 0.009 DB02746 0.098 0.073 DBMET01121 0.109 0.06 DB00142 | DB02746 | |
| 0.012 | 0.346 | 0.051 | Elastase inhibitor | 0.05 0.041 DBMET01119 0.051 0.04 DB03091 | DB03091 | |
| 0.014 | 0.348 | 0.036 | Somatostatin 4 agonist | 0.036 0.027 DBMET03446 | DBMET03446 | |
| 0.004 | 0.34 | 0.237 | Cholecystokinin A antagonist | 0.033 0.029 DBMET01115 0.213 0.004 DBMET01119 0.092 0.01 DBMET01120 0.106 0.008 DBMET01121 0.237 0.004 DB03091 0.075 0.013 DB00130 0.092 0.01 DB00142 | DB03091 | |
| 0.055 | 0.391 | 0.19 | Factor V inhibitor | 0.11 0.051 DBMET01115 0.102 0.064 DBMET01116 0.095 0.081 DBMET01117 0.162 0.013 DBMET01119 0.142 0.023 DBMET01120 0.114 0.046 DB02746 0.142 0.022 DBMET01121 0.19 0.006 DB03091 0.165 0.013 DB00130 0.179 0.009 DB00142 | DB03091 | |
| 0.045 | 0.381 | 0.305 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.305 0.063 DB02746 | DB02746 | |
| 0.001 | 0.338 | 0.009 | KiSS-1 receptor agonist | 0.009 0.007 DB03091 | DB03091 | |
| 0.031 | 0.371 | 0.263 | Xanthine oxidase inhibitor | 0.084 0.082 DBMET01119 0.263 0.011 DB02746 0.131 0.042 DBMET01121 0.089 0.073 DB00142 | DB02746 | |
| 0.004 | 0.345 | 0.094 | Kynurenine 3 monooxygenase inhibitor | 0.094 0.004 DB02746 0.024 0.022 DB03091 0.023 0.022 DB00130 0.071 0.004 DB00142 | DB02746 | |
| 0.08 | 0.423 | 0.219 | Transcription factor inhibitor | 0.219 0.21 DB02746 | DB02746 | |
| 0.008 | 0.352 | 0.228 | Macrophage elastase inhibitor | 0.072 0.014 DBMET03457 0.052 0.023 DBMET01115 0.053 0.022 DBMET01116 0.057 0.02 DBMET01117 0.113 0.008 DBMET01119 0.068 0.015 DBMET01120 0.073 0.014 DBMET01121 0.228 0.004 DB03091 0.149 0.005 DB00130 0.18 0.005 DB00142 | DB03091 | |
| 0.024 | 0.37 | 0.119 | Gastric antisecretory | 0.087 0.083 DBMET01119 0.119 0.043 DB02746 0.086 0.084 DBMET01121 | DB02746 | |
| 0.008 | 0.355 | 0.097 | Thromboxane antagonist | 0.097 0.012 DB02746 0.06 0.032 DBMET01121 0.063 0.03 DB00142 | DB02746 | |
| 0.004 | 0.353 | 0.026 | Purinergic P2T antagonist | 0.026 0.013 DBMET01121 0.026 0.013 DB00142 | DB00142 | |
| 0.001 | 0.352 | 0.027 | G-protein-coupled receptor 120 agonist | 0.027 0.006 DB02746 | DB02746 | |
| 0.002 | 0.356 | 0.024 | Carbonic anhydrase IV stimulant | 0.024 0.005 DB00130 0.016 0.009 DB00142 | DB00130 | |
| 0.005 | 0.36 | 0.104 | Glutamate (mGluR2) agonist | 0.104 0.006 DB02746 0.048 0.014 DB00142 | DB02746 | |
| 0.071 | 0.427 | 0.325 | 15-Lipoxygenase inhibitor | 0.325 0.114 DBMET01117 0.312 0.124 DB02746 | DBMET01117 | |
| 0.004 | 0.36 | 0.023 | Thyroid hormone alpha agonist | 0.016 0.012 DB03091 0.023 0.005 DB00142 | DB00142 | |
| 0.004 | 0.36 | 0.094 | Urate transporter 1 inhibitor | 0.094 0.005 DB02746 | DB02746 | |
| 0.036 | 0.396 | 0.369 | Dual specificity phosphatase inhibitor | 0.171 0.074 DBMET01117 0.369 0.018 DB02746 0.135 0.112 DBMET01121 | DB02746 | |
| 0.007 | 0.367 | 0.115 | Glutamate (mGluR group II) agonist | 0.115 0.005 DB02746 0.081 0.009 DB00142 | DB02746 | |
| 0.029 | 0.392 | 0.499 | DNA directed RNA polymerase inhibitor | 0.499 0.004 DBMET03457 | DBMET03457 | |
| 0.042 | 0.407 | 0.199 | Amyloid beta precursor protein antagonist | 0.199 0.058 DB02746 | DB02746 | |
| 0.002 | 0.369 | 0.061 | Peroxisome proliferator-activated receptor alpha antagonist | 0.061 0.007 DB02746 | DB02746 | |
| 0.006 | 0.374 | 0.051 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.038 0.019 DBMET01119 0.035 0.023 DBMET01120 0.051 0.009 DB02746 0.048 0.01 DB03091 0.042 0.014 DB00130 0.039 0.018 DB00142 | DB02746 | |
| 0.009 | 0.378 | 0.02 | Granulocyte colony stimulating factor receptor agonist | 0.019 0.01 DB00130 0.02 0.008 DB00142 | DB00142 | |
| 0.034 | 0.405 | 0.363 | Phospholipase A2 inhibitor | 0.188 0.049 DBMET01115 0.173 0.058 DBMET01116 0.142 0.084 DBMET01117 0.349 0.008 DBMET01119 0.363 0.007 DBMET01120 0.285 0.016 DB02746 0.315 0.011 DBMET01121 0.332 0.009 DB03091 0.325 0.01 DB00130 0.305 0.013 DB00142 | DBMET01120 | |
| 0.015 | 0.388 | 0.218 | Pim-1 kinase inhibitor | 0.218 0.012 DBMET03446 | DBMET03446 | |
| 0.004 | 0.377 | 0.118 | Cholecystokinin agonist | 0.069 0.005 DBMET01119 0.023 0.011 DBMET01120 0.023 0.011 DBMET01121 0.118 0.004 DB03091 0.046 0.008 DB00130 0.05 0.007 DB00142 | DB03091 | |
| 0.035 | 0.409 | 0.099 | Interleukin 5 antagonist | 0.099 0.042 DB02746 | DB02746 | |
| 0.054 | 0.429 | 0.217 | Cardiotonic | 0.217 0.104 DBMET01118 0.17 0.151 DBMET01121 | DBMET01118 | |
| 0.015 | 0.391 | 0.042 | HCV polyprotein inhibitor | 0.039 0.013 DBMET01119 0.039 0.013 DBMET01120 0.042 0.01 DBMET01121 0.037 0.016 DB03091 0.037 0.017 DB00130 0.039 0.014 DB00142 | DBMET01121 | |
| 0.021 | 0.399 | 0.057 | Parathyroid hormone antagonist | 0.043 0.039 DB03091 0.057 0.014 DB00130 0.049 0.023 DB00142 | DB00130 | |
| 0.011 | 0.39 | 0.099 | Check point kinase 2 inhibitor | 0.099 0.066 DBMET03446 | DBMET03446 | |
| 0.016 | 0.4 | 0.044 | Calcium-independent phospholipase A2 inhibitor | 0.035 0.02 DBMET01119 0.033 0.028 DBMET01120 0.044 0.006 DB02746 0.036 0.017 DBMET01121 0.035 0.022 DB03091 0.035 0.021 DB00142 | DB02746 | |
| 0.02 | 0.406 | 0.142 | Peroxisome proliferator-activated receptor gamma antagonist | 0.074 0.044 DBMET01117 0.082 0.03 DBMET01119 0.08 0.034 DBMET01120 0.123 0.009 DB02746 0.142 0.007 DBMET01121 0.077 0.039 DB00142 | DBMET01121 | |
| 0.011 | 0.397 | 0.097 | Neuraminidase (Influenza A) inhibitor | 0.043 0.036 DBMET03456 0.052 0.021 DBMET01118 0.064 0.01 DBMET01119 0.066 0.009 DBMET01120 0.097 0.004 DB02746 0.069 0.008 DBMET03446 0.055 0.018 DBMET01121 0.067 0.009 DB03091 0.069 0.008 DB00130 0.058 0.014 DB00142 | DB02746 | |
| 0.035 | 0.423 | 0.402 | Insulin sensitizer | 0.187 0.087 DBMET01115 0.156 0.125 DBMET01116 0.191 0.083 DBMET01117 0.285 0.019 DBMET01119 0.291 0.018 DBMET01120 0.286 0.019 DB02746 0.336 0.01 DBMET01121 0.328 0.011 DB03091 0.326 0.012 DB00130 0.402 0.006 DB00142 | DB00142 | |
| 0.039 | 0.427 | 0.248 | Prostaglandin dehydrogenase inhibitor | 0.248 0.128 DB02746 | DB02746 | |
| 0.025 | 0.416 | 0.198 | Neurotrophic factor | 0.129 0.082 DBMET01116 0.122 0.091 DBMET01120 0.13 0.081 DB02746 0.198 0.029 DB03091 0.179 0.038 DB00130 0.124 0.089 DB00142 | DB03091 | |
| 0.026 | 0.42 | 0.155 | Caspase 9 inhibitor | 0.073 0.028 DBMET01115 0.066 0.036 DBMET01116 0.073 0.028 DBMET01117 0.137 0.007 DBMET01119 0.109 0.011 DBMET01120 0.127 0.008 DBMET01121 0.144 0.006 DB03091 0.133 0.007 DB00130 0.155 0.005 DB00142 | DB00142 | |
| 0.008 | 0.407 | 0.1 | Leukotriene B4 antagonist | 0.053 0.039 DBMET01119 0.049 0.047 DBMET01120 0.1 0.01 DB02746 0.061 0.027 DBMET01121 0.054 0.036 DB03091 0.059 0.03 DB00142 | DB02746 | |
| 0.003 | 0.404 | 0.045 | Peroxisome proliferator-activated receptor delta agonist | 0.045 0.014 DB02746 | DB02746 | |
| 0.002 | 0.405 | 0.027 | Human T-cell leukemia virus type I protease inhibitor | 0.022 0.014 DBMET01119 0.021 0.014 DBMET01120 0.02 0.015 DB03091 0.027 0.009 DB00130 | DB00130 | |
| 0.006 | 0.409 | 0.062 | Phosphodiesterase 4A inhibitor | 0.062 0.029 DBMET03457 | DBMET03457 | |
| 0.02 | 0.425 | 0.127 | Sphingosine 1-phosphate receptor antagonist | 0.084 0.038 DBMET01119 0.075 0.056 DBMET01120 0.094 0.026 DB02746 0.127 0.011 DBMET01121 0.086 0.036 DB03091 0.106 0.018 DB00142 | DBMET01121 | |
| 0.029 | 0.44 | 0.075 | Heme oxygenase stimulant | 0.075 0.019 DB02746 | DB02746 | |
| 0.026 | 0.444 | 0.136 | Thioredoxin inhibitor | 0.095 0.055 DBMET03456 0.087 0.067 DBMET01117 0.098 0.05 DB02746 0.136 0.022 DB00142 | DB00142 | |
| 0.018 | 0.438 | 0.065 | Histone deacetylase stimulant | 0.065 0.061 DBMET03456 | DBMET03456 | |
| 0.018 | 0.438 | 0.065 | Histone deacetylase SIRT1 stimulant | 0.065 0.061 DBMET03456 | DBMET03456 | |
| 0.011 | 0.433 | 0.056 | Farnesyltransferase inhibitor | 0.056 0.023 DBMET01120 0.056 0.023 DBMET01121 0.045 0.033 DB03091 0.05 0.027 DB00130 0.05 0.027 DB00142 | DBMET01121 | |
| 0.022 | 0.451 | 0.14 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.14 0.084 DBMET03446 | DBMET03446 | |
| 0.038 | 0.47 | 0.331 | Nitric oxide antagonist | 0.331 0.035 DBMET03456 0.128 0.121 DBMET03444 0.139 0.106 DB02746 0.128 0.121 DBMET01114 0.137 0.109 DB00142 | DBMET03456 | |
| 0.011 | 0.444 | 0.137 | Sphingosine 1-phosphate receptor 5 agonist | 0.059 0.027 DBMET01115 0.071 0.016 DBMET01117 0.055 0.035 DBMET01119 0.068 0.018 DB02746 0.066 0.019 DBMET01121 0.085 0.011 DB03091 0.137 0.005 DB00142 | DB00142 | |
| 0.018 | 0.456 | 0.219 | Potassium channel (Ca-activated) activator | 0.088 0.066 DBMET01120 0.219 0.011 DB02746 0.143 0.03 DBMET01121 0.098 0.057 DB00130 0.152 0.027 DB00142 | DB02746 | |
| 0.003 | 0.442 | 0.032 | Angiotensin AT1A receptor antagonist | 0.032 0.005 DB02746 0.022 0.015 DBMET01121 | DB02746 | |
| 0.004 | 0.444 | 0.051 | Oleamide hydrolase inhibitor | 0.051 0.026 DB02746 | DB02746 | |
| 0.017 | 0.458 | 0.07 | Integrin alpha1beta1 antagonist | 0.036 0.035 DBMET01115 0.04 0.02 DBMET01117 0.051 0.007 DBMET01119 0.052 0.006 DBMET01120 0.067 0.004 DBMET01121 0.049 0.008 DB03091 0.052 0.006 DB00130 0.07 0.004 DB00142 | DB00142 | |
| 0.004 | 0.446 | 0.108 | Peroxisome proliferator-activated receptor alpha agonist | 0.108 0.011 DB02746 0.063 0.025 DBMET01121 | DB02746 | |
| 0.009 | 0.458 | 0.095 | CC chemokine 5 receptor antagonist | 0.074 0.016 DBMET01116 0.095 0.009 DBMET01117 | DBMET01117 | |
| 0.004 | 0.454 | 0.522 | Leukotriene A4 hydrolase inhibitor | 0.067 0.013 DBMET01119 0.065 0.013 DBMET01120 0.068 0.012 DB02746 0.078 0.009 DBMET01121 0.369 0.004 DB03091 0.343 0.004 DB00130 0.522 0.003 DB00142 | DB00142 | |
| 0.004 | 0.455 | 0.023 | Bombesin agonist | 0.023 0.014 DB02746 | DB02746 | |
| 0.006 | 0.458 | 0.056 | Retinoic acid gamma receptor agonist | 0.056 0.003 DB02746 | DB02746 | |
| 0.019 | 0.477 | 0.129 | Estrogen receptor beta antagonist | 0.094 0.075 DBMET03458 0.124 0.028 DBMET00034 0.129 0.024 DBMET03444 0.093 0.077 DBMET01114 | DBMET03444 | |
| 0.015 | 0.477 | 0.142 | M18 aspartyl aminopeptidase inhibitor | 0.128 0.065 DB02746 0.142 0.056 DBMET01114 | DBMET01114 | |
| 0 | 0.466 | 0.021 | Mannitol 2-dehydrogenase inhibitor | 0.021 0.002 DB02746 | DB02746 | |
| 0.005 | 0.475 | 0.057 | Bradykinin B2 receptor agonist | 0.039 0.012 DBMET01120 0.031 0.017 DBMET01121 0.054 0.007 DB03091 0.057 0.006 DB00130 0.045 0.009 DB00142 | DB00130 | |
| 0.005 | 0.476 | 0.132 | Leukotriene antagonist | 0.065 0.045 DBMET01119 0.132 0.013 DB02746 0.092 0.025 DBMET01121 0.061 0.05 DB00142 | DB02746 | |
| 0.035 | 0.505 | 0.345 | Platelet adhesion inhibitor | 0.34 0.022 DBMET03456 0.284 0.039 DBMET01119 0.311 0.03 DBMET01120 0.323 0.027 DB02746 0.345 0.021 DBMET01121 0.279 0.04 DB03091 0.277 0.041 DB00130 0.334 0.024 DB00142 | DBMET01121 | |
| 0.007 | 0.478 | 0.076 | Growth hormone secretagogue receptor antagonist | 0.076 0.01 DB03091 | DB03091 | |
| 0.019 | 0.494 | 0.129 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.129 0.021 DB02746 | DB02746 | |
| 0.013 | 0.492 | 0.108 | Topoisomerase II alpha inhibitor | 0.108 0.035 DBMET03456 | DBMET03456 | |
| 0.023 | 0.503 | 0.148 | Death-associated protein kinase 3 inhibitor | 0.148 0.126 DBMET03446 | DBMET03446 | |
| 0.018 | 0.498 | 0.094 | Carbonic anhydrase II stimulant | 0.062 0.021 DBMET01120 0.053 0.033 DBMET01121 0.085 0.008 DB03091 0.094 0.005 DB00130 0.087 0.007 DB00142 | DB00130 | |
| 0.02 | 0.505 | 0.088 | DNA helicase inhibitor | 0.055 0.038 DBMET01117 0.056 0.034 DBMET01119 0.056 0.034 DBMET01120 0.088 0.008 DB02746 0.063 0.024 DBMET01121 0.051 0.047 DB03091 0.051 0.047 DB00130 0.053 0.04 DB00142 | DB02746 | |
| 0.009 | 0.497 | 0.032 | Estrogen-related receptor beta antagonist | 0.032 0.022 DBMET00034 | DBMET00034 | |
| 0.016 | 0.507 | 0.121 | AXL receptor tyrosine kinase inhibitor | 0.121 0.027 DBMET03446 | DBMET03446 | |
| 0.013 | 0.505 | 0.134 | Prostaglandin F2 alpha antagonist | 0.076 0.026 DBMET01115 0.095 0.013 DBMET01117 0.093 0.014 DBMET01119 0.056 0.053 DBMET01120 0.134 0.005 DB02746 0.112 0.008 DBMET01121 0.093 0.014 DB03091 0.11 0.008 DB00142 | DB02746 | |
| 0.013 | 0.506 | 0.045 | Cathepsin F inhibitor | 0.045 0.021 DBMET01119 | DBMET01119 | |
| 0.007 | 0.505 | 0.096 | Carbonic anhydrase I stimulant | 0.045 0.02 DBMET01120 0.046 0.019 DB03091 0.096 0.005 DB00130 0.078 0.007 DB00142 | DB00130 | |
| 0.007 | 0.505 | 0.133 | Endothelin-converting enzyme inhibitor | 0.054 0.028 DBMET01119 0.074 0.019 DBMET01120 0.065 0.022 DBMET01121 0.087 0.016 DB03091 0.133 0.01 DB00130 0.104 0.014 DB00142 | DB00130 | |
| 0.041 | 0.54 | 0.379 | Hepatoprotectant | 0.362 0.017 DBMET03456 0.176 0.083 DBMET01119 0.184 0.076 DBMET01120 0.209 0.06 DB02746 0.204 0.062 DBMET01121 0.249 0.043 DB03091 0.32 0.024 DB00130 0.379 0.015 DB00142 | DB00142 | |
| 0.003 | 0.506 | 0.07 | Angiotensin AT2 receptor antagonist | 0.07 0.007 DB02746 0.018 0.017 DBMET01121 | DB02746 | |
| 0.012 | 0.518 | 0.166 | Human rhinovirus A protease inhibitor | 0.057 0.037 DBMET01116 0.073 0.027 DBMET01119 0.095 0.018 DBMET01120 0.056 0.037 DBMET01121 0.108 0.014 DB03091 0.166 0.007 DB00130 0.08 0.023 DB00142 | DB00130 | |
| 0.03 | 0.54 | 0.514 | Antioxidant | 0.514 0.019 DBMET03456 0.188 0.124 DBMET00034 0.191 0.121 DBMET03444 0.161 0.152 DBMET01120 0.247 0.085 DB02746 0.231 0.094 DBMET01114 0.185 0.127 DBMET01121 0.239 0.09 DB03091 0.277 0.071 DB00130 0.333 0.051 DB00142 | DBMET03456 | |
| 0.015 | 0.525 | 0.404 | Cell adhesion molecule inhibitor | 0.091 0.042 DBMET03456 0.289 0.005 DBMET01115 0.071 0.068 DBMET01116 0.102 0.033 DBMET01117 0.17 0.012 DBMET01119 0.267 0.005 DBMET01120 0.113 0.027 DB02746 0.365 0.005 DBMET01121 0.16 0.013 DB03091 0.26 0.006 DB00130 0.404 0.004 DB00142 | DB00142 | |
| 0.005 | 0.522 | 0.035 | Protein 30S ribosomal subunit inhibitor | 0.035 0.011 DBMET03456 0.023 0.018 DBMET03446 | DBMET03456 | |
| 0.005 | 0.523 | 0.206 | Retinoic acid beta receptor agonist | 0.019 0.015 DBMET01118 0.206 0.002 DB02746 0.02 0.014 DBMET01121 | DB02746 | |
| 0.029 | 0.549 | 0.286 | Lipoxygenase inhibitor | 0.219 0.123 DBMET01117 0.286 0.079 DB02746 | DB02746 | |
| 0.006 | 0.528 | 0.067 | Amidase inhibitor | 0.067 0.054 DB02746 | DB02746 | |
| 0.002 | 0.524 | 0.044 | Protease activated receptor agonist | 0.023 0.01 DBMET01119 0.044 0.005 DB03091 0.021 0.011 DB00130 | DB03091 | |
| 0.003 | 0.531 | 0.021 | Calcium-sensing receptor antagonist | 0.021 0.008 DB02746 | DB02746 | |
| 0.004 | 0.534 | 0.019 | Bombesin 3 receptor agonist | 0.019 0.012 DB02746 | DB02746 | |
| 0.005 | 0.566 | 0.183 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.048 DBMET01120 0.183 0.011 DB02746 0.089 0.03 DBMET01121 | DB02746 | |
| 0.002 | 0.565 | 0.019 | Calcium-dependent phospholipase A2 inhibitor | 0.017 0.005 DB03091 0.019 0.005 DB00130 0.018 0.005 DB00142 | DB00130 | |
| 0.009 | 0.572 | 0.03 | GHS receptor antagonist | 0.03 0.028 DBMET03446 | DBMET03446 | |
| 0.005 | 0.573 | 0.044 | Plasmepsin I inhibitor | 0.044 0.01 DBMET01119 0.028 0.024 DBMET01120 0.042 0.011 DB03091 | DBMET01119 | |
| 0.009 | 0.596 | 0.041 | Purinergic P2Y2 antagonist | 0.041 0.015 DB02746 | DB02746 | |
| 0.004 | 0.593 | 0.151 | Complement C3a chemotactic receptor antagonist | 0.04 0.033 DBMET01115 0.072 0.017 DBMET01116 0.069 0.018 DBMET01117 0.084 0.013 DBMET01119 0.124 0.005 DBMET01120 0.128 0.005 DBMET01121 0.103 0.008 DB03091 0.131 0.004 DB00130 0.151 0.004 DB00142 | DB00142 | |
| 0.024 | 0.614 | 0.066 | Lipocortins synthesis agonist | 0.061 0.033 DBMET03456 0.066 0.026 DB03091 0.062 0.032 DB00142 | DB03091 | |
| 0.022 | 0.614 | 0.145 | Toll-Like receptor 4 antagonist | 0.145 0.024 DBMET03456 0.124 0.04 DB03091 0.101 0.067 DB00130 0.132 0.033 DB00142 | DBMET03456 | |
| 0.017 | 0.611 | 0.072 | Bcl-xL inhibitor | 0.06 0.041 DBMET01116 0.072 0.017 DBMET01117 | DBMET01117 | |
| 0.004 | 0.598 | 0.167 | Retinoic acid receptor agonist | 0.167 0.003 DB02746 0.022 0.018 DBMET01121 | DB02746 | |
| 0.003 | 0.598 | 0.094 | Cholecystokinin A agonist | 0.041 0.005 DBMET01119 0.018 0.01 DBMET01120 0.019 0.009 DBMET01121 0.094 0.004 DB03091 0.022 0.008 DB00130 0.026 0.006 DB00142 | DB03091 | |
| 0.004 | 0.605 | 0.016 | Integrin beta6 antagonist | 0.015 0.008 DB03091 0.016 0.006 DB00142 | DB00142 | |
| 0.009 | 0.611 | 0.283 | M17 leucyl aminopeptidase inhibitor | 0.119 0.078 DBMET01119 0.129 0.07 DBMET01120 0.283 0.014 DB02746 0.164 0.047 DBMET01121 | DB02746 | |
| 0.007 | 0.612 | 0.208 | Neuraminidase (influenza) inhibitor | 0.063 0.047 DBMET03456 0.07 0.034 DBMET01118 0.086 0.022 DBMET01119 0.096 0.018 DBMET01120 0.208 0.004 DB02746 0.074 0.03 DBMET03446 0.075 0.029 DBMET01121 0.083 0.024 DB03091 0.081 0.024 DB00130 0.066 0.042 DB00142 | DB02746 | |
| 0.011 | 0.617 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.016 DBMET03456 0.06 0.024 DB02746 | DBMET03456 | |
| 0.001 | 0.61 | 0.267 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.014 0.01 DBMET01115 0.02 0.007 DBMET01116 0.061 0.004 DBMET01117 0.031 0.005 DBMET01119 0.044 0.004 DBMET01120 0.017 0.009 DB02746 0.14 0.003 DBMET01121 0.068 0.004 DB03091 0.049 0.004 DB00130 0.267 0.003 DB00142 | DB00142 | |
| 0.004 | 0.614 | 0.047 | HIV-1 protease inhibitor | 0.044 0.028 DBMET01119 0.046 0.026 DBMET01120 0.04 0.035 DB03091 0.047 0.025 DB00130 | DB00130 | |
| 0.036 | 0.646 | 0.425 | Folate antagonist | 0.136 0.028 DBMET01115 0.125 0.035 DBMET01118 0.15 0.022 DBMET01117 0.307 0.003 DBMET01119 0.336 0.003 DBMET01120 0.226 0.007 DB02746 0.425 0.002 DBMET01121 0.258 0.005 DB03091 0.241 0.005 DB00130 0.334 0.003 DB00142 | DBMET01121 | |
| 0.008 | 0.621 | 0.085 | Protein 50S ribosomal subunit inhibitor | 0.085 0.018 DBMET03456 | DBMET03456 | |
| 0.005 | 0.619 | 0.178 | HIV-1 integrase (Strand Transfer) inhibitor | 0.178 0.011 DB02746 | DB02746 | |
| 0.002 | 0.619 | 0.024 | KiSS-1 receptor antagonist | 0.023 0.007 DB03091 0.024 0.007 DB00130 | DB00130 | |
| 0.047 | 0.666 | 0.376 | Sodium/bile acid cotransporter inhibitor | 0.202 0.185 DBMET00033 0.291 0.087 DBMET01115 0.294 0.085 DBMET01116 0.273 0.105 DBMET03444 0.329 0.054 DBMET01117 0.317 0.065 DBMET01119 0.319 0.063 DBMET01120 0.376 0.026 DB02746 0.345 0.043 DBMET01121 0.354 0.037 DB03091 0.356 0.036 DB00130 0.367 0.03 DB00142 | DB02746 | |
| 0.009 | 0.629 | 0.073 | Cathepsin B inhibitor | 0.073 0.027 DBMET01119 0.063 0.033 DBMET01120 0.06 0.036 DBMET01121 0.054 0.042 DB03091 0.052 0.046 DB00130 | DBMET01119 | |
| 0.005 | 0.63 | 0.107 | Cathepsin L2 inhibitor | 0.074 0.012 DBMET01119 0.101 0.008 DBMET01120 0.107 0.007 DBMET01121 | DBMET01121 | |
| 0.006 | 0.636 | 0.182 | Plasminogen activator inhibitor antagonist | 0.124 0.007 DBMET01117 0.051 0.031 DBMET01119 0.182 0.004 DB02746 0.089 0.013 DBMET01121 0.058 0.025 DB03091 0.097 0.011 DB00142 | DB02746 | |
| 0.005 | 0.636 | 0.178 | Neuraminidase inhibitor | 0.067 0.036 DBMET01118 0.088 0.02 DBMET01119 0.101 0.015 DBMET01120 0.178 0.005 DB02746 0.079 0.026 DBMET03446 0.082 0.024 DBMET01121 0.076 0.028 DB03091 0.078 0.027 DB00130 0.062 0.041 DB00142 | DB02746 | |
| 0.007 | 0.639 | 0.129 | VCAM-1 antagonist | 0.046 0.013 DBMET01119 0.05 0.009 DBMET01120 0.064 0.005 DBMET01121 0.048 0.01 DB03091 0.056 0.006 DB00130 0.129 0.004 DB00142 | DB00142 | |
| 0.007 | 0.639 | 0.131 | VCAM antagonist | 0.046 0.013 DBMET01119 0.05 0.009 DBMET01120 0.063 0.005 DBMET01121 0.048 0.01 DB03091 0.056 0.006 DB00130 0.131 0.004 DB00142 | DB00142 | |
| 0.049 | 0.681 | 0.326 | Catenin beta inhibitor | 0.17 0.066 DBMET01115 0.171 0.065 DBMET01117 0.326 0.005 DBMET01119 0.248 0.011 DBMET01120 0.207 0.027 DB02746 0.306 0.005 DBMET01121 0.311 0.005 DB03091 0.226 0.018 DB00130 0.296 0.005 DB00142 | DBMET01119 | |
| 0.006 | 0.638 | 0.194 | Retinoic acid alpha receptor agonist | 0.049 0.015 DBMET01118 0.045 0.019 DBMET01119 0.045 0.019 DBMET01120 0.194 0.003 DB02746 0.057 0.01 DBMET01121 | DB02746 | |
| 0.006 | 0.642 | 0.073 | Vanilloid 1 antagonist | 0.073 0.041 DBMET00033 | DBMET00033 | |
| 0.013 | 0.651 | 0.454 | Free radical scavenger | 0.454 0.021 DBMET03456 0.163 0.131 DBMET00034 0.167 0.127 DBMET01120 0.266 0.062 DB02746 0.21 0.089 DBMET01114 0.188 0.108 DBMET01121 0.226 0.08 DB03091 0.259 0.065 DB00130 0.312 0.049 DB00142 | DBMET03456 | |
| 0.006 | 0.647 | 0.61 | HIV-1 reverse transcriptase inhibitor | 0.61 0.003 DBMET03457 | DBMET03457 | |
| 0.003 | 0.646 | 0.043 | Prostaglandin EP3 antagonist | 0.031 0.02 DBMET01119 0.031 0.02 DB02746 0.043 0.013 DBMET01121 | DBMET01121 | |
| 0.018 | 0.672 | 0.148 | Adenine nucleotide translocase inhibitor | 0.055 0.04 DBMET03456 0.056 0.036 DBMET01118 0.065 0.02 DBMET01119 0.071 0.015 DBMET01120 0.148 0.003 DB02746 0.075 0.011 DBMET01121 0.06 0.029 DB03091 0.086 0.007 DB00130 0.099 0.005 DB00142 | DB02746 | |
| 0.002 | 0.668 | 0.092 | Retinoic acid receptor gamma antagonist | 0.092 0.003 DB02746 | DB02746 | |
| 0.004 | 0.671 | 0.218 | Nicotinic acid receptor 2 agonist | 0.218 0.004 DB02746 | DB02746 | |
| 0.002 | 0.678 | 0.23 | Retinoid X beta receptor agonist | 0.021 0.014 DBMET01119 0.23 0.002 DB02746 0.029 0.009 DBMET01121 | DB02746 | |
| 0.001 | 0.678 | 0.105 | Retinoic acid beta receptor antagonist | 0.105 0.002 DB02746 | DB02746 | |
| 0.002 | 0.679 | 0.02 | Prostacyclin agonist | 0.02 0.008 DB00142 | DB00142 | |
| 0.004 | 0.69 | 0.135 | Protease activated receptor 1 antagonist | 0.108 0.013 DBMET01119 0.053 0.031 DBMET01120 0.135 0.008 DB03091 0.078 0.02 DB00130 | DB03091 | |
| 0.013 | 0.704 | 0.38 | Platelet aggregation inhibitor | 0.203 0.079 DBMET01117 0.177 0.1 DBMET01119 0.226 0.064 DBMET01121 0.282 0.04 DB03091 0.145 0.135 DB00130 0.38 0.021 DB00142 | DB00142 | |
| 0.016 | 0.706 | 0.125 | Vanilloid agonist | 0.082 0.063 DBMET01120 0.122 0.018 DB03091 0.125 0.016 DB00130 0.109 0.025 DB00142 | DB00130 | |
| 0.016 | 0.711 | 0.284 | Amyloid beta aggregation inhibitor | 0.284 0.048 DB03091 0.19 0.083 DB00130 | DB03091 | |
| 0.01 | 0.705 | 0.08 | Carnitine palmitoyltransferase 1B inhibitor | 0.08 0.008 DB02746 | DB02746 | |
| 0.013 | 0.71 | 0.105 | Glucagon-like peptide 1 receptor antagonist | 0.038 0.032 DBMET01118 0.068 0.007 DBMET01119 0.041 0.024 DBMET01120 0.037 0.035 DB02746 0.048 0.015 DBMET01121 0.105 0.005 DB03091 0.052 0.012 DB00130 0.066 0.007 DB00142 | DB03091 | |
| 0.002 | 0.7 | 0.135 | Retinoid X gamma receptor agonist | 0.135 0.003 DB02746 0.027 0.012 DBMET01121 | DB02746 | |
| 0.004 | 0.706 | 0.042 | Protocollagen prolyl hydroxylase inhibitor | 0.042 0.007 DB02746 0.033 0.011 DBMET01121 | DB02746 | |
| 0.001 | 0.706 | 0.022 | Protease activated receptor 1 agonist | 0.011 0.008 DBMET01119 0.022 0.004 DB03091 0.012 0.008 DB00130 | DB03091 | |
| 0.002 | 0.707 | 0.099 | Retinoic acid alpha receptor antagonist | 0.099 0.003 DB02746 | DB02746 | |
| 0.009 | 0.723 | 0.364 | Aminoacyl-tRNA synthetase inhibitor | 0.104 0.041 DBMET01115 0.097 0.048 DBMET01116 0.085 0.068 DBMET01117 0.104 0.041 DBMET01119 0.106 0.039 DBMET01120 0.088 0.061 DB02746 0.096 0.05 DBMET01121 0.326 0.005 DB03091 0.33 0.005 DB00130 0.364 0.004 DB00142 | DB00142 | |
| 0.004 | 0.721 | 0.31 | Selectin antagonist | 0.31 0.005 DBMET03456 0.175 0.014 DBMET01119 0.177 0.014 DBMET01120 0.109 0.025 DB02746 0.163 0.016 DBMET01121 0.238 0.009 DB03091 0.206 0.01 DB00130 0.194 0.012 DB00142 | DBMET03456 | |
| 0.002 | 0.735 | 0.055 | Squalene synthetase inhibitor | 0.055 0.013 DB02746 | DB02746 | |
| 0.004 | 0.739 | 0.236 | Prostaglandin EP2 antagonist | 0.054 0.047 DBMET01118 0.052 0.049 DBMET01117 0.09 0.022 DBMET01119 0.236 0.005 DB02746 0.127 0.013 DBMET01121 0.059 0.042 DB03091 0.073 0.031 DB00142 | DB02746 | |
| 0.003 | 0.739 | 0.054 | Purinergic P2Y12 antagonist | 0.031 0.012 DBMET01119 0.045 0.008 DBMET01121 0.036 0.01 DB03091 0.054 0.006 DB00142 | DB00142 | |
| 0.003 | 0.743 | 0.079 | Integrin alphaVbeta1 antagonist | 0.02 0.012 DBMET01119 0.029 0.006 DBMET01120 0.052 0.004 DBMET01121 0.024 0.009 DB03091 0.035 0.005 DB00130 0.079 0.004 DB00142 | DB00142 | |
| 0.012 | 0.753 | 0.065 | Factor IXa inhibitor | 0.058 0.028 DBMET03456 0.061 0.026 DBMET01120 0.065 0.023 DB02746 | DB02746 | |
| 0.008 | 0.758 | 0.368 | Hypolipemic | 0.168 0.119 DBMET03456 0.178 0.111 DBMET01117 0.368 0.031 DB02746 0.191 0.101 DBMET01121 0.195 0.098 DB00142 | DB02746 | |
| 0.01 | 0.766 | 0.174 | Streptokinase A inhibitor | 0.174 0.151 DB02746 | DB02746 | |
| 0.002 | 0.76 | 0.09 | Retinoic acid receptor antagonist | 0.09 0.003 DB02746 | DB02746 | |
| 0.005 | 0.763 | 0.127 | CDC25A inhibitor | 0.127 0.017 DB02746 0.074 0.051 DBMET01121 0.066 0.065 DB00142 | DB02746 | |
| 0.017 | 0.779 | 0.282 | Toll-Like receptor 7 agonist | 0.224 0.173 DBMET01121 0.282 0.122 DB00142 | DB00142 | |
| 0.021 | 0.784 | 0.533 | Hypoglycemic | 0.533 0.013 DBMET03456 0.167 0.152 DBMET01117 0.262 0.07 DBMET01119 0.263 0.069 DBMET01120 0.429 0.023 DB02746 0.327 0.044 DBMET01121 0.305 0.051 DB03091 0.293 0.055 DB00130 0.395 0.028 DB00142 | DBMET03456 | |
| 0.006 | 0.77 | 0.203 | Lipid peroxidase inhibitor | 0.203 0.04 DBMET03456 0.134 0.08 DB02746 0.124 0.09 DB03091 0.151 0.068 DB00130 0.182 0.049 DB00142 | DBMET03456 | |
| 0.003 | 0.769 | 0.039 | HMG CoA reductase inhibitor | 0.032 0.03 DBMET01117 0.032 0.03 DB03091 0.039 0.016 DB00142 | DB00142 | |
| 0.015 | 0.787 | 0.326 | Toll-Like receptor agonist | 0.241 0.157 DBMET01121 0.326 0.095 DB00142 | DB00142 | |
| 0.003 | 0.778 | 0.045 | Retinoid X gamma receptor antagonist | 0.045 0.004 DB02746 0.026 0.022 DBMET01121 | DB02746 | |
| 0.002 | 0.781 | 0.015 | Thyroid hormone alpha antagonist | 0.015 0.012 DB00142 | DB00142 | |
| 0.005 | 0.789 | 0.1 | Maillard reaction inhibitor | 0.053 0.04 DBMET01119 0.061 0.034 DBMET01120 0.098 0.018 DB02746 0.084 0.023 DB03091 0.094 0.019 DB00130 0.1 0.017 DB00142 | DB00142 | |
| 0.005 | 0.794 | 0.057 | Guanylate cyclase stimulant | 0.057 0.015 DB02746 | DB02746 | |
| 0.004 | 0.793 | 0.352 | Prostaglandin E2 antagonist | 0.052 0.034 DBMET01118 0.074 0.022 DBMET01119 0.352 0.004 DB02746 0.122 0.011 DBMET01121 | DB02746 | |
| 0.012 | 0.802 | 0.059 | Vanilloid 2 antagonist | 0.059 0.025 DB00130 | DB00130 | |
| 0.021 | 0.822 | 0.175 | Transcription factor NF kappa B stimulant | 0.106 0.033 DBMET03456 0.131 0.021 DBMET01119 0.112 0.029 DBMET01120 0.086 0.058 DB02746 0.107 0.033 DBMET01121 0.175 0.012 DB03091 0.148 0.016 DB00130 0.145 0.017 DB00142 | DB03091 | |
| 0.011 | 0.819 | 0.168 | Farnesoid X receptor antagonist | 0.128 0.086 DBMET01115 0.158 0.044 DBMET01117 0.168 0.036 DB02746 0.119 0.106 DBMET01121 0.127 0.088 DB00142 | DB02746 | |
| 0.002 | 0.815 | 0.018 | Free fatty acid receptor 1 agonist | 0.018 0.012 DB00142 | DB00142 | |
| 0.004 | 0.818 | 0.244 | Purinergic P2Y14 antagonist | 0.244 0.003 DB02746 | DB02746 | |
| 0.01 | 0.824 | 0.353 | Insulin secretagoues | 0.167 0.058 DBMET03456 0.156 0.068 DBMET01119 0.163 0.062 DBMET01120 0.196 0.038 DB02746 0.215 0.029 DBMET01121 0.289 0.014 DB03091 0.225 0.025 DB00130 0.353 0.008 DB00142 | DB00142 | |
| 0.005 | 0.82 | 0.103 | Nitric oxide donor | 0.061 0.047 DBMET01119 0.062 0.045 DBMET01120 0.063 0.043 DB02746 0.066 0.039 DBMET01121 0.085 0.018 DB03091 0.097 0.01 DB00130 0.103 0.007 DB00142 | DB00142 | |
| 0 | 0.818 | 0.008 | Insulin like growth factor 3 antagonist | 0.008 0.003 DB02746 | DB02746 | |
| 0.003 | 0.828 | 0.118 | Prostacyclin antagonist | 0.048 0.014 DBMET01119 0.051 0.013 DBMET01120 0.051 0.013 DB02746 0.089 0.005 DBMET01121 0.051 0.013 DB03091 0.056 0.011 DB00130 0.118 0.004 DB00142 | DB00142 | |
| 0.003 | 0.836 | 0.019 | Factor IX inhibitor | 0.019 0.013 DBMET01116 0.019 0.013 DBMET01117 | DBMET01117 | |
| 0.002 | 0.843 | 0.053 | Leukotriene B4 receptor 2 antagonist | 0.053 0.004 DB02746 | DB02746 | |
| 0.008 | 0.85 | 0.052 | Aggrecanase 1 inhibitor | 0.041 0.024 DBMET01121 0.052 0.013 DB00142 | DB00142 | |
| 0.005 | 0.847 | 0.433 | Protein-tyrosine phosphatase inhibitor | 0.25 0.031 DBMET01116 0.123 0.11 DBMET01118 0.301 0.019 DBMET01117 0.274 0.025 DBMET01119 0.259 0.028 DBMET01120 0.433 0.007 DB02746 0.294 0.02 DBMET01121 0.217 0.041 DB03091 0.174 0.06 DB00130 0.203 0.045 DB00142 | DB02746 | |
| 0.004 | 0.85 | 0.148 | Peroxisome proliferator-activated receptor gamma agonist | 0.115 0.021 DBMET01117 0.148 0.013 DB02746 0.088 0.035 DBMET01121 0.089 0.035 DB00142 | DB02746 | |
| 0.004 | 0.852 | 0.269 | Prostaglandin antagonist | 0.047 0.043 DBMET01117 0.062 0.031 DBMET01119 0.269 0.005 DB02746 0.12 0.014 DBMET01121 0.047 0.043 DB00142 | DB02746 | |
| 0.003 | 0.854 | 0.034 | Catechol O-methyltransferase inhibitor | 0.034 0.021 DB02746 | DB02746 | |
| 0.018 | 0.869 | 0.153 | ABCA1 expression enhancer | 0.153 0.017 DB02746 | DB02746 | |
| 0.004 | 0.86 | 0.346 | Protein-tyrosine phosphatase 1B inhibitor | 0.12 0.063 DBMET01116 0.176 0.036 DBMET01117 0.203 0.028 DBMET01119 0.181 0.035 DBMET01120 0.346 0.008 DB02746 0.227 0.022 DBMET01121 0.158 0.042 DB03091 0.109 0.07 DB00130 0.148 0.046 DB00142 | DB02746 | |
| 0.003 | 0.868 | 0.046 | Peroxisome proliferator-activated receptor delta antagonist | 0.046 0.011 DB02746 0.036 0.018 DBMET01121 | DB02746 | |
| 0.009 | 0.876 | 0.154 | Potassium channel large-conductance Ca-activated activator | 0.154 0.01 DB02746 0.078 0.037 DBMET01121 0.087 0.03 DB00142 | DB02746 | |
| 0.014 | 0.892 | 0.167 | Interleukin 4 antagonist | 0.167 0.037 DB02746 0.111 0.1 DB03091 | DB02746 | |
| 0.004 | 0.899 | 0.147 | 5-Lipoxygenase inhibitor | 0.147 0.039 DB02746 | DB02746 | |
| 0.002 | 0.909 | 0.042 | Sphingosine 1-phosphate receptor 3 agonist | 0.042 0.02 DB03091 0.037 0.023 DB00142 | DB03091 | |
| 0.005 | 0.926 | 0.11 | Purinergic P2X2 antagonist | 0.11 0.025 DB02746 | DB02746 | |
| 0.002 | 0.936 | 0.089 | Leukotriene D4 antagonist | 0.089 0.006 DB02746 0.027 0.017 DBMET01121 | DB02746 | |
| 0.004 | 0.951 | 0.393 | Uric acid excretion stimulant | 0.084 0.076 DBMET01119 0.393 0.004 DB02746 0.122 0.037 DBMET01121 | DB02746 | |
| 0.002 | 0.949 | 0.062 | Leukotriene B4 receptor 1 antagonist | 0.062 0.005 DB02746 0.024 0.023 DBMET01121 0.026 0.021 DB00142 | DB02746 | |
| 0.003 | 0.954 | 0.079 | Protease activated receptor antagonist | 0.069 0.035 DBMET01119 0.079 0.025 DB03091 | DB03091 | |
| 0.004 | 0.958 | 0.213 | Leukotriene synthesis inhibitor | 0.213 0.005 DB02746 0.068 0.046 DBMET01121 | DB02746 | |
| 0.002 | 0.961 | 0.131 | Prostaglandin EP1 antagonist | 0.131 0.004 DB02746 | DB02746 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |